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II. Abstract 
This thesis is composed of two parts: Part 1 reports the design and synthesis of 
magnetic nanoparticle-DNA conjugates for DNA and ECOR-I detection. Part 2 
reports the studies on the synthesis of Ag nanomaterials and evaluation of their 
antimicrobial properties.  
 
Part I  
The ability of ultrasensitive detection of specific genes and discrimination of disease 
related single nucleotide polymorphisms (SNPs) is important for biomedical research 
and clinical disease diagnosis. Herein, we report an ultrasensitive approach for label-
free detection and discrimination of full-match target-DNA from its cancer related 
SNPs by combining magnetic nanoparticle (MNP) capture and poly-enzyme 
nanobead signal amplification. It uses a MNP linked capture-DNA and a biotinylated 
signal-DNA to sandwich the target followed by ligation to offer high SNP 
discrimination: only the perfect-match target-DNA yields a MNP covalently linked 
biotinylated signal-DNA for subsequent binding to a neutravidin-horseradish 
peroxidase conjugate (NAV-HRP) and signal amplification. The use of polymer 
nanobeads each tagged with thousands of copies of HRPs greatly improves the 
signal amplification power, allowing for detection of 10 aM target-DNA with a large 
dynamic range of 5 orders of magnitude (0.01-1000 fM). Moreover, this sensor also 
offers excellent signal discrimination between the perfect-match gene and its cancer-
related SNPs and can positively detect 1 fM perfect-match target-DNA in the 
presence of 100 fold excess of co-existing SNPs. Furthermore, it works robustly in 
clinical relevant media (e.g. 10% human serum) and gives almost identical SNP 
discrimination as that in clean buffers. This ultrasensitive SNP sensor appears to 
have excellent potential for rapid detection and diagnosis of genetic diseases.  
 
This study also reports the design of a MNP-DNAss-HRP nanoprobe for the label-free 
detection of DNA and ECOR-I. The Fe3O4 MNP were prepared by thermal 
decomposition and coated with silica by the reverse micelle method yielding core-
shell nanoparticles. These silica coated MNP were modified with amino groups for 
further conjugation with DNA. In Design-1, the capture DNA contain DBCO and biotin 
group at the 5’ and 3’ end respectively. The capture DNA was linked to the amino 
modified MNP through copper free click chemistry approach. The NAV-HRP was 
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linked to the DNA strands through biotin-strepatividin interaction. The MNP-DNA 
conjugates were further incubated with NHS-PEG~17-OCH3 to cap unreacted amines. 
In Design-2, the capture DNA also contain DBCO group at 5’ end but a thiol (-SH) 
group at 3’ end. The capture DNA strand was linked to MNP and the unreacted 
surface amines were blocked following the same strategy for Design-1. Incubation 
with maleimide-HRP led to the covalent linking of the enzyme to the DNA strands. 
The MNP-DNAss-HRP nanoprobes and target DNA are hybridized and the resulting 
double strand DNA contains specific sequence that is recognized and cleaved by 
ECOR-I. This releases thousands of HRP enzyme to the solution which in turn can 
catalyse a colourimetric reaction. Using Design-2, the optimal incubation temperature 
was 30 °C and 1 hour incubation time with ECOR-I. This approach can detect 10 
U·mL-1 of ECOR-I and 1 nm of target DNA.  
 
Part 2  
 
Silver nanomaterials have been widely utilized for antimicrobial applications. Silver 
nanoparticles (Ag NPs) have been used in many biomedical and environmental 
applications for many years. Interestingly, silver nanoclusters (Ag NCs) have 
emerged as a new class of silver nanomaterials and currently being investigated for 
its antibacterial properties. In this study, we report the antibacterial properties of Ag 
NPs and NCs that were synthesized using the same protocol and capped with the 
same dihydrolipoic acid (DHLA) based ligands against S. aureus and E. coli. These 
ligands were DHLA-EGn-NH2 (n=3,12), DHLA-PEGn-OCH3 (n ~17, 23) and DHLA-
zwitterion. The Ag NC-DHLA and Ag NC-PEG~23-OCH3 inhibited S. aureus and E. 
coli with MIC results of 128, 64 and 64, 128 μg·mL-1 respectively. The Ag NPs were 
observed to be more effective antimicrobial agents as revealed by MIC results. The 
5.7 nm Ag NP-zwitterion is the most potent antibacterial agent among all the Ag NPs 
tested with an MIC of 8 μg·mL-1 for both bacterial strains. This study demonstrated, 
for the first time, that the antibacterial properties of silver nanomaterials differ 
significantly when coated with different ligands. Moreover, surface coating and 
charge are most likely the key factors that control the antimicrobial efficacy of Ag NCs 
and NPs. 
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VII. List of Abbreviations 
APTES (3-aminopropyl)triethoxysilane 
ABNC Active but not culturable 
Ag NPs Silver nanoparticles 
aM Attomolar 
Au NPs Gold nanoparticles 
avidin-HRP Avidin-Horse Raddis Peroxidase 
Bbc-Au NP Gold nanoaprticles tagged with biobarcode dnas  
BEAM Beads, Emulsion, Amplification, and Magnetics 
BSA Bovine serum albumin 
CCLR Enzyme-free click chemical ligation reaction 
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Dhs Hydrodynamic diameter (nm) 
DHLA Dihydrolipoic acid 
DLS Dynamic light scattering 
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dNTPs Deoxyribonucleotide triphosphate 
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GMR Giant magnetoresistive 
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HAADF  High annular dark field  
HABA (4'-hydroxyazobenzene-2-carboxylic acid) 
HCR Hybridization chain reaction 
HIV Human immunodeficieny virus  
HOMO-LUMO 
 
Highest occupied molecular orbital- lowest unnocupied 
molecular orbital 
HRP Horseradish peroxidase  
1H-NMR  Proton numclear magentic resosnance spectroscopy 
ICP-MS Inducitvely coupled plasma - Mass spectrometry 
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MNBs Magnetic beads  
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Silica–modified magnetic nanoparticle treated with 350 
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MNP -NH2- 500 
 
Silica–modified magnetic nanoparticle treated with 500 
ml of APTES 
MNP -NH2- 750 
 
Silica–modified magnetic nanoparticle treated with 750 
ml of APTES 
MNP -NH2-1000 
 
Silica–modified magnetic nanoparticle treated with 
1000 ml of APTES 
MNP-SiO2 Silica modified magnetic nanoparticle 
MS Mass spectrometry 
MW Molecular weight 
NAV Neutravidin 
NAv-HRP Neutravidin- horse raddish proxidase 
NHS N-hydorxyssuccinamide 
PB Polymer bead 
PBS Phosphate-buffered saline PBS 
PCR Polymerase chain reaction 
PDDA Poly(diallyldimethyl) ammonium chloride 
PMAO Poly-(maleicanhydride-alt-1-octadecene 
PMAO-PEG 
Amphiphilic polymer containing polyethylene glycol- 
azide units 
PPh3 Triphenylphosphine 
QD Quantum dots 
qRT-PCR 
 
Quantitative reverse transcription polymerase chain 
reaction 
QY Quantum yield 
RCA Rolling circle amplification 
RNA Ribonucleic acid 
SERS Surface enhanced Raman spectroscopy 




SNPs Single-nucleotide polymorphism  
SPR Surface palsmon resonance 
SPR Surface plasmon resonance 
SPRI Surface plasmon resosnance imaging 
TA Thiocitc acid 
TEM Transmission electron microscopy 
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THF Tetrahydrofuran 
THMP Triple-helix magnetic probe 
UV Ultraviolet 
UV-Vis Ultraviolet-visible 
v/v Volume by volume concentration  
VSM Vibrating sample magnetometer 
WOT Without target, control expriment 
WS2-AB Tungsten disulphide/acetylene black 
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VIII. Glossary 
Allelic - Pertaining to allele which is a possible forms of a gene. An allele can be 
dominant or recessive. 
 
Codon- A sequence of three DNA or RNA nucleotides that corresponds with a 
specific amino acid or stop signal during protein synthesis. 
 
KRAS- First identified as oncogene in Kirsten RAt Sarcoma virus. A gene that acts 
as a switch (on/off) in cell signaling. The normal gene control cellular proliferation but 
mutation can cause cells to continuously proliferate leading into cancer. 
 
Multiplexing- The ability to detect several targets simultaneously in clinical 
diagnostics.  
 
Mutation- Permanent alteration of the nucleotide sequence of the genome of an 
organism. 
 
Nicked- A single-stranded cut or break in a DNA molecule.  A single-stranded break 
in a double stranded DNA at which one or more nucleotide are missing or there is a 
break in the phosphodiester bond between two adjacent nucleotides on one strand of 
the DNA duplex.  
 
Plasmonic- The study of the interaction between electromagnetic field and free 
electrons in a metal nanoparticles. The free electrons in the metal nanoparticle 
surface can be excited by the electric component of light to have collective 
oscillations.  
 
Polymorphism- A DNA sequence variation that is common in the population. 
 
Somatic- Refers to the cells in the body in contrast to the germ line cells (sperm and 
egg). 
 
Somatic mutation- An alteration in DNA that occurs after conception. These 
alterations can (but do not always) cause cancer or other diseases 
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Streptavidin  - tetrameric protein purified from the bacterium streptomyces avidinii 
that have an extraordinarily high affinity for biotin (Kd on the order of ≈10−14 mol/L). 
 
Via - refers to “by means of...” 
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Chapter 1  
Nano-enabled Bioanalytical Approaches to Ultrasensitive 




The completion of the human genome project in 20031 has led to several important 
discoveries relating to structure of the human genome: it is characterized by 
variations in DNA nucleotide sequences of one or more bases in genes of the same 
population.2, 3 These variations in DNA impart certain phenotypic traits that 
distinguish an organism from another. If such variations occur in greater than one 
percent of the human population, they are collectively referred to as polymorphisms. 
On the other hand, variations occurring in less than one percent of the population are 
often termed as “mutations” which are associated with a detrimental phenotype such 
as those linked with various cases of cancer.3 The most common sequence variation 
occurring in the human genome is the stable substitution of a single nucleotide, also 
known as single nucleotide polymorphisms (SNPs). More than 10 million SNPs are 
estimated to distribute across the whole human genome at an frequency of at least 
one nucleotide every 1000 base pairs with apparent regional differences.4, 5 While 
most SNPs do not alter the metabolic function and expression levels of a gene, some 
do result in differences in predisposition to certain heritable diseases,6-8 response to 
drugs (pharmacogenetics),9, 10 and perception of pain. 11 Several studies have shown 
that SNPs are closely associated with many types of cancer and presupposes the 
risk of cancer progression.12-15 For instance, it was observed that single point 
mutations in the KRAS gene at codons 12, 13, and 61 are associated with the 
development of certain pancreatic14 and lung cancers.15 Moreover, numerous 
detrimental and inheritable diseases such as diabetes,7  vascular diseases,16 some 
forms of neurodegenerative and mental illness17, 18 have also been linked to SNPs. 
On the other hand, microRNAs (miRNAs) which are 17–24 base short RNA 
molecules, play important roles in numerous cellular processes such as 
differentiation, cellular growth, and apoptosis. Point mutations in miRNAs have been 
- 2 - 
associated with several forms of cancers, affecting the cancer risk and treatment 
efficacy in some non-small cell lung cancer patients.19, 20 These are just a few 
examples which highlight the association of SNPs to human diseases and treatment 
responses, and demonstrate the tremendous value of SNPs in biomedical research. 
Indeed, SNPs are considered as an important class of biomarkers that could allow 
scientists and medical practitioners to better understand certain diseases, develop 
novel non-invasive diagnostics tools and ultimately allow for a more personalized 
approach to disease treatment and therapies.  
 
The most established techniques for point mutation detections in DNA have largely 
relied on the amplification power of the polymerase chain reaction (PCR) coupled 
with quantitative fluorescence detection and/or DNA sequencing techniques such as 
pyro-/next generation sequencing of the amplified product. Although highly sensitive 
and widely used, such methods can sometimes introduce errors during the PCR 
amplification process which is sensitive to contaminations and amplification bias, and 
hence may affect diagnostic accuracy21, 22. PCR is also often regarded as labour-
intensive and time-consuming, making it unsuitable for rapid, point-of-care 
diagnostics. Moreover, it also requires an expensive thermal cycler and thereby the 
cost per analysis might be high for developing countries. These limitations have 
largely hampered the wide use of PCR for rapid, on-site diagnostics. In the case of 
point mutation detections involving miRNAs, the real-time quantitative reverse 
transcription polymerase chain reaction (qRT-PCR) is often the method of choice due 
to its high sensitivity. However, it also suffers several drawbacks which include 
complex analytical processes, requiring reverse transcription and multiple primer 
design and fluorophore labelled reporters, and the need of precise temperature 
control. 23 Unsurprisingly, many of the recent developments have focused on 
developing PCR-free alternatives in SNP biosensing. The reliable detection of low 
abundance specific SNPs without PCR pre-amplification represents an extremely 
challenging, albeit exciting research area of the bioanalytical science.  
 
Recently, the BEAMing Digital PCR method shown in Figure 1-1 named after its 
principal components (i.e. Beads, Emulsion, Amplification and Magnetics) was 
developed for detecting genetic variations24. In this method, biotinylated 
oligonucleotide primers are bound to streptavidin coated magnetic microbeads .  
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Figure 1-1. Schematic illustration of the processes in BEAMing. Step 1: 
streptavidin coated magnetic bead are bound to the biotinylated 
oligonucleotide. Step 2: Formation of microemulsions containing all the 
components for PCR and oligonucleotide bound magnetic beads, Step 3: 
Emulsion based PCR  thermal cycling. Step 4: Emulsions are broken and 
magnetic beads are collected by a magnet and purified, Step 5: After 
denaturation, the magnetic beads are incubated with fluorescent-tagged 
probes specific for wild-type or for a specific point mutation to hybridize to 
the amplified DNA on MNP. Step 6: Flow cytometry of the beads to detect the 
fluorescent tag and quantify the beads containing mutated DNA. Reprinted 
from reference 24 
 
In the next step, an aqueous mixture containing all the components for conventional 
PCR and primer-bound magnetic beads are stirred together with an oil/detergent 
mixture to create micro emulsions, ensuring each emulsion containing no more than  
one bead and one target DNA. These micro emulsions are temperature-cycled for a 
defined period of time which produce amplified DNA strands conjugated to the 
microbeads and emulsions are subsequently broken.  The magnetic microbeads are 
separated from the rest of the mixture using a magnet. After denaturation, the beads 
are incubated again with oligonucleotides that can distinguish between the 
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sequences of the different kinds of templates. Fluorescently labelled DNA are used 
to label the bound probes via hybridisation. This step renders the beads containing 
PCR product as either red or green after appropriate laser excitation. Finally, the red 
and green beads are analysed using flow cytometry where the proportion mutation 
can be quantified. This method allows the identification and quantification of allelic 
variations. Moreover, the DNA sample can be recovered from the flow cytometer 
for subsequent analysis. BEAming is extremely sensitive (detection down to 0.01%  
mutation level) but this  method is expensive and involves a number of  complex 
steps 25. 
 
Over the past few years, enormous efforts have been directed towards the 
development of novel, ultrasensitive PCR-free SNP assays and a number of 
techniques have been developed 22, 26-29. The detection and quantification of known 
SNPs are primarily based on the specificity of target hybridization 30, 31 and enzyme 
discriminations, such as specific enzymatic cleavage, 32 and single base primer 
extension 33, 34. Of particular interest in the early stages of PCR-free SNP biosensing 
development has been based on using water-soluble, cationic conjugated polymers 
(CCPs) as fluorescence transducers. For example, the Leclerc group 35, 36 has 
pioneered and developed DNA detection based on the electrostatic attraction 
between a cationic polythiophene and DNA. The colour and fluorescence changes of 
the polymer in the presence of single stranded and double-stranded DNAs were used 
as the basis for biosensing. They have reported the first detection of SNPs directly 
from clinical samples without the need of DNA pre-amplification with an impressive 
detection limit of 3 zeptomolar. The Bazan and Jaeger groups have also detected 
specific DNA sequences via CCP sensitised Förster resonance energy transfer 
(FRET) to dye-labelled probes. 37, 38 The electrostatic attraction between the cationic 
CCPs and the anionic DNAs leads to short distance donor (CCP)–acceptor (DNA 
dye-label), hence strong FRET. 39 A substantive review of such work has already 
been provided by Swager et al. 40 and hence this will not be main topic here.  
 
Recently, the use of various nanomaterials has provided the capability of ultra-
sensitivity and high specificity in SNP detection. Nanomaterials have been well-
studied primarily because of their unique, size dependent physical and chemical 
properties. In terms of biosensing applications, such useful properties include the 
extremely large surface area, tuneable surface chemical composition that allow easy 
and controlled immobilization of stable bioreceptors for efficient transduction of target 
binding into strong readout signals. These properties are advantageous for achieving 
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ultrasensitivities, allowing easy integration into miniaturized devices ushering an era 
of next generation cost-effective SNP diagnostics. Nanomaterials such as metallic 
nanoparticles (NPs),41-46,47 quantum dots (QDs), 48-51 magnetic nanoparticles 
(MNPs),51-56 and carbon based nanomaterials 57 have been combined with 
biomolecules such as enzymes, oligonucleotides and DNAzymes to develop sensors 
for detection and quantification of cancer-specific SNPs. Such nanomaterial-based 
SNP assays have been coupled with a number of different readout strategies, 
including colorimetry, fluorimetry, surface enhanced Raman spectroscopy (SERS), 
electrochemical and electrochemiluminescence etc. For example, Boudreau and 
colleagues recently reported the use of FRET-based CCP transducers by combining 
them with highly fluorescent core–shell nanoparticles. The Ag nanoparticle core was 
used to amplify the optical signal generated upon target recognition. This plasmonic 
enhancement resulted to the direct detection of unamplified target nucleic acid at 
femtomolar concentration regime. 58-60  Table 1-1 summarizes some of the recently 
developed ultrasensitive SNP assays using different nanomaterials coupled with 
different probe and/or signal amplification strategies.  
 
The sensitivities and specificities of these assays are already comparable to, or even 
surpass those of many PCR based techniques, demonstrating the high suitability of 
nanomaterials for ultrasensitive SNP detection. Despite significant developments, it 
is important to consider some other burgeoning challenges in clinical diagnosis, 
particularly in the quantification of extremely low abundant SNPs in an overwhelming 
background of wild-type genes in clinical settings. Moreover, the ability of 
simultaneous detection of multiple biomarker targets is also important for high 
diagnostic accuracy because “no tumour marker identified to date is sufficiently 
sensitive or specific to be used on its own to screen for cancer”.61 The practical 
importance of these relies on the fact that most cancer cases are only diagnosed in 
the late stage and when the chances of patient survival are already slim. As a result, 
early diagnosis is of paramount importance for improving the survival and prognosis 
of cancer patients. All these necessitate the development of ultrasensitive assays 
with multiplexing capability that can detect the extremely low concentrations of 
cancer-specific SNPs in clinically media.  
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Table 1-1: Comparison of the sensing performance of some ultrasensitive 
nanomaterial based SNP detection assays. PCR: polymerase chain reaction, 
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A survey of literature shows that three main approaches have been widely employed 
to improve the assay detection limits that we group into three main categories: target, 
probe, and signal amplification. Among these, target amplification is mainly achieved 
via enzyme-mediated replication of target nucleic acid sequences, leading to ca. 108–
109 fold amplification of target concentration to make it high enough to be readily 
detected by traditional approaches such as gel electrophoresis 22. An excellent 
example here is the well-established PCR. More recently, isothermal target (DNA) 
amplification strategies have also been developed and displayed sensitivities 
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comparable to that of the PCR 26-29, 70. These methods do not need a thermal cycler, 
making them cost effective, simple to use and potentially suitable for point-of-care 
diagnostics 71.  In contrast, probe amplification does not change the copy number of 
the target (DNA), instead the probe sequence which is complementary to the target 
is amplified and detected. Signal amplification is to amplify the analytical signal 
generated by each labelled or unlabelled target so as to increase the assay 
sensitivity.   
 
In this chapter, some of the most recent advances in the field of nanomaterial-based 
SNP detection will be discussed, with a particular focus on those techniques capable 
of detecting and quantifying extremely low target concentrations, down to the 
attomolar regimes or below. Given the high specificity, the hybridization-based 
method remains one of the most popular methods for nanomaterial based SNP 
assays. In general, the ultra-sensitivity of these assays has been achieved through 
one of the following five different strategies, (i) nanoparticle assisted PCR target 
amplification, (ii) nanoparticle assisted probe amplification, (iii) target recycling 
coupled with probe and/or signal amplification, (iv) tandem amplification coupled with 
signal catalytic cascades, and (v) nanomaterial enhanced signal amplification. Each 
of these classes will be discussed with a focus on the assay sensitivity and comment 
on their applicability to real biological matrices. Moreover, a critical categorization of 
such approaches on the basis of different amplification strategies is proposed. 
 
1.2 Nanoparticle assisted PCR target amplification strategy 
An essential first step in this approach is to pre-amplify the extremely low abundant 
SNP target into sufficiently high number of copies so that it can be readily detected 
by conventional methods. Given its extremely powerful exponential amplification 
power, it is unsurprising that PCR-based SNP biosensing assays have high 
sensitivities. 72 In particular, the incorporation of plasmonic nanomaterials such as Au 
and Ag nanoparticles has been recently combined with PCR pre-amplification of the 
target DNA,  leading to unprecedented sensitivities. For example, Kotov and 
colleagues have reported an unexpected chirality of bridged metallic nanoparticle 
dimers and have exploited this in ultrasensitive biosensing. They have prepared 
different sized Au and Ag NPs and functionalized them with specific antibodies so 
that they can sandwich bind the specific target protein (e.g. prostate specific antigen 
PSA, a prostate cancer marker) and assemble into hetero-nanoparticle dimers. 
These biomolecule bridged NP heterodimers are chiral, leading to an observable 
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change in circular dichroism (CD) spectra over 350–600 nm region. The authors 
found that this assay was extremely sensitive, capable to detecting PSA down to the 
sub-aM level with an extremely impressive detection limit (DL) of 1.5 × 10−20 M and 
a linear dynamic range of ∼3 orders of magnitude. Such a highly impressive 
sensitivity has been attributed to plasmonic enhancement of intrinsic chirality of 
biomolecules, strong optical coupling of photons with twisted NP heterodimers, and 
bisignate nature of the CD spectra. 73, 74 This assay has been recently modified to suit 
the detection of ultralow concentrations of DNA 62 by applying a PCR amplification of 
the dsDNA with primers linked to Au NPs (25 nm Au NP-linked forward primer and 
10 nm Au NP-linked reverse primer) in the presence of Taq polymerase and dNTPs 
as shown in Figure 1-2.  The DNA-bridged Au NP heterodimers displayed circular 
dichroism (CD) bands at 260 and 525 nm, attributed to the chiral secondary 
structures of duplex DNA and the chiral NP dimers, respectively. These dimers 
displayed unexpected chirality due to the ellipsoidal shape of the NPs and a scissor-
like configuration with two long NP axes forming a dihedral angle of 10°. Coating of 
the Au NP dimers with Ag or Au are found to affect their chiro-plasmonic activity: as 
the thickness of the Ag shell increased, the intensity of the CD bands also increased 
and shifted from 525 to 418 nm. In the case of Au coating, increasing the Au shell 
thickness resulted in a colour change of the dispersion from pink to purple and the 
CD bands exhibited a 61 nm red shift. 
 
More importantly, Au coating of DNA bridged Au NP dimers gave fairly narrow 
spectra with high optical anisotropy. Optimization of assay parameters such as 
specific design of primers and number of PCR cycles has yielded ultrasensitive DNA 
assay with a linear dynamic range spanning 7 orders of magnitude (from 160 zM to 
1.6 pM) and an extremely low DL of 17 zM. Currently, this method reported the 
highest sensitivity for DNA detection using nanomaterials based sensing platforms, 
and hence appears to have good potential for genetic based early diagnostic 
applications. Despite such great sensitivity, the applicability of this assay towards the 
detection and discrimination of specific SNP’s in complex media such as the wild-
type DNA background has yet to be demonstrated. Moreover, given the fact that this 
assay requires PCR pre-amplification, it is less well-suited to applications that require 
rapid results such as the point-of-care diagnostics. 
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1.3 Nanoparticle assisted probe amplification strategy 
Rolling circle amplification (RCA) 75-77 and ligase chain reaction (LCR) 78-80 are two of 
the most extensively used probe amplification strategies in SNP detections. Recently, 
nanomaterials have been combined with these probe amplification assays, leading 
 
Figure 1-2. Chiroplasmonic core–shell DNA-bridged nanoparticle 
heterodimers. (A) Schematic illustration of the PCR based assembly of Au 
nanoparticle dimers. (B) Deposition of Au and Ag on the DNA-bridged Au 
nanoparticle dimers leading to single and multiple core–shell heterodimers. 
(C) CD and UV–vis spectra of Au coated heterodimers with DNA 
concentrations varying from 16 zM to 1.6 pM. (D) Calibration curve relating 
the intensity of CD bands of Au coated heterodimers and the concentration 
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to further improvements in detection limits. These assays typically use a 
complementary oligonucleotide capture probe chemically linked to an Au 
nanoparticle, a quantum dot, or a magnetic nanoparticle to directly interact with their 
specific analytes, thereby amplifying molecular recognition events such as DNA 
hybridization. In addition, magnetic nanoparticles have been further used for target 
capture, enrichment and separation which can further enhance the assay sensitivity. 
Unlike PCR which requires thermal cycles, RCA is an isothermal probe amplification 
strategy using a single-stranded DNA as a padlock probe as shown in Figure 1-3.  
The 5′-(phosphate modified) and 3′-terminal fragments of the padlock probe are 
specifically designed to be complementary to the target DNA. Hybridisation of the 
target to the padlock probe then brings its 5′- and 3′-terminus close to each other, 
forming a nicked circle which can be covalently ligated together by a DNA ligase if 
the padlock and target sequences are fully-matched, forming a circularized padlock 
probe. The circularised padlock probe is then amplified by a ϕ29 polymerase in the 
presence of dNTP’s, producing a greatly elongated single-stranded DNA containing 
numerous copies of repeat tandem sequence units complementary to the circular 
padlock probe. However, the presence of a single-base mismatch at the nicked 
target/padlock duplex probe can prevent the specific ligation and formation of the 
circular padlock probe, and therefore no RCA amplification (Figure 1-3 (B)). The 
stringent requirement of full sequence complementary between the padlock and 
target to form the ligated circular padlock probe allows the RCA strategy to have 
excellent specificity for SNP detection.44, 81  In summary, RCA has two fold benefits, 
first, is the simple reaction mechanism which requires only a single primer and a 
productive enzyme. Second, the reaction is carried out in isothermal conditions, thus, 
requiring simple laboratory equipment. Incubation temperature in RCA are usually 
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Figure 1-3. Schematic principle of the rolling cycle amplification and SNP 
discrimination. (A) Hybridization of the perfect-match target DNA to 
circular padlock probe leads to covalent ligation, producing a target DNA 
hybridized circular probe where in the presence of phi29 polymerase and 
dNTP’s, the target serves as primer to initiate the circular extension of long 
single-stranded DNA with repeat sequence complementary to the padlock 
probe. (B) The presence of a single base mismatch between the target DNA 
to the padlock probe leads to no ligation and hence no amplification. 
 
Similar to PCR, the ligase chain reaction (LCR) also requires multiple thermal cycles 
to achieve specific ligation of two short DNA probes catalysed by a DNA ligase into 
a single strand templated by a full-match DNA target. 26-29 In a typical SNP assay, 
LCR uses two pairs of probes each containing two short complementary 
oligonucleotides, but the overall sequence is complementary to the target DNA 
sequence as shown in Figure 1-4.  
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Figure 1-4. Schematic principle of the ligase chain reaction (LCR) based DNA 
amplification strategy. Each of the two DNA strands in the duplex target serves 
as a template to ligate its respective two short DNA strands, leading to 
doubling of the ligated product in each cycle and hence an exponential 
amplification of the target DNA. The amplified target sequences can then be 
detected by using their specific and tags. 
 
After thermal denaturation followed by annealing, a pair of the probes are hybridized 
to one of the denatured target DNA strand. They are subsequently ligated by a DNA 
ligase if the probes and target sequences are fully complementary at the nick site. 
On the other hand, the presence of single base mismatch at the nick site can prevent 
specific ligation, allowing for the LCR to have high SNP selectivity. After the first 
ligation round, each ligated product can then function as a new template to ligate 
further probes in the following thermal cycles. Repeating the thermal cycles thus 
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leads to an exponential increase of the ligated probes. Ligation reactions have better 
single-base mismatch discriminatory ability than primer extension methods, making 
LCR more specific for SNP detection than PCR based methods. 26  
 
A particularly attractive SNP assay has been the colorimetric sensing using Au NPs 
because of their extremely strong surface plasmon resonance (SPR) absorption at 
∼520 nm (ε > 109 M−1 cm−1 for a 20 nm Au NP, 4–5 orders of magnitudes stronger 
than typical organic dyes), making it strongly coloured even at sub-nM 
concentrations. Moreover, its SPR band is also sensitive to aggregation, isolated Au 
NPs appear red but aggregated ones are blue or purple. The resulting colour change 
is distinct and clearly visible by the naked eye.29 Here specific DNA targets that can 
induce the aggregation of Au NPs have been used to detect SNPs, taking the full 
advantage of the very sharp melting transition for the sandwich duplex formed 
between the target DNA and a pair of probe DNA (with sequence complementary to 
each half of the DNA target) modified Au NPs. The sharp melting transition means a 
single-base mismatch between the target and probes can be distinguished due to 
their slightly different thermal stability. This leads to distinct colour changes at 
elevated temperatures that can be exploited for SNP detection. 82, 83 Combined with 
various amplification strategies, such assays have achieved pretty low detection 
limits, down to the femtomolar region. More recently, LCR has been combined with 
Au NP for ultrasensitive colorimetric SNP detection by the Gao group. 42 The assay 
involves the real time ligation of oligonucleotide coated Au NPs templated by the 
complementary SNP target as shown in Figure 1-5 (A).  
 
In each LCR cycle, there is an increasing amount of Au NPs being ligated that are 
subsequently used to template the ligation of further Au NPs, leading to an 
exponential increase in the amount of covalently linked Au NPs. Since the SPR band 
of Au NPs is sensitive to NP assembly, this resulted in a colour change that can be 
directly monitored by UV-vis as shown in Figure 1-5 (B). This assay has an 
impressive linear dynamic range of 6 orders of magnitude and is capable of detecting 
specific DNA targets down to 20 aM. This assay also has high selectivity: it can 
specifically detect the wild-type (WT) KRAS gene in the presence of large excesses 
of genomic DNAs even at 1:100 000 (KRAS: genomic DNA) base pair ratios when 
readings were taken at 90°C. At this temperature, all non-chemically ligated DNA–
Au NP conjugates were dislodged, leaving only the covalently ligated Au NPs in the 
solution. Thus, the incorporation of ligation allowed for easy elimination of 
interferences from coexisting DNA, giving a greatly reduced background.  







Figure 1-5. (A) Schematic illustration of the real-time Au NP mediated LCR 
assay. (B) UV–Vis spectra of the solution containing 100 fM target DNA and 
10 nM CP-coated Au NPs (CP refers to the  trithiolated capture probes) during 
the LCR process. Inset: colour of solution after addition of 0, 5, and 50 nM 




- 15 - 
This assay has been further employed to detect the WT-KRAS in the presence of 
KRAS single point mutants, yielding an impressive SNP selectivity factor of 2000. 
This assay can be used as an efficient approach for detecting specific mutant DNAs 
by simply redesigning the sequences of capture probes and signal probes, and thus 
has great potential for ultrasensitive detection of various disease-related SNPs.  
 
Despite such great promises, the relatively long assay time and the requirement of 
multiple thermal cycles may limit its use in rapid, point-of-care applications. Although 
the LCR strategy appears to be a highly attractive alternative to PCR amplification, 
an apparent weakness has been its low amplification efficiency when being combined 
with nanomaterials. This is due to the restricted accessibility of the ligases to the 
ligation site in oligonucleotide modified Au NPs. In an attempt to overcome the 
limitations of conventional LCR, a process called enzyme-free click chemical ligation 
reaction (CCLR) that involves Au NP and magnetic bead was developed by Kato and 
colleagues 63 as shown in  Figure 1-6 (A). Unlike the earlier cross-linked Au NP 
systems, this assay does not require the use of ligases to carry out LCR or the 
formation of large assemblies. The CCLR method uses an azide-containing DNA 
modified Au NP and a dibenzocyclooctyne-containing biotin-DNA probe. Sandwich 
hybridization of the target DNA (RNA) with the azide-DNA modified Au NP and biotin-
DNA lead to enzyme-free covalent ligation via the copper free click chemistry, 
producing biotin-ligated Au NPs. Repeating the thermal cycles lead to the biotin-
ligated Au NPs being exponentially amplified, which are then captured by using 
streptavidin-modified magnetic beads. After magnetic separation, the strong 
absorption of the Au NP can be used to detect and quantify the target DNA (RNA). 
Using this assay strategy, a DNA sequence associated with the hepatitis A virus Vall 
7 polyprotein gene (HAV) has been detected at a concentration as low as 50 zM with 
a linear dynamic range of 3 orders of magnitude as shown in Figure 1-6 (B), which 
is highly impressive. However, it should be noted that the absolute signal difference 
throughout the whole dynamic range was relatively small, being only ∼30% (e.g. 
increased from ∼1.0 to 1.3), which can significantly limit its diagnosis accuracy. 
 
The rather small signal difference is likely due to the non-specific nature of the 
copper-free click reaction: the azide and DBCO-modified DNA probes can react with 
each other to form covalent linkage even in the absence of a template DNA target, 
albeit at a slower rate, which is a drawback of this assay design. Nevertheless, this 
method can discriminate specific single point mutations, with the G-, T-, and C-Mutant 
signals being 17, 0, and 0% of that of the full-match control, respectively. This result 
- 16 - 
shows that this essay has an excellent SNP discrimination, although a more useful 
demonstration of the SNP specificity would be the ability to detect low specific target 






Figure 1-6. (A) Schematic illustration of Enzyme Free Click Chemical Ligation 
on Au nanoparticles involves the hybridization of the target DNA with an 
azide-modified Au NP (N3-AuNP), dibenzocyclooctyne-modified probe 
(DBCO-probe). (B) A plot of the A525(bk)/A525(s) ratio at different target DNA 
concentrations using 40 thermal cycles. Inset shows a photograph of the 
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Hybridization chain reaction (HCR) is a new DNA assembly technique which based 
on a chain reaction of recognition and hybridization events between two sets of 
DNA hairpin molecules 84.  More importantly, this technique offers an enzyme-free 
alternative for the rapid detection of specific DNA sequences thereby making it 
simple and cost-effective for DNA biosensor technology 85, 86. Figure 1-7 shows 
the basic reactions taking place in HCR. A single-stranded DNA initiator is added 
to a  stable mixture of two DNA hairpins, it opens a hairpin of one species, exposing 
a new single-stranded region that opens a hairpin of the other species.   
 
 
This process, in turn, exposes a single-stranded region identical to the original 
initiator. The resulting chain reaction leads to the formation of a nicked double helix 
that grows until the hairpin supply is exhausted. However, unlike PCR, HCR is a 
linear amplification technique, although research is underway to develop non-
linear HCR techniques 87-89 which could lead to the possibility of attaining a PCR-
like level of sensitivity. Recently, Shuai and colleagues 90 developed an ultrasensitive 
 
Figure 1-7. Schematic representation of HCR. In Hybridization chain reaction 
the addition of an initiator strand of DNA to the stable mixture of two 
hairpin species triggers a chain reaction of hybridization events between 
the hairpins. Reprinted from reference 84. 
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DNA biosensor by combining tungsten disulphide/acetylene black (WS2-AB) 
nanocomposite coupled with HCR. Figure 1-8 shows the design principle of the DNA 
biosensor. In their work, tungsten disulphide/acetylene black (WS2–AB) composite 
nanosheets were synthesized by a hydrothermal method. The  electrochemical DNA 
biosensor was fabricated based on the Au nanoparticles (Au NPs) and a WS2–AB 
composite modified glassy carbon electrode (GCE) to form the Au NPs/WS2–
AB/GCE. The ssDNA probe was linked to the modified electrode via an Au–S bond.  
In the presence of target DNA, the probe DNA can hybridize with target DNA on the 
electrode. After that, an auxiliary DNA (sequence complementarity to target DNA) 
hybridizes with target DNA and the two species of DNA hairpins biotin-H1 and biotin-
H2 are opened by the recognition probe, and hybridized one by one. The nicked 
double helices from hybridization chain reaction were used to immobilize Neutravidin-
horseradish peroxidase  via the strong biotin–avidin interaction, converting each 
target DNA into multiple copies of HRP for signal-amplification through the catalytic 
reaction of the H2O2 + hydroquinone system. As a 2D layered nanostructure, the as-
prepared WS2–AB displayed a large effective surface area. This allowed more 
biomolecules (capture DNA) to be immobilized at the electrode surface, which 
reduced the distance for electron transfer and ion diffusion paths between the capture 
DNA and nanomaterials. As a result, the electron transfer to the electrodes became 
easier. Under optimal conditions, the as-prepared biosensor showed a good linear 
relationship between the current value and logarithm of the target DNA concentration 
ranging from 0.001 pM - 100 pM with an LOD as low as 0.12 fM. Moreover, the 
fabricated biosensor exhibits good selectivity to differentiate the single base 
mismatched DNA sequence. However, the need to design multiple DNA probes and 
multiple steps may limit its potential for cost-effective and rapid DNA detection.  
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(A) 
 
(B)                                                           (C) 
 
Figure 1-8. (A) Schematic illustration of the working principle of DNA 
detection based on the hybridization chain reaction. (B) DPV curves 
responding to different target DNA concentrations (from a to j): 0, 1.0 x 10-
15, 1.0 x 10-14, 5.0 x 10-14, 1.0 x 10-13, 5.0 x 10-13, 1.0 x 10-12, 5.0 x 10 -12, 1.0 x 
10-11, 1.0 x 10-10 M, respectively. Inset: the relationship between the peak 
current and the negative logarithm of the target DNA concentration,  and 
(C) The specificity of the HCR-based DNA sensor hybridized to different 
target sequences: blank (PBS 7.0) (a), 1.0 x 10-11 M non-complementary 
sequence (b), 1.0 x 10-11 M three-based mismatch sequence (c), 1.0 x 10-11 
one-base mismatch sequence (d) and 1.0 x 10-11 M complementary 
sequence (e). Reprinted from reference 90. 
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1.4 Target recycling coupled with probe and/or signal 
amplification 
Target recycling is another useful strategy to amplify low copy number SNPs. In this 
strategy, the target DNA is cycled in a number of hybridization events, each time 
producing one or several copies of the complementary probe, depending on the 
approaches used. However, the linear amplification nature of target recycling has 
largely limited its detection limit to the fM regime only 56, 91. More recently, target 
recycling has been combined with other probe amplification strategies to further 
improve detection limits. A significantly higher sensitivity has been achieved by Ji and 
colleagues  49 who have designed a template enhanced hybridization process (TEHP) 
coupled with rolling cycle amplification. This assay uses a biotinylated molecular 
beacon [MB] bound to a streptavidin coated plate as the template. Hybridization of 
the target DNA and an assistant DNA to the loop region of the MB forms a “Y” shaped 
junction as shown in Figure 1-9 (A). This configuration provided a specific nucleotide 
sequence that can be nicked by a suitable endonuclease. Once released, the target 
DNA and assistant DNA initiate another round of hybridization and strand scission 
cycle. The numerous MB fragments left in the plate then served as primers for the 
RCA process to produce thousands of repeat oligonucleotide sequences. These 
repeated sequences then are hybridized to an oligonucleotide functionalized CdTe 
QD and separated. The QDs are then dissolved by an acid, releasing greatly 
amplified Cd2+ ions that are detected by square wave voltammetry. The combination 
of TEHP and RCA coupled with the use of QD signal tags has offered an enormous 
amplification of the DNA target, allowing for greatly increased assay sensitivity. An 
impressive sensitivity of 11 aM has been attained together with a wide dynamic range 
of 6 orders of magnitude as shown in Figure 1-9 (B) and (C). This assay was also 
able to discriminate the perfect complementary DNA target against various mismatch 
targets with a discrimination ratio of 3.8, 5.7 and 6.6 fold for the single-base, three-
base mismatch and non-complementary oligonucleotides, respectively. Despite a 
high sensitivity, its SNP discrimination ratio is relatively moderate compared to other 
SNP assays, which may limit its potential for applications in real clinical samples 
where the presence of large background genomic DNAs and/or wild-type genes may 
strongly interfere the specific SNP detection. 
  




Figure 1-9 (A) Schematic illustration of the TEHP amplification strategy for 
DNA detection, (B) stripping voltammetric curves of cadmium ions 
corresponding to (left to right) 10−18, 10−17, 10−16, 10−15, 10−14, 10−13, 10−12, 
10−11, and 10−10 M of target DNA. (C) The corresponding analytical 
quantitative dynamic range. Reprinted from reference49. 
1.5 Tandem amplification schemes and signal catalytic 
cascades 
In order to achieve detections in even lower concentration regimes, several 
researchers have reported the use of tandem amplification schemes.44 64, 81 The 
combination of two amplification strategies has been deemed necessary to further 
improve the sensitivity and specificity of SNP detection. Moreover, this strategy can 
overcome the low amplification efficiency of a single amplification strategy. For 
example, the colorimetric detection of SNPs using a combination of RCA and nicking 
endonuclease-assisted nanoparticle amplification strategy was developed by Xu and 
colleagues. 44 In this assay, ligation was performed when the target DNA was 
hybridized with the padlock probe, leading to a circularized template. Subsequent 
RCA reaction in the presence of dNTPs led to the formation of a long single strand 
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single-stranded DNA occurred simultaneously. Upon completion of the strand 
scission cycles, the addition of a specific oligonucleotide modified Au NP provided a 
simple, colorimetric detection of target DNA down to 1 pM.  
 
The sensitivity of ligation assays can be further improved when being coupled to 
another probe amplification scheme. For example, the combination of LCR and RCA 
in detecting SNPs has been recently demonstrated by Cheng and colleagues, 79 who 
have demonstrated the sensitive detection of 1 fM of unlabelled target DNA under 
the optimised assay conditions. Further improvements of assay sensitivity have been 
achieved by incorporation of DNAzymes (catalytic nucleic acids) based catalytic 
cascades signal amplification. In this regard, Zhang and colleagues 53 have designed 
a new RCA amplification approach where the presence of the target KRAS SNP 
triggers the ligation of the padlock probe. Subsequently, multiple other circular 
templates were interlocked to the padlock probe by means of complementary 
sequence forming an ABABAB-type DNA copolymer as shown in Figure 1-10 (A). 
The inter-locked circular primers containing the HRP-mimicking DNAzymes 
subsequently underwent another round of RCA, producing long, single-strand DNA 
products each containing thousands of copies of the repeated DNAzyme sequences 
acting catalytic units. The incorporation of numerous such catalytic units thereby 
greatly enhanced the chemiluminescence signal in the presence of luminol and H2O2, 
leading to an impressive detection limit of 71 aM for the target SNP. This assay also 
provided excellent performance in quantitative analysis in human blood serum with a 
linear dynamic range of 2 orders of magnitude with good signal linearity from 0.1–10 
fM as shown in Figure 1-10 (B) and (C). The excellent sensitivity of this assay lies 
on the inherent capacity to generate great amplification as a consequence of the high 
turnover reaction of DNAzymes. This assay was also highly specific, and can detect 
1 fM specific mutant target in the presence of 10 pM wild-type gene background, 
representing a SNP detection capability of 1 in 10 000 (SNP versus wild-type target) 
level, which was among the best reported in literature. Hence, combining high 
sensitivity and specificity, this assay appears to have excellent potential for SNP 
based disease diagnostics by specific detection of the low abundant mutated target 
in clinical laboratory settings. This assay, however, is relatively complex and requires 
multiple amplification cycles, making it less well-suited for rapid, point-of-care 
applications. 






Figure 1-10. (A) Schematic representation of interlocked DNA scaffold 
mediated RCA reaction and DNAzyme amplification assay for the 
detection of G12C mutation in the KRAS gene. (B) Chemiluminescence 
signals for the HRP-mimicking DNAzyme-catalyzed luminol-H2O2 
system corresponding to different concentrations of single-base 
mutant target DNA: (a) 0; (b) 0.1; (c) 0.2; (d) 0.4; (e) 0.6; (f ) 0.8; (g) 1.0; 
(h) 2.0; (i) 4.0; ( j) 6.0; (k) 8.0; (l) 10.0 fM, and (C) The corresponding 
calibration curve of peak height versus the concentration of target 
DNA.  Reprinted from reference 53. 
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Recently, the Zhang group developed an ultrasensitive miRNA assay based on 
primer generation-mediated rolling circle amplification [PG-RCA]. This assay was 
used to analyse the point mutation of mir-196a2 [T→C] in the lung tissue samples of 
non-small cell lung cancer patients. 64 In this assay, the presence of target mir-
196a2T circularizes the padlock probe and the mir-196a2T further functioned as a 
primer to initiate the next round of RCA reaction in the presence of Vent (exo-) 
polymerase. This resulted in a long single-stranded RCA product containing 
numerous restriction sites for Nb.BsmI. The RCA product was then nicked by 
Nb.BsmI, generating a large number of new primers that was further used to initiate 
a new RCA reaction. The amplified DNA products were subsequently hybridized with 
a biotin/Cy5-labeled capture probes to form a double-stranded DNA. This DNA 
duplex contains a recognition site for the Nt.BstNBI nicking enzyme, and after the 
nicking reaction the capture probe was cleaved, separating Cy5 and biotin. This also 
resulted in the release of the amplified DNA product which can repeatedly hybridize 
with new biotin/Cy5-labeled to initiate the next rounds of cleavage. In a similar 
strategy, mir-196a2C was detected using the designed mir-196a2C padlock probes. 
In the absence of the mir-96a2T, more Cy5/biotin capture probes were cleaved, 
leading to smaller amounts of the intact capture probes to bind to the streptavidin-
coated QD. Consequently, this reduced the FRET between the QD donor and Cy5 
acceptors, resulting in decreased Cy5 counts being detected in the single particle 
FRET detection measurement. On the other hand, the mir-196a2T-specific linear 
padlock probe cannot be circularized in the absence of mir-196a2T. Under these 
conditions, RCA amplification and cleaving reactions will happen. Hence, the 
biotin/Cy5-labeled capture probe remains intact which can bind to the QD surface via 
specific streptavidin–biotin interactions, resulting in strong QD sensitised Cy5 FRET 
signal. With the integration of the PG-RCA reaction and nicking enzyme-driven 
recycling amplification, this QD-based miRNA nanosensor exhibited an impressive 
detection limit of 50.9 aM and a large dynamic range of 7 orders of magnitude from 
0.1 fM to 1 nM for the specific microRNA target. Moreover, this assay can even 
distinguish variant frequencies down to as low as 0.001% in the mixtures of mir-
196a2C and mir196a2T. Importantly, this QD-based miRNA nanosensor can be used 
to analyse the point mutation of mir-196a2 in the lung tissues of NSCLC patients, 
holding great potentials for clinical diagnosis in the clinical laboratory settings. Its 
complex signal amplification and assay procedures together with a relatively complex 
single-particle counting readout method may, however, limit its use in applications 
that require rapid results. 
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1.6 Nanomaterial assisted signal amplification 
In signal amplification, nanomaterials are often functionalised with biomolecules for 
target-specific recognitions and/or carrying high loads of signal moieties, catalysts, 
optical emitters, and electronic conductors. Biofunctionalised nanomaterials can 
amplify the signal transduction events due to their capability of direct interaction with 
their target, allowing for detection of biomolecules down to the single-molecule level 
92. Signal amplification can eliminate some requirements of the target/probe 
amplification schemes such as the need of enzymes and thermal cycles (ca. PCR). 
As a result, this can simplify experimental protocols, reduce the assay cost, and 
provide amenability to miniaturisation. Hence, the use of biofunctionalised 
nanomaterials for signal amplification has been very attractive in the development of 
simple, ultrasensitive DNA assays without the need of target and probe 
amplifications. The following section presents some ultrasensitive detection of SNPs 
achieved through use nanomaterials for signal amplification. 
 
1.6.1 Nanoparticle bio-barcode amplification 
An excellent example of the earlier developments here is the Bio-barcode assay  
developed by the Mirkin group. 65 It uses a short DNA modified Au NP tagged with 
hundreds of copies of the biobarcode DNAs (Bbc-Au NP) as signal probe, and 
another DNA modified magnetic microparticle (Oligo-MMP) as capture probe as 
shown in Figure 1-11. The two DNAs are complementary to each half of the target 
DNA, so that they can sandwich bind to the target DNA, forming a Bbc-Au NP/DNA 
target/Oligo-MMP hybrid structure. After magnetic separation and washing to remove 
any unbound species, thermal denaturation of the hybrid releases the bio barcode 
DNAs, converting each capture DNA target into hundreds of copies of barcode DNAs. 
These are then detected by a sensitive scanometric assay coupled with silver 
amplification to achieve ultrasensitivity. 93 This assay provides an impressive label-
free detection of target DNA down to 500 zM, comparable to many PCR based 
methods. 65 It can also discriminate the perfect match DNA from the SNP target. 
Although its relatively modest discrimination ratio, ∼3:1, may limit its capability of 
detecting low abundant SNP targets in wild-type gene background. 
 




Figure 1-11. Schematic illustration of the DNA-Bio-bar-code based 
ultrasensitive assay for DNA detection. (A) The preparation of the DNA 
modified Au NP and magnetic microparticle probes. (B) Schematics of the 
nanoparticle-based PCR-free DNA amplification and detection scheme.  
Reprinted from reference 65. 
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1.6.2 Signal amplification using labelled and enriched 
nanoparticle probes 
Metallic nanoparticles can be employed as scaffold for loading not only the capture 
but also signal molecules. These labelled nanoparticles present an important signal 
amplification strategy as they can directly enhance the readout signal for each target 
and probe recognition while retaining a high binding specificity. An interesting 
ultrasensitive biosensor was demonstrated by Taylor and colleagues 94 by developing 
a metallic core-shell nanoparticle signal amplifier which they termed “ultrabright 
SERS nanorattle”. These ultrabright SERS nanorattles are composed of an Au core 
and a shell with resonance Raman reporters loaded in the gap space between the 
core and the shell as shown in Figure 1-12 (A). These metallic core-shell 
“nanorattles” greatly enhanced the signal readout using surface enhanced Raman 
scattering (SERS) as compared to the conventional Raman reporters (Au or Ag NP) 
coated with Raman reporter tags. The fabrication of the “nanorattle” signal amplifier 
and the biosensing principle are shown in Figure 1-12 (B).  The biosensing approach 
is based on the hybridization of the target DNA to the magnetic bead (MB) modified 
with DNA capture probe and nanorattle modified with DNA forming a MB-DNA-
Nanorattle sandwich. A permanent magnet is then used to concentrate the “MB-DNA-
Nanorattle sandwich” onto a small spot for SERS measurement. The nanorattle’s 
intense SERS brightness can be attributed to two factors. First, with a nanometre 
size gap between the nanorattle’s core and shell which could be loaded with a greater 
number of Raman reporters than monolayer coated Au NPs. Second, the E field 
enhancement in the gap space of the nanorattle was estimated to be several times 
higher than that on Au NP surface. Using this method and under optimal conditions, 
a specific DNA sequence of the malaria parasite Plasmodium falciparum was 
detection with a detection limit of approximately 100 attomoles (30 µL reaction 
volume). The biosensor could also discriminate SNP of wild type malaria DNA and 
mutant malaria DNA (SNP discrimination ratio ~ 8:1) 94.  
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Figure 1-12. (A) SERS nanorattle synthesis process and TEM image of 
nanorattles with core-gap-shell structure (inset: higher magnification TEM 
image). Raman reporters were loaded into the gap space between the core 
and the shell. The nanorattle-based DNA detection method using sandwich 
hybridization of (1) magnetic bead that are loaded with capture probes, (2) 
target sequence, and (3) ultrabright SERS nanorattles that are loaded with 
reporter probes. (b) A magnet is applied to concentrate the hybridization 
sandwiches at a detection spot for SERS measurements. (C) SERS spectra 
at different concentrations of wild type target P. falciparum gene 
PF3D71343700 (vertically shifted for clarity). (b) SERS intensities at 923 
cm−1 (normalized) vs. log(target concentration/(M)). Error bars represent 
standard deviations (n = 3). Reprinted from reference 94. 
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Over the past few years, silica particles have been used as another platform for 
carrying signal tags due to their large surface areas, well-known surface chemistries 
and good biocompatibility. Wu and colleagues have reported a labelling-based signal 
amplification strategy for ultrasensitive detection of target DNA using QD assembled 
SiO2 microspheres. 66 This method is used as an indirect method for ultrasensitive 
detection of HIV DNA using hydride generation atomic fluorescence 
spectrophotometry [HG-AFS]. This assay involves the use of sandwich hybridization 
between the target DNA, biotin-capture probe and streptavidin tagged QD-SiO2 
assembly, converting each captured DNA target into thousands of SiO2 tagged QDs. 
After acid dissolution of the QDs, the resulting Cd2+ ions were detected by HG-AFS, 
giving a highly impressive detection limit of 0.8 aM for the target DNA and a dynamic 
range of 3 orders of magnitude (from 1 aM to 1 fM). The outstanding sensitivity 
suggests that the HG-AFS method is suitable for the ultrasensitive biosensing.  
 
An ultrasensitive chemiluminescent method using Au NP based signal amplification 
has recently been developed by Zhang and colleagues. 67 Using the Watson–Crick 
base pairing, a guanine monomer modified Au NP probe is coupled to the cytosine 
mutated DNA duplex in the presence of DNA polymerase I. Each guanine modified 
Au NP probe is also linked to 77 CuS NPs which act as signal generator. After acid 
dissolution of the CuS NPs, the released Cu2+ ions are coordinated to cyanides to 
form [Cu(CN)4]2− complexes which are then reacted with luminol to give rise to 
chemiluminescence signal for target DNA quantification. A further improvement in the 
signal sensitivity is achieved by incorporating a pre-concentration of Cu2+ ions by 
anodic stripping voltammetry (ASV). These have enabled this assay to achieve a low 
detection limit of 19 aM for one base mutant DNA and a linear range of 80 aM to 10 
fM. 
 
Zhang and colleagues 95 have recently demonstrated a simple electrochemical DNA 
biosensor based on CdSe QDs as signal amplifier combined with MspI restriction 
endonuclease.  The design concept of the biosensor is shown in Figure 1-13. 
 





Figure 1-13. (A) Schematic diagram of the biosensor approach (B) SWV of 
the MspI/target DNA/CdSe QDs–SA/MCH/probe DNA/AuNPs modified glass 
carbon electrode in the presence of different concentrations of target DNA 
(0, 10-14, 10-13, 10-12,10-11, 10-10 and 10-9 M from top to bottom) in 0.1 M HAc–
NaAc buffer solution (pH 4.6). (C) The linear relationship between the 
currents (i) and the negative logarithm of target DNA concentrations. 
Reprinted from reference 95. 
 
The biosensor is glassy carbon electrode modified with Au NPs . The electrode is 
labelled with biotin-DNA-SH probes and bound to CdSe QD–streptavidin (SA) via the 
specific biotin-streptavidin interaction. After hybridization to the complimentary target 
DNA probe,  the MspI endonuclease recognize the specific sequence in the ds DNA 
and cleaves the dsDNA-CdSe QDs from the electrode. This results to  a decrease in 
the electrochemical signal. The concentrations of target DNA could be 
simultaneously detected by the signal of metal markers. Using mycobacterium 
tuberculosis (Mtb) DNA as a model, under the optimal conditions, the proposed 
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magnitude spanning from 1.0 x 10-14 to 1.0 x 10-9 M. Furthermore, the biosensor was 
also shown to be able to discriminate single nucleotide mismatch from target DNA.  
 
The labelling of the target DNA with a large number of signal generators coupled with 
sensitive electrochemiluminescence SNP detection was demonstrated by the Willner 
group54. In this assay, a mutant DNA with one base mismatch (C→G mutation) was  
hybridised to a complementary DNA modified magnetic NP. It was then treated with 
a DNA polymerase in the presence of biotin-dCTP and other dNTPs. This was 
followed by multiple thermal cycles of dissociation, annealing and labelling, resulting 
in poly-labelling of the magnetic NPs with biotins. After magnetic separation and 
treatment with avidin-horseradish peroxidase (Avidin-HRP), the resulting avidin-HRP 
functionalised magnetic NPs and napthoquinone NPs were deposited on an 
electrode guided by an external magnetic field. Applying an electric potential reduces 
napthoquinone to hydroquinone, which simultaneously reduces O2 to H2O2, triggering 
the HRP catalysed oxidation of luminol and yielding a chemiluminescence signal. 
Under optimized conditions, this assay has reported an impressive sensitivity of 8.3 
aM for the M13φ DNA (50 copies in 10 μL sample) and 10 aM for a mutant DNA. 
Despite showing impressive sensitivities, none of the above ultrasensitive assays 
have reported the simultaneous detection of multiple targets. Further developments 
on the multiplexing capability of an SNP assay are highly desirable for improving the 
diagnostic accuracy.  
 
Recently, Gambari and colleagues 68 have reported the direct detection of SNPs in 
non-amplified human genomic DNA carrying the mutated β°39-globin gene sequence 
by surface plasmon resonance imaging (SPRI). This gene is involved in the 
hereditary blood disorder diseases known as β-thalassemia. The detection is 
achieved by using Au NP conjugated with multiple copies of DNA β°39, an 11-mer 
oligonucleotide. Prior to analysis, the surfaces of 6 microfluidic channels are modified 
with PNA-N and PNA-M probes whose nucleic acid sequences are complementary 
to the normal and mutant genes respectively as shown in Figure 1-14. The samples 
are directly fluxed into these channels to allow the direct hybridisation between each 
of the samples (e.g. normal βN/βN; homozygous β°39/β°39 and heterozygous 
β°39/βN) on PNA functionalized surfaces. The SPRI responses between the samples 
and the two different PNA probes are used as controls. Subsequently, the conjugated 
Au NPs are fluxed into the microchannels and captured by specific hybridization 
between their surface DNA β°39 strands and exposed target DNA sequence not 
involved in binding to the PNA probes, allowing for greatly enhanced SPRI signal. 
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This assay has achieved the sensitive detection of genomic DNAs down to 2.6 aM (5 
pg μL−1) without PCR amplification. It can also discriminate between the normal, 
homozygous β°39/β°39, and heterozygous β°39/βN sequences, albeit with a 




Figure 1-14. Schematic illustration of the nanoparticle-enhanced SPRI 
strategy used to detect the normal βN/βN, heterozygous β°39/β°N, and 
homozygous β°39/β°39 genomic DNAs. The PNA-N and PNA-M recognize 
specifically the normal β-globin and the mutated β°39-globin genomic 
sequences, respectively. Reprinted from reference 68. 
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1.6.3 Signal amplification using functionalized nanocontainers 
The use of nanomaterials with hollow structures for encapsulation of signalling 
elements is another attractive strategy for ultrasensitive biosensing. Lin and 
colleagues 51 have used a similar base-pairing mechanism to target DNA point 
mutations using a novel signal amplification strategy. It uses DNA polymerase I 
(Klenow fragment) to couple a guanine modified NP probe to the mutation site of a 
duplex DNA. The signal enhancement is achieved by incorporating Cd2+ ions inside 
an engineered protein with a hollow cage of interior cavity diameter of 8 nm. This NP 
probe is also modified with guanine nucleotide to specifically pair with cytosine point 
mutation in the DNA duplex. As a result, hybridization of the mutant DNA (cytosine 
point mutation) and the biotin-labelled DNA probe forms a stable duplex DNA 
structure which is then captured by avidin-modified magnetic NPs. The Cd2+ ions 
released from the nanoparticle cavity is then detected electrochemically by square 
wave voltammetry. This assay is sensitive, allowing for detection of 21.5 attomol 
mutant DNA and can detect SNPs down to frequencies as low as 1%.  
 
Recently, Zhang and colleagues 69 has developed a new approach using QD-based 
SNP detection without the need for target or probe amplification. This assay uses a 
reporter probe modified-liposome (liposome–QD-reporter probe; L@QD complex) 
serving as a “nano-container” for encapsulation of hundreds of QDs. The presence 
of the target DNA (T-DNA) and capture probe modified magnetic bead (CP-MB) lead 
to sandwich hybridization, forming a liposome–QD-reporter probe/T-DNA/CP-MB 
hybrid structure which is then separated magnetically. The subsequent disruption of 
liposome–QD complexes results in release of the encapsulated QDs, which are 
sensitively detected by single-particle counting as shown in Figure 1-15. 




Figure 1-15. (A) Schematic illustration for Liposome–QD complexes 
(L@QD complex) based ultrasensitive detection of attomolar DNA using 
single-particle detection techniques. The assay involves the sandwich 
type hybridization of the target DNA to L@QD complex-tagged reporter 
probes and capture probe modified-magnetic bead. Liposome disruption 
leads to the release of QD’s for single particle detection. (B) A plot of burst 
counts from the released QDs as a function of the concentrations of HIV-1 
(green) and HIV-2 (red). There was no change in the burst counts in the 
control groups with non-complementary DNA (black and blue), and (C) 
Simultaneous detection of HIV-1 (green) and HIV-2 (red). The error bars 
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An advantage of this approach is that each pair of reporter/ capture probes can be 
encoded with a different coloured QD, allowing for easy detection of multiple DNA 
targets simultaneously. As shown in as shown in Figure 1-15, the presence of HIV-
1 only produces fluorescence bursts from the green QDs but not the red QDs. In 
contrasts, the presence of HIV-2 only produces red QD fluorescence, but not green 
QD, and thus indicating high assay specificity. Multiplexing has been achieved by 
encapsulating red and green QDs into the respective reporter probe 1 and reporter 
probe 2 tagged liposomes, whereupon specific sandwich hybridization leads to the 
formation of specific magnetic bead-liposome complexes. After magnetic separation, 
the use of two different coloured liposome–QD complexes has enabled the 
simultaneous detection of the HIV-1 and HIV-2 genes as shown in Figure 1-15 (B) 
and (C).  
 
The great target amplification (each captured DNA targeted is converted into several 
hundreds of QDs) coupled with sensitive single-particle counting method has enabled 
this assay to be ultrasensitive, with detection limits down to 1 and 2.5 aM for HIV-1 
and for HIV-2, respectively. With the judicious design of capture and signal probes, 
this assay may provide an ultrasensitive approach for simultaneous detection of 
multiple DNA targets. However, this assay is unlikely to be able to provide high 
enough SNP discrimination ratio useful for detection of specific low abundant SNPs 
in wild-type gene background because of the small stability difference of the 
sandwich DNAs for the wild-type and SNP DNAs formed with the reporter/capture 
probes. Its single particle counting readout strategy may also limit its application in 
resources poor environment. 
 
Instead of QDs being encapsulated inside liposomes, fluorescent dye molecules can 
offer better alternative because of much simpler signal detection read outs leading to 
more cost-effective biosensors. An interesting work here was reported by Li and 
colleagues 96 wherein they developed a biosensor for p53 gene. The biosensor is 
based on coupling a triple-helix magnetic probe (THMP) to a fluorescent liposome 
hybridization assembly The design concept of the biosensor is shown in Figure 1-16. 
The sensing platform consist of the triple-helix DNA immobilized on a streptavidin-
magnetic beads (MNBs). 
 
 






Figure 1-16. (A) Schematic illustration of the THMP coupled with the 
hybridization assembly of fluorescent liposomes for p53 gene detection. 
(B) Fluorescence emission spectra obtained in the proposed sensing 
strategy for p53 genes at varying concentrations and (C) linear relationship 
between the fluorescence intensity and the concentration of p53 genes. 
The error bars represent the standard deviation of three repetitive 
measurements. Reprinted from reference 96. 
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In the presence of p53, the loop portion of the THMP is unfolded, thus forming a 
double-stranded DNA and subsequently releasing the aDNA-MNB probes. The 
nicking endonuclease (Nt·BstNBI) specifically recognized the specific asymmetric 
sequence 5′- GAGTC-3′ in this duplex, thereby cleaving the fourth base from its 3′ 
end. In this way, the loop portion of the THMP is cleaved into two and liberates p53 
gene for another round of enzyme cleavage cycle. The aDNA-MNB probes were 
separated to trigger the subsequent RCA process producing long DNA strands. After 
interaction with the long single DNA strands, multiple fluorescent dye-encapsulated 
liposome probes were appended on the DNA strands to form a duplex structure. After 
hydrolysis of the fluorescent liposomes, a dramatically enhanced fluorescence signal 
was obtained. In the absence of p53, the THMP remained intact and blocked the 
aDNA-MNB probe release and fluorescent liposome assembly, thus yielding a very 
low background signal. The significant enhancement of sensitivity  of the developed 
biosensor are due to the following factors (i) integrates p53 gene-triggered enzyme 
cleavage recycling for primary target amplification, (ii) fluorescent liposome 
hybridization assembly initiated by RCA for secondary signal amplification, and  (iii) 
magnetic isolation for background signal elimination. Under optimal conditions, this 
biosensor approach reported a  detection limit of 0.07 fM. Moreover, the biosensor 
showed a remarkable selectivity for p53 against single-base mismatches due to 
ability of the THMP to specifically detect the involved targets and the precise site-
specific endonuclease cleavage.  
 
1.6.4 Signal amplification using enzyme catalysed crystal growth  
Stevens and colleagues have recently developed a novel plasmonic nanosensor that 
works on a principle of inverse sensitivity signal-generation mechanism 97, 98 where 
an amplified signal is observed when less target molecules are present. The inverse 
sensitivity procedure is achieved using glucose oxidase (GOx) which catalyses the 
generation of hydrogen peroxide to tailor the plasmonic response of the gold 
nanosensors. Depending on the concentration, GOx can control the in situ rate of 
nucleation of nascent Ag nanocrystals or Ag coating on Au nanostars, resulting in 
variations of the localized surface plasmon resonance (LSPR). At low GOx 
concentration, a low supply of H2O2 favours the deposition of a homogeneous silver 
coating on the Au nanostars, leading to blueshift of the LSPR band. Whereas a high 
GOx concentration favours the nucleation of silver nanocrystals instead of depositing 
on Au nanostars, leading to less LSPR shifts as shown in  Figure 1-17 (A). This 
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principle is used to develop a plasmonic ELISA using a GOx conjugated antibody in 





Figure 1-17 (A) Schematic illustration of the proposed signal-generation 
mechanism by means of enzyme-guided crystal growth for the plasmonic 
ELISA assay. (B) Immunoassay for the ultrasensitive detection of PSA with 
GOx-labelled antibodies and of PSA (red) and BSA (green) spiked into 
whole serum. Reprinted from reference 98. 
 
The concentration of GOx is directly related to the target concentration. Prostate 
specific antigen (PSA) and HIV-1 capsid antigen p24 are used as model protein 
targets in whole serum conditions. This assay has demonstrated an extremely 
impressive sensitivity of 40 zM 99 and 1 aM 97 for PSA and HIV-1 capsid antigen, 
respectively. Moreover, the assay results can be directly visualised by the naked eye, 
and therefore offers a simple, highly attractive alternative to the costly nucleic acid 
based HIV infection diagnosis test. In principle, it can be adapted for the detection of 
any analyte with a suitable antibody, making it a versatile tool for ultrasensitive 
diagnostics. Despite of great simplicity and ultrasensitivity, the plasmonic ELISA 
(A) 
(B) 
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however, has a rather small absolute signal change, making it difficult to quantify the 




Significant advances have been made over the past few years in the development of 
PCR-free assays suitable for specific and ultrasensitive detection of SNPs. The 
incorporation of various biofunctionalised nanomaterials coupled with novel 
amplification strategies have permitted the detection of extremely low concentrations 
of SNPs, down to the aM–zM range. Such levels of sensitivity have already compared 
very favourably with many PCR based methods. The amplification strategies may be 
classified as one of the following categories: 
 
(i) Nanoparticle assisted target PCR amplification.  
(ii) Nanoparticle assisted probe amplification. 
(iii) Target recycling coupled with probe and/or signal amplification. 
(iv) Tandem amplification schemes and signal catalytic cascades. 
(v) Nanomaterial enhanced signal amplification. 
 
In general, the sensitivity of a nanomaterial-based SNP assay can be greatly 
enhanced by combining target, probe and signal amplification schemes. Most of the 
recent target and probe amplification schemes have exploited the great catalytic 
power and specificity of enzymes to achieve ultra-sensitivity and specificity. Of 
particular interest here is the use of DNAzymes that can undergo the so-called 
enzymatic cascade reactions, where the activation of multiple enzymes by a target 
DNA can result in ultra-sensitivity, comparable many PCR based assays. Another 
widely used strategy is the use of restriction enzymes that specifically recognise the 
restriction sites to degrade the reporter probe, allowing for target recycling. These 
autocatalytic strategies have resulted in unmatched sensitivities while still 
maintaining high specificity. However, a limitation here is that restriction enzymes can 
only recognize a specific sequence and therefore are not suitable for universal SNP 
detection. Several ingenious ways in the design of nanomaterials for signal 
amplification strategies have also been developed, including the use of multiple 
tagging and enrichment of nanoparticle probes with signal moieties to enable ultra-
sensitivity. Some of these strategies also hold great promises for multiplexed 
detection, an important property for high diagnostic accuracy. Despite significant 
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advances, several limitations still need to be resolved before they can be translated 
into clinical diagnostic assays. For example, although a number of assays have 
reported aM, even zM sensitivity, most of which were still at the proof-of-concept 
stage and were carried out under clean buffers. They have not yet been tested in 
clinically related media, such as blood, serum, saliva and urine. Furthermore, most 
assays have reported a rather limited SNP discrimination ratio (<10 fold), making 
them potentially unsuitable for detection of low abundant disease related SNPs in the 
background of wild-type gene/genomic DNA because of the strong interference from 
the background DNAs. Moreover, the lack of the multiplexing capability could pose a 
significant limiting factor for the real clinical potential. The stability of the 
biofunctionalised nanomaterials is another important issue for such nano-enabled 
SNP biosensors. In this regard, the fundamental understanding of the biomolecule-
nanomaterial interactions is imperative to alleviate problems of high background 
signals due to non-specific adsorptions in serum and/or other complex clinical 
samples.  
 
The use of biofunctionalised nanomaterials together with novel amplification 
strategies has transcended barriers to the attainment of extremely low detection limits 
of disease-related SNPs. This ultimately ushers the way for more practical concerns 
such as the realistic applications of the technology in clinical settings. Even more 
challenging is the development of a robust, portable, point-of-care diagnostic system 
that can specifically detect the ultralow level of disease-related SNPs rapidly and 
conveniently on the site of the patient and in places such as the doctor’s office, school 
clinic and in patients’ residence. 82 These also call for improving the assays’ 
amenability towards automation and miniaturization because most current assays 
still require the use of expensive and complex instrumentation and complex 
procedures, limiting their potential in rapid diagnosis. Electro-chemical signal 
transduction can provide an option for the miniaturization and automation but these 
methods are prone to false positives.(26) The recent advances in microfluidics 100, 101 
may be able to address sample throughput and automation challenges in SNP 
assays. If all of these challenges were met, the automation of these ultrasensitive 
assays may lead to the integration of sample processing, quantification and signal 
measurement in an all-in-one device in real clinical setting. This would greatly 
facilitate the rapid, accurate disease diagnosis and prognosis. In view of this, these 
are still crucial challenges that need to be addressed, and more efforts will be needed 
to improve the analytical sensing performance and portability of SNP assays. 
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1.8 Aim of the project  
The overall project objective is to develop a rapid, ultrasensitive sensing technology 
that can specifically detect the tiny amount of cancer gene mutants in the background 
of overwhelming wide type genes for early cancer diagnosis and prognosis. The 
biosensor that is currently being developed is a simple and sensitive fluorimetric 
magnetic nanoparticle-enzyme based DNA sandwich assay that is suitable for label 
free quantitation of DNA targets down to the low attomolar level. The sensing 
approach is based on the use of a specific pair of DNA probes, with one covalently 
conjugated to the MNP for target capture (i.e. capture-DNA). The other (i.e. signal-
DNA) is modified with biotin for linking to a neutravidin conjugated enzyme for signal 
amplification. Each capture DNA and signal-DNA is complimentary to each half of 
their DNA target, allowing for the specific sandwich hybridization of the target DNA. 
Ligation using Taq enzyme enables the MNP conjugated capture-DNA to be 
covalently linked to the signal-DNA, ensuring that the signal DNA (together with its 
attached biotin group) will not detach from the MNP during the subsequent washing 
steps (without ligation, the double-stranded DNA sandwich structure may dissociate 
during washing steps). After washing to remove any unbound species, excess 
neutravidin-enzyme conjugates are added to bind to the MNP surface biotins, 
converting each captured target DNA into an active enzyme for powerful enzymatic 
signal amplification. This DNA biosensor is expected to be robust and effective in 
discriminating between wild type DNA targets and cancer specific SNPs because the 
ligation is highly specific, a single base mismatch at the nicked double-stranded site 
can prevent covalent ligation.  
 
Enzymatic signal amplification can offer higher sensitivity than dye labelled affinity 
reagents because each enzyme can turn over tens to hundreds copies of a 
fluorogenic substrate per second, leading to greatly amplified signals as compared 
for methods using dye labelled affinity reagents. Enzyme labelling works through the 
use of an enzyme conjugated to a target specific affinity reagent (e.g. neutravidin). 
Previously, the Zhou group has shown that by converting each captured DNA target 
into a single horseradish peroxidase (HRP) enzyme for signal amplification as shown 
in Figure 1-18, fM levels of target DNA can be detected in 40 min 52. 
 
 




Figure 1-18. Principle of the MNP–Enzyme Sandwich Assay for Simultaneous 
Detection of Two DNA Targets Using Two Sets of Unique MNP–cDNA and 
sDNA–Enzyme Probe. The cDNA and sDNA probes are complementary to 
each half of their DNA targets for specific sandwich hybridization, linking 
HRP (with T-DNA1) or ALP (with T-DNA2) to the MNP. Therefore, HRP/ALP-
amplified enzyme products, resorufin (λmax = 571 nm) and fluorescein (λ max = 
485 nm), are used to quantitate T-DNA1/T-DNA2, respectively. Reprinted from 
reference 52. 
 
This project aims to build upon such results and further improve the sensitivity of the 
assay by developing a novel signal amplification strategy with greater amplification 
power: the development poly neutravidin-horseradish peroxidise (NAv-HRP) tagged 
polymer bead (PB-HRPm). The amino modified polymer bead is first biotinylated by 
N-hydroxysuccinimide-Biotin in a bicarbonate buffer (pH= 8.3) and linked to NAV-
HRP enzyme via the strong “biotin-neutravidin” interaction. Biotin is a small ligand 
molecule (molecular mass of ~250 Da) that specifically binds to a larger cationic 
glycoprotein, avidin (isoelectric point (pI) ~ 10.5 and molecular mass ∼67 kDa) with 
high affinity (binding constant, Kd 10-15)102. The biotin-avidin interaction is the 
strongest known non-covalent biochemical bond103. Streptavidin is a non-
glycosylated protein with a near-neutral isoelectric point (pI ~ 5-6 and molecular mass 
∼60 kDa). The biotin-binding properties of non-glycosylated avidin (i.e. streptavidin) 
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have been reported to be equivalent to those obtained for the native (glycosylated) 
avidin molecule 104. Similar to avidin, streptavidin binds to biotin at four binding sites, 
two binding sites on each of two opposing faces of the molecule, with an extremely 
high binding constant (KD∼10−13 M) 105, 106. The binding affinity of Neutravidin® (pI 
~6.3, and molecular mass 60 kDA) 107 is similar to  avidin and streptavidin but NAV 
exhibits the lowest non-specific binding (based on Thermo Pierce ®product 
description).  
 
In this biosensing assay, the polymer bead detector can bind with the MNP-ligated 
DNA ensemble through the biotin-neutravidin interaction. The HRP in the presence 
of H2O2 is capable of converting a non-fluorescent substrate amplex red into a strong-
fluorescent product (i.e. resorufin). The rate of fluorescence production is linearly 
proportional to the number of HRPs conjugated on the MNPs, which implies the 
concentration of the target DNA in the solution. 
 
In order to achieve this biosensing strategy, uniform and stable magnetic 
nanoparticles must be prepared. In our earlier work (results not included in this 
thesis), we prepared amino modified silica coated magnetic nanoparticles. The amino 
modified silica surface were first modified with a heterobifunctional linker (i.e. NHS-
PEG-Maleimide). The NHS (i.e. N-hydroxysuccinimide) moiety reacts with surface 
amines and the maleimide groups react with the thiol modified DNA (capture probe) 
and thiolated zwitterion ligand. The zwitterion ligand was previously shown to resist 
non-specific adsorption of proteins 108 and was used to passivate the surface of the 
nanoparticle. Moreover, the surface was further blocked by bovine serum albumin 
(BSA). Initial results show low background signals due to the reduction of non-specific 
adsorption by the zwitterion ligand and BSA. However, this biosensing procedure 
was not very reproducible due to the inconsistency of achieving high DNA loading 
(capture DNA efficiency was only ~ 38 - 40 %), and differences in capture DNA 
loading per mg of MNPs were also observed in different batches of MNPs even 
though the conjugation were done using the same protocol. These problems affected 
the reproducibility of the biosensing data and lead to re-design the biosensor 
platform. More importantly, these observations suggest an important aspect in 
designing nanoparticles probes for biosensing applications - that is to consider the 
surface chemistry of the nanoparticles to ensure a low background and obtain 
reproducible conjugation efficiency of the capture probes  (i.e. DNA).  Moreover, 
experimental optimizations must be done in order to ensure the low background 
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signal possible. This can be done by optimizing  biosensing parameters such as 
effect of washing conditions, effect of DNA loading (nmol·mg-1 MNP), and effect of 
signal DNA concentration. Furthermore, signal amplification as discussed earlier will 
be developed in order to attain the attomolar sensitivity.  
 




Chapter 2  
Preparation, Surface Functionalization, and Bioconjugation  of 




Magnetic nanoparticles (MNP) are among the most promising nanomaterials developed 
for biomedical applications so far. Among Iron oxide nanoparticles (IONPs), magnetite 
(Fe3O4) and maghemite (-Fe2O3) have attracted research attention for use in medical 
and biosensing applications because of their non-toxicity and excellent biocompatibility 
109, 110. The distinctive properties of MNP offers many exciting opportunities in biology 
and medicine. First, the size of MNPs can be easily tuned and optimized from a few to 
hundreds of nanometres to match the interest or purpose  of the study. Second, their 
superparamagnetic property makes them easily manipulated by an external magnetic 
force, allowing for easy sample retrieval from the matrix and for further re-use. Indeed, 
the “action at a distance” provides a tremendous advantage for a plethora of applications 
(e.g. bacterial detection 111, protein purification 112, removal of toxins 113). Third, the 
magnetic moment of MNPs can enhance the magnetic relaxation signal of nearby 
protons, allowing MNPs to act as important MRI contrast agents 114. Fourth, the MNPs 
can transform electromagnetic energy from an external high-frequency field into heat, 
providing promising applications in magnetic hyperthermia treatment of cancerous 
tumours 115. Similar to any other nanomaterials, the nanometre size of MNPs imparts a 
large surface to volume ratio and a high surface energy, making them to aggregate 
and/or oxidise readily in the absence of proper surface coating. This can adversely affect 
their intrinsic magnetic properties and applications. In this regard, MNPs are often 
capped with a protective coating to improve their stability and water-dispersibility, and 
more importantly, to introduce reactive functional groups to facilitate further conjugation 
to biomolecules. There are several different types of coatings already reported in the 
literature such as silica, amphiphilic polymer micelles, and polymeric ligands 116-119.  




This chapter will present a brief overview of the properties of  MNPs, the synthesis of 
iron (III) oxide (Fe3O4) nanoparticles using co-precipitation and thermal decomposition 
methods, silica coating and amino modification, and the synthesis of heterobifunctional 
ligands to improve the water dispersion of silica coated MNPs. These water dispersible 
MNPs are then used for biosensing applications.  
 
2.2.1 Physical Property of Magnetic Nanoparticles 
MNPs consist of elements such as iron, nickel, and cobalt or their chemical compounds 
and show some response to an applied magnetic field 120. Magnetic effects is a 
consequence of the movement of particles with charge and mass. Specifically, the origin 
of magnetic moments in individual atoms is governed by two electronic movements: 
orbital movement which is the movement of electrons around the nucleus and spin 
movement which originates from the movement of electrons around its own axis 117. In 
general, materials can be classified into three categories depending on their response 
to an external magnetic field as shown in Figure 2-1 121: diamagnetic  (no net moment 
and produce a weak magnetic field in the direction opposite to an applied magnetic 
field), paramagnetic (zero net moment, produce a weak magnetic field in the direction 
of the applied magnetic field), and ferromagnetic (have net moment, all its magnetic 
moments can align in one direction creating a high magnetic moment) materials 121.  
 
 
Figure 2-1. Schematic representation of diamagnetic, paramagnetic, and 
ferromagnetic materials microscopic structures at rest and in the presence of a 
magnetic field (H). Figure reprinted from reference 121 
 
Bulk ferromagnetic materials contain smaller regions called magnetic domains whose 
atoms spins are all pointing in the same direction giving a net magnetization 109, 117. Each 
magnetic domains are separated by domain walls and the overall magnetization is the 
sum total of all the different magnetizations of all domains. The formation of magnetic 
domains results from a balance of several energy terms: the exchange energy which 




aligns all magnetic moments in the same direction, magnetocrystalline anisotropy 
energy which orients magnetic moments along specific directions, and the 
magnetostatic energy which eliminates the magnetization in the material 110. When the 
size of a ferromagnetic material is reduced below a critical value, it  becomes single 
domain wherein the electron spins rotate in the same direction 109. The MNP coercivity 
which is the magnetic field required to bring the magnetization back to zero is critically 
size dependent. MNPs show a maximum coercivity at the transition from multi-domain 
to single domain 109. As the size of the particle is reduced to the single domain limit, the 
coercivity reaches the maximum, further reducing the MNP size leads to decreased 
coercivity and finally reaches zero, where the MNPs become superparamagnetic as 
shown in Figure 2-2 110.  
 
Figure 2-2. Schematic illustration of the coercivity-size relations of small 
particles. Reprinted from reference 110 
 
 
The interaction of ferromagnetic materials on an applied field is best described by a 
magnetization curve, which is characterized by two main parameters: remanence 
(residual magnetism) and coercivity (Hc) (coercive force) as shown in Figure 2-3 (b-d).  
  





Figure 2-3. Schematic illustration of the relationship between coercivity, 
nanoparticle size and their corresponding magnetization curves. Figure 
reprinted from reference 109 
 
 
Extremely small MNPs exhibit an almost linear relationship between the magnetization 
(M) and magnetic field (H). The magnetization is not saturated until very high magnetic 
field is applied as shown in Figure 2-3(b). MNPs with bigger sizes but still in the single 
domain range exhibit a superparamagnetic property. When a magnetic field is applied, 
MNPs in the superparamagnetic state display a fast response to the changes of the 
magnetic field without remnant (residual) magnetization and coercivity as shown Figure 
2-3 (c). Further increase of the particle size leads to a ferromagnetic behaviour which 
displays appreciable remanence and coercivity in the magnetization curve. 
 
 
2.2.2 Overview of the Project 
The  ability to detect ultralow concentrations of biochemical molecules such as nucleic  
acids and enzymes by using simple and inexpensive assays is highly desirable in clinical 
diagnostics and biomedical research. Polymerase chain reaction (PCR) coupled with 
gel electrophoresis or molecular fluorophore assays is still considered as the golden 
standard among nucleic acid detection techniques because it offers high sensitivity of 




detection. However, PCR methods suffer from complex handling procedures, high cost, 
easy contamination, and lack of portability. On the other hand, the enzyme linked 
immune absorbent assay (ELISA) is a method of choice for detection of peptides, 
proteins, antibodies and hormones because it offers high sensitivity and specificity 122, 
123. There are different types of ELISA assays but the major steps include the 
immobilization or capture of the antigen onto a solid surface followed by binding to an 
enzyme-linked detection antibody . The detection step is accomplished by incubating a 
substrate to produce a measurable coloured product. The high sensitivity of ELISA 
comes from the enzymatic amplification which can catalyse a chromogenic reaction at 
a high rate. Moreover, the high specificity is due to the selectivity of the antigen-antibody 
recognition. However, ELSIA also suffers from several drawbacks such as the labelling 
of antibodies for each specific ELISA system can be very time-consuming and 
expensive 124. Furthermore, there is no flexibility in choice of antibody label from one 
experiment to another 122.  
 
MNPs have been utilized in various applications involving the sensitive detection of DNA 
and protein targets. Motivated by the attractive features of MNPs such as target capture 
and ease of retrieval from the sample matrix, a colourimetric biosensor for the detection 
of a cancer related DNA target and endonuclease is designed. Endonucleases are a 
class of enzymes known as “molecular scissors” because they can specifically cleave 
the phosphodiester bond within the DNA at defined positions 125. Endonucleases are 
deemed important targets in antimicrobial and antiviral drug discoveries 126, 127. The 
biosensor platform is based on a biofunctionalized magnetic nanoparticle. The MNP 
probe contains a capture DNA that is linked to a horse radish peroxidase (HRP). 
Specifically, 2 designs of the MNP-DNAss-HRP (ss stands for single strand DNA) probe 
were prepared.  Both types of capture-DNAs contained a DBCO moiety at the 5 end, 
the 3 end was modified with a biotin or a thiol group for design 1 or 2 respectively. The 
attachment of HRP were carried out using two different methods because of the 
difference in the functional groups at the of the 3 end of the DNA. The first manner of 
HRP linking termed as Design-1 involves the non-covalent interaction of NAV-HRP to 
the biotin group of MNP-DNAss-Biotin probes. Scheme 2-1 shows the schematic 
illustration for the preparation of MNP probe Design-1.  






Scheme 2-1. Schematic illustration for the preparation of MNP-DNAss-HRP 
Design-1. The reaction conditions are (a) 1% NHS-PEG~23-N3, 99 %, NHS-PEG~17-
OCH3 ; (b) DBCO-DNA-Biotin, PBS; (c) Neutravidin–HRP, PBS. The X and Y in 
the MNP denotes PEG~23-DNA-HRP and PEG~17-OCH3 respectively. 
 
 
Scheme 2-2 shows the schematic route to prepare MNP-DNAss-HRP Design-2 by 
covalently linking the maleimide modified HRP to the thiol modified DNA strand on the 
MNP surface. This was accomplished by reacting HRP with a heterobifunctional linker 
(i.e. NHS-PEG12-Maleimide) where the NHS ester reacted with the terminal amino 
groups of HRP at pH 7.4 to introduce maleimide groups. Thereafter, the maleimide 
modified HRP reacted with the MNP-DNAss-SH to form covalent conjugation. The 
amounts of the MNP linked HRP molecules were determined spectrophotometrically. 






To test the feasibility of the biosensor, the ECOR-I is used as a model endonuclease 
enzyme. The enzyme cuts specifically the  phosphodiester bond of the duplex DNA  128, 
129. The biosensor is further used for DNA detection by incubating  the MNP-DNAss-HRP 
probes with different concentrations of the target DNA. After hybridization, ECOR-I was 
used to cleave the ds DNA and the same colourimetric assay was used to correlate the 
absorbance and target DNA concentration. Overall, this biosensor design is simple, 
inexpensive, and can be easily used to detect either DNA or ECOR-I. 
 
 
Scheme 2-2. Schematic illustration for the preparation of MNP-DNAss-HRP 
Design-2 probes. The X and Y denote PEG~23-DNA-HRP and PEG~17-OCH3 
respectively. 




2.3 Materials and Methods 
2.3.1 Instruments 
Transmission electron microscopy (TEM) micrographs were taken on the Philips CM200 
transmission electron microscope. The specimen for TEM study was prepared by 
depositing a drop of the MNP solution onto a carbon-coated TEM grid. Hydrodynamic 
size and zeta potential measurements were determined using Malvern® zetasizer-nano 
with  BI-APD detector using a He-Ne laser at 633 nm (scattering angle: 90o, temperature, 
25oC). UV-vis absorption spectra were conducted using a UV-Vis Cary50 ® 
spectrophotometer, Agilent technologies, USA. XRD (X-ray diffraction) measurements 
were performed on Bruker XRD. The scan range (2) was from 10° to 90° at increments 
of 0.0332° with a scan speed of 0.5 second/step. pH adjustments were done using a 
Fischer brand Hydrus 300 pH meter at room temperature. Ultrapure water (resistance 
>18.2 M·cm) was purified by ELGA Purelab classic UVF system, was used for all 
experiments. Proton NMR (1H NMR) and Mass spectrometry (MS) data of the 
synthesized ligands were collected using BRUKER DPX400®, 400 MHz nuclear 
magnetic resonance spectrometer and high resolution BRUKER Maxis Impact ® mass 
spectrometer respectively. The magnetic property of Fe3O4 MNP were measured using 
the superconducting quantum interference device-vibrating sample magnetometer 
(SQUID-VSM) at the School of Physics, Leeds University.  
 
2.3.2 Reagents 
Iron (II) chloride tetrahydrate (>98%), Iron (III) chloride hexahydrate (> 98%), Iron (III) 
acetyl acetonate (> 99.9), IGEPAL CO-520, Oleylamine (technical grade 70%), Oleic 
acid (technical grade, 70%), 1,2-hexadecanediol (technical grade, 90%), 
Tetraethylorthsilicate (TEOS, 98%), and 3-(aminopropyl) triethoxysilane (APTES, 
>98%), succinic anhydride, N-hydroxysuccinimide (NHS, 98%), methane sulfonyl 
chloride (>99.7%), Sodium azide (NaN3), triphenylphosphine (PPh3, >98.5%) were 
purchased from Sigma Aldrich (UK). Trisodium citrate,  ammonium hydroxide (35% v/v), 
ethanol, hydrogen peroxide (30% v/v), and ninhydrin (>98%) were purchased from 
Fischer Scientific.  
 




2.3.3 DNA Probes and Biochemical Reagents 
All DNA probes and target DNA strands were purchased commercially from IBA GmbH 
(Germany). They were all HPLC purified by the supplier and their sequences are 
summarized in Table 2-1. High fidelity (HF) ECOR-I (20,000 U·mL-1)and CutSmart ® 
buffer (50 mM Potassium acetate 20 mM Tris-acetate 10 mM Magnesium acetate 100 
µg/ml BSA pH 7.9 at 25°C supplied as a 10X concentrated stock) were purchased from 
New England Biolabs. High activity Horse Radish Peroxidase (HRP), Neutravidin-HRP 
(NAV-HRP), and N(Hydroxysuccinamide)-PEG12-Maleimide (NHS-PEG12-Maelimide) 
were purchased from Thermo Scientific.  30Amplex red was purchased from Invitrogen 
Life Technologies (UK). 20 mM PBS buffer (150 mM NaCl, pH 7.4) and 1 M NaN3 was 
made with ultra-pure MilliQ water (resistance > 18 M.cm-1).  
 
  
Table 2-1. DNA sequences used in this study.  
DNA Name Sequence (53) 
DBCO-DNA-Biotin DBCO-T3 GAA TTC AAC ATC AGT CTG ATA GCT ATT-Biotin 
DBCO-DNA-SH DBCO-T9 GAA TTC AAC ATC AGT CTG ATA AGC TA T7-SH 
Target DNA AGA CTG ATG TTG AAT TCA AA 
 




2.3.4 Synthesis Fe3O4  MNPs using co-precipitation method, silica 
coating and amino modification 
  Synthesis of Fe3O4 MNPs using co-precipitation method 
The Fe3O4 MNPs were prepared using the co-precipitation method under a nitrogen 
atmosphere 130, 131. Briefly, 5 mmol of FeCl2 and 10 mmol of FeCl3 were dissolved in 50.0 
mL of deoxygenated water at pH 5.0. The solution was bubbled with nitrogen and  25.00 
mL of NH4OH (35% v/v) was added dropwise until the solution reached pH 11.0. The 
solution was heated to 80 oC for 30 minutes and then was raised to 90 oC for the next 2 
hours. A 50.0 mL of 0.20 M trisodium citrate was added and was allowed to react with 
the Fe3O4 magnetic particles for another 30 minutes at the same temperature. The Fe3O4 
MNPS which appeared as black precipitates were centrifuged at 4 500 rpm for 5 minutes 
and were washed with acetone once. The citrate capped Fe3O4 MNPs were re-dispersed 
in ultrapure water to a total volume of 30.0 mL. 
 
 Silica coating of Fe3O4 MNPs  
Different amounts of as-prepared Fe3O4 MNPs and volumes of tetraethylorthsilicate 
(TEOS) were used to coat the Fe3O4 nanoparticles with silica. Specifically, 1.0 mL of 
4.13, 8.3, 12.4, 16.5, and 20.7 mg mL-1 of Fe3O4 MNPs were dispersed in a mixed 
solution of 4.0 mL ultrapure water and 20.0 mL absolute ethanol. The dispersions were 
homogenized using an ultrasonicator for 15 minutes purged with nitrogen gas for 15 
minutes. 0.430 mL of NH4OH (35% v/v) and a known volume of tetraethylorthoslicate 
(TEOS) were added consecutively. The resulting solution was stirred at room 
temperature (ca. 15°C) under an N2 atmosphere for 3 hours. The silica coated Fe3O4 
MNPs (i.e. Fe3O4-SiO2) were centrifuged at 4500 rpm for 5 minutes and washed with 
ultrapure water three times. The Fe3O4-SiO2 nanoparticles were re-dispersed in water to 
a final volume of 1.0 mL. The concentration of the Fe3O4-SiO2 suspension was estimated 
by comparing the suspensions weight with pure water of the same volume. It should be 
noted that the density difference of the Fe3O4/SiO2 core/shell MNP in water was 
ignored.52  
  





 Pre-treatment of Fe3O4-SiO2 with polydiallyldimethyl 
ammonium chloride (PDDA) 
A 50.0 mg of the as-synthesized Fe3O4-SiO2 MNPs was added dropwise to a solution 
containing 0.1 % v/v polydiallyldimethyl ammonium chloride solution under vigorous 
stirring and room temperature. After 1 hour, the PDDA coated MNPs were 
magnetically separated and were washed with water three times. The resulting 
PDDA modified MNPs were re-dispersed in water. 
 
 Amino modification of Fe3O4-SiO2 MNPs 
The amine functionalized F3O4-SiO2 core-shell MNPs were synthesized under a N2 
atmosphere as follows: ~ 20.0 mg of the F3O4-SiO2  (as-prepared  and PDDA treated) 
were dispersed in 4.00 mL ultrapure water and 20.0 mL of absolute ethanol. Then 0.430 
mL NH3·H2O (35% v/v) and 3-aminopropyl-triethoxysilane (APTES) were consecutively 
added to the solution under vigorous stirring. The reaction was heated at 65°C for 3 
hours and then cooled to room temperature (20°C). The amine modified MNPs (MNP-
NH2) were separated by centrifugation (5 minutes, 7000 rpm), washed with ultrapure 
water three times and re-dispersed in 1.00 mL of ultrapure water. 
 
2.3.5 Synthesis of Fe3O4 MNPs via thermal decomposition method, 
silica coating, and amino modification 
 Synthesis of Fe3O4 MNPs via thermal decomposition  
The high temperature synthesis of the iron oxide MNPs was done under a nitrogen 
atmosphere 132, 133. A 0.71 g iron (III) acetylacetonate (2 mmol), 2.58 g hexadecanediol 
(10 mmol), 2 mL oleylamine (6 mmol), and 2.0 mL oleic acid (6 mmol), were magnetically 
stirred in 20.0 mL benzyl ether. The solution was heated to 200 oC for 2 hours and then 
heated to reflux (300 oC) for another 1 hour. The solution gradually turned black when 
the temperature reached 300 oC, indicating the formation of the iron oxide nanoparticles. 
The solution was cooled down slowly to room temperature. A 50.0 mL of ethanol was 
added to the mixture and the resulting suspension was centrifuged at 4 500 rpm for 5 
minutes. 20.0 mL hexane containing 0.05 mL oleic acid and 0.05 mL oleylamine was 
added to the black coloured material and was sonicated for 5 minutes. The mixture was 
centrifuged at 4600 rpm for 5 minutes and the undispersed residue was discarded. 50.0 




mL of ethanol was again added to the hexane solution containing the MNPs which was 
then centrifuged (4600 rpm, 5 minutes). The black coloured material was collected using 
a permanent magnet and dispersed finally in 10 mL hexane. 
 
 Seed mediated growth of Fe3O4 MNPs 
Seed mediated growth was done to increase the particles size of the MNPs previously 
synthesized in section 2.3.5.1. Specifically, 50.0 mg of the as-prepared MNPs was 
added to a solution containing 0.71 iron (III) acetylacetonate (2mmol), 2.58 g 
hexadecanediol (10 mmol), 2 mL oleylamine (6 mmol), 2.0 mL oleic acid (6 mmol) in 
20.0 mL benzyl ether. The mixture was heated for 1 hour at 100 °C to remove hexane. 
The mixture was heated at 200 °C for 1 hour and refluxed at 300 °C for another hour 132. 
The black mixture was cooled down gradually to room temperature. The same steps 
were carried out to purify the MNPs as described in section 2.3.5.1 
 
 Silica coating of Fe3O4 using micro-emulsion method 134 
A solution containing 0.500 g of IGEPAL-CO 250 in 11.0 mL cyclohexane was prepared 
and sonicated for 10 minutes at room temperature. Approximately 1.3 mg of Fe3O4 
MNPs (obtained after the first seed mediated growth) were dispersed in 1.00 mL 
cyclohexane, sonicated for 5 minutes, and then dispersed in the IGEPAL CO-250 
mixture, sonicated again for 10 minutes, and stirred for 12 hours at room temperature. 
After which 0.100 mL of 28% v/v NH4OH was added and the resulting solution was 
stirred for 1 hour. Subsequently, 0.300 mL of TEOS was added via equally fractionated 
drop of 0.075 mL per two hours. After that, acetone was added to precipitate the formed 
Fe3O4-SiO2 core-shell nanoparticles. The nanoparticles were collected by centrifugation  
at 5000 rpm for 3 minutes, followed by washings with 10  mL of butanol: hexane mixture 
(1:1), 10 mL of  isopropanol: hexane (1:1) mixture and 10 mL of ethanol: hexane (1:1) 
mixture.  The nanoparticles were further washed three times with pure ethanol and finally 
dispersed in 10.0 mL ethanol 134. The final concentration of Fe3O4-SiO2 was determined 
to be 55 mg·mL-1. 
 
  




 Optimization of silica coating parameters: (i) Effect of 
amount of TEOS and (ii) Effect of amount of MNP 
 
Optimization of synthesis parameters for Fe3O4 - SiO2 was done by (i) changing the 
amount of TEOS and (ii) changing the amount of MNPs while all other reaction 
conditions and purification steps were kept constant. First, the amount of TEOS  were 
varied as shown in Table 2-2. TEOS were added at an increment volume of 75 µL every 
three hours till the total volume was added to the reaction mixture.  
 
The weight of MNPs used the reaction was varied as shown in Table 2-3. 
 
 Amino modification of Fe3O4-SiO2 MNPs 
A  20.0 mg of the as-prepared F3O4-SiO2 MNPs were dispersed in 4.00 mL ultrapure 
water and 20.0 mL of absolute ethanol. Then 0.430 mL NH3·H2O (35% v/v) and 3-
(aminopropyl)triethoxysilane (APTES) were added to the solution under vigorous 
stirring. The reaction was heated at 65°C for 3 hours and cooled to room temperature 












1.3 0.50 100 75 1 x 
1.3 0.50 100 150 2 x 
1.3 0.50 100 300 4 x 
1.3 0.50 100 450 6 x 
 












1.3 0.50 100 300 4  x 
4.0 0.50 100 300 4  x 
10.0 0.50 100 300 4 x 
 




(20°C). The amine modified MNPs (MNP-NH2) were separated by centrifugation (5 
minutes, 6000 rpm), washed with ethanol three times and re-dispersed in 5.00 mL 
ethanol and kept in the fridge (4oC) until use. Further experiments were carried out by 
aliquoting 1.0 mL of the MNP-NH2 in ethanol and washing the nanoparticles three times 
with pure water. The final MNP-NH2 were dispersed in 1.0 mL of water.  
 
2.3.6 Quantification of amine loading on the Fe3O4 MNPs 
The amount of MNP surface amine (AM, mol/g) was determined by a  ninhydrin test. 
First, ninhydrin reagent was reacted with various concentrations of APTES to form 
coloured products and used as calibration standards 135. The absorbance at 570 nm of 
the above samples was recorded to establish the calibration curve by plotting the 
absorbance versus the APTES concentration.  A 1.0 mg of the amine-modified MNPs 
(weight of MNP-NH2 beads, Ws) was added to the solution containing 1.00 mL of 
ninhydrin reagent. The mixture was heated at 65 °C for 30 minutes and then cooled to 
30 oC in a dry bath incubator for another 30 minutes. The mixture was centrifuged (5 
minutes, 14000 rpm) and the supernatant was collected and diluted to 1.5 mL with 
absolute ethanol. The supernatant volume was designated as V (L) and its absorbance 
at 570 nm was measured against blank reference (absence of MNP-NH2) on a UV-Vis 
spectrophotometer. By using the calibration curve, the corresponding amine 
concentration (M, mol/L) was determined. The molar quantity of amine, (AM, mol·g-1) on 




𝐀𝐌(𝐦𝐨𝐥 𝐠⁄ ) =  
𝐌 𝐕
𝐖𝐬
 Equation 2-1 




2.3.7 Synthesis of NHS-PEG-N3 heterobifunctional linker ligand 
Scheme 2-3 shows the synthetic procedures of NHS-PEG-N3. The product of each step 
was confirmed by thin layer chromatography (TLC),  nuclear magnetic resonance (NMR) 
spectroscopy, and high resolution mass spectrometry (MS). The synthesis of amine-
PEG23-azide (MW ~1000, consisting an average of ~23 PEG units) was carried out as 
described by Mattoussi and colleagues 136 with some modifications. The amine-PEG~23-
azide was further reacted with succinic anhydride to give a carboxylic acid-PEG~23-azide 
ligand (d), which was reacted with N-hydroxysuccinimide (NHS) to give an NHS ester 
activated bifunctional linker, NHS-PEG~23-Azide (e). The NHS ester readily reacts with 
the primary amine group to form covalently linked PEG-N3 groups on the MNP surface 
to improve the MNP water dispersion stability and provide functional N3 groups for 




Scheme 2-3. Chemical structures and the synthetic route of NHS-PEG~23-N3. (i) 1. 
MsCl, THF, Et3N, 2. H2O, NaHCO3, NaN3;   (ii) 1. EtOAc/CHCl3, 1M HCl, 2.PPh3; (iii) 
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 Synthesis of N3-PEGn-N3 (n = ~23) 
Poly(ethylene glycol) (average MW =1000, 37.0 g, 37 mmol) was dissolved in 150 mL 
of dry THF containing methane sulfonyl chloride (11.0 g, 92.5 mmol) in a 500 mL three 
neck round bottom flask equipped with an addition funnel, septa and magnetic stirrer. 
The mixture was stirred under a N2 atmosphere and cooled to 0 ºC in an ice bath. 
Triethylamine (13 mL, 92.5 mmol) was added dropwise to the reaction mixture through 
the addition funnel over ~ 30 minutes. The reaction mixture was gradually warmed up 
to room temperature (~ 20 -25 ºC) and was stirred for 12 hours. The mixture turned 
cloudy white and was filtered to remove the white powdery material. The product was 
checked by TLC with MeOH: CHCl3= 1:15 (vol/vol) as elution solvent, Rf (MsO-PEG23-
OMs) = 0.14, Rf (OH-PEG23-OH) = 0.08, Rf (N3-PEG23-N3) = 0.20.  The filtrate was 
transferred to a round bottom flask and diluted with water (150 mL) and added with 
NaHCO3 (3.73 g, 44.4 mmol). The resulting mixture was transferred to a separation 
funnel and extracted with CHCl3 (60 mL x 3). The combined organic phase was 
evaporated to dryness on a rotary evaporator, yielding the desired product as a waxing 
solid (weight ~40 g). The above product (40 g), sodium azide (10 g, 154 mmol), THF ( 
50 mL), H2O (50 mL) and NaHCO3 (0.5 g) were then added to a two-necked round 
bottom flask equipped with a distilling head connected with a round bottom flask as 
solvent trap placed in an ice bath. The reaction was heated to distill off the THF. After 
all the THF have been removed, the reaction mixture was refluxed overnight. After 
cooling to room temperature, the reaction mixture was transferred to a separatory funnel 
and was repeatedly extracted with CHCl3 (100 mL x 5). The organic layers were 
combined and dried over anhydrous Na2SO4 (~50 g, for 30 minutes), filtered and 
concentrated in vacuum yielding a pale brown oil which solidifies into a waxy material at 
low temperature (~ 53 g). A ~ 1.50 g portion of the crude compound was purified by 
column chromatography using silica gel with 15:1 (vol/vol) CHCl3:MeOH as the eluent. 
Each fraction was checked by TLC (Rf for N3-PEG-N3 = 0.24) and the fractions 
containing the pure product were combined. The solvent was removed by rotary 
evaporation to yield  0.852 g of the desired product (58% yield) as a waxing solid. The 
chemical structure of N3-PEG-N3 was confirmed by 1H NMR as shown in Figure 2-4. N3-
PEG23-N3: 1H NMR (400 MHz, CDCl3 residue solvent peak = 7.27 ppm): 3.65-3.70 (m), 
3.35-3.4 (t, 4H, J = 5.0 Hz). 
 
 








Figure 2-4. (A) 1H NMR spectrum for N3-PEG~23-N3 (MW ~1000) in CDCl3. (B) The 
enlarged regions showing proton assignment: the larger peaks at ~ 3.65 ppm 
are the CH2 groups of the repeating PEG units. The 3.1 -3.6 ppm region was 
enlarged for clarity. The triplet peaks at ~3.4 ppm were the resonances of CH2 
groups of the terminal CH2 connected to the azide group.  
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The chemical structure of N3-PEG-N3 was further characterized by mass spectrometry. 
The PEG (average MW ~ 1000) used is a mixture of different lengths of ethylene glycol 
chain. The general molecular formula for the N3-PEG-N3 can be written as 
(CH2)2(C2H4O)nN6: 
 
Where n corresponds to the number of the ethylene gylcol units (EG, MW = 44 g·mol-1). 
The MW peaks reported in the mass spectra were determined as sodium ion abductions 
[MW+NH4+]. Therefore, the EG chain length of N3-PEG-N3 was estimated using the 
following formula: 
 
~130 + 44 𝑛 
Equation 2-2 
The mass spectra of N3-PEGn-N3 and the assignment of the corresponding EG chain 




Figure 2-5. Typical mass spectra of N3-PEGn-N3. The ion peaks are reported as 
(MW + NH41+) and the corresponding ethylene glycol chain lengths (n) 






































The mass error in ppm was calculated using the formula 137: 
 
𝑒𝑟𝑟𝑜𝑟 (𝑝𝑝𝑚) =  
𝑚𝑖 − 𝑚𝑎
𝑚𝑎
 𝑥 106 
Equation 2-3 
 
Where mi and ma refers to the measured accurate mass (experimentally observed m/z) 
and monoisotopic calculated exact mass (theoretical m/z) respectively. The ma was 
determined by summing the masses of the individual isotopes for a given ion. The 
molecular formula for N3-PEGn-N3 with 21 PEG units and ammonium ion is C44H92N7O21. 
Therefore, the measured accurate mass (from the mass spectra) and monoisotopic 
calculated exact mass are 1054.6344 and 1054.6351 respectively. The mass error in 
ppm = - 0.66. The same calculation can be carried out to calculate the mass error of an 
assignment with the other mass spectral peaks in Figure 2-5 (C).  
 
 Synthesis of N3-PEGn-NH2  (n = ~23)  
N3-PEG-N3 (4.5 g, 4.36 mmol) was dissolved in a mixture of 15 mL EtOAc and 15 mL 
CHCl3 and 1.0 M HCl (10 mL, 10 mmol) in a 500 mL two necked round bottom flask 
equipped with an addition funnel, septa and magnetic stirrer. The solution was stirred 
under a N2 atmosphere and cooled to 0 ºC in an ice bath. Then triphenylphosphine (TPP, 
1.25 g, 4.76 mmol) dissolved in ethyl acetate (17.0 mL) was transferred to the addition 
funnel and added dropwise to the reaction mixture while maintaining the temperature at 
0-5ºC. After the addition was complete, the reaction was gradually warmed up to room 
temperature (20-25 ºC) and was allowed to stir overnight (~12 hours) under a N2 
atmosphere. The biphasic mixture was transferred to a separatory funnel and the 
aqueous layer was collected and washed with EtOAc (100 mL x 2). The aqueous layer 
was transferred to a round bottom flask with a magnetic stirrer and placed in an ice bath.  
Potassium hydroxide (5.05 g, 90.0 mmol) was slowly added and the mixture was stirred 
until all solid KOH dissolved. The aqueous layer was transferred to a clean separatory 
funnel and was repeatedly extracted with EtOAc (100 mL x 5).  The combined organic 
layers were dried over anhydrous Na2SO4 (~50 g, for 30 min), filtered and concentrated 
in vacuum yielding a pale colourless oil which solidifies into a waxy material at low 
temperature (~ 5.1 g).  A ~1.5 g portion of the crude compound was purified by flash 
chromatography using silica gel with 5:1 (vol/vol) CHCl3:MeOH as the eluent. Each 
fraction was checked by TLC (Rf for N3-PEG-NH2 = 0.28) and fractions containing the 




pure desired compound were combined. After removal of the solvent, 0.875 g of the 
pure product was obtained (68% yield) and its 1H NMR spectrum was shown in Figure 
2-6. 1H NMR spectrum for NH2-PEGn-N3 in CDCl3 (n = ~23). (B) The enlarged 2.6 -3.6 
ppm region showing proton assignment. The residual methanol peak is observed at ~ 
3.48 ppm. NH2-PEG~23-N3: 1H NMR (400 MHz, ppm): 7.27 (CDCl3 solvent peak); 3.65-
3.70 ((m, -CH2 in PEG repeat units, 4), 3.52 (m, -CH2, 3), 3.40 (t, 2H, J = 4.8 Hz, -CH2-






Figure 2-6. 1H NMR spectrum for NH2-PEGn-N3 in CDCl3 (n = ~23). (B) The 
enlarged 2.6 -3.6 ppm region showing proton assignment. The residual 
























The chemical structure of NH2-PEG-N3 linker was further characterized by MS. 
Assuming a mono azide reduction of the N3-PEG-N3 linker, the general molecular 





The MW peaks [MW + H+] for NH2-PEGn-N3 was estimated using the following formula: 
 
~87 + 44 𝑛 
Equation 2-4 
 
The mass spectra of NH2-PEG-N3 and the assignment of the corresponding EG chain 
length for each molecular ion peak is shown in Figure 2-7. 
 
 
Figure 2-7. Typical mass spectra of NH2-PEGn-N3. The ion peaks are reported 
as (MW + H1+) and the corresponding ethylene glycol chain lengths were 












































The molecular formula for N3-PEGn-NH2 with 19 EG units and proton is C40H83O19N4. 
Therefore, the measured accurate mass (from the mass spectra) and monoisotopic 
calculated exact mass are 923.4975 and 923.5670 respectively. The mass error in ppm 
= -73.84. The same calculation can be carried out to calculate the mass error of an 
assignment with the other mass spectral peaks in Figure 2-7 (C).  
 
 Synthesis of carboxylic acid-PEG-N3 ligand 
NH2-PEG-N3 (1.23 g, 1.23 mmol) was transferred to a round bottom flask equipped with 
magnetic stirrer and 10.0 mL of dry DCM. Triethylamine (173 µL, 1.23 mmol) was added 
and the solution was stirred under a N2 atmosphere for 30 minutes. Succinic anhydride 
(0.247 g,  2.47 mmol) was dissolved in 10 mL of dry DCM with the aid of sonication and 
was added dropwise to the reaction mixture at room temperature. The reaction was 
stirred overnight (~12 hours) under a N2 atmosphere. After removal of the DCM solvent, 
the crude product was obtained a pale waxy material.  The crude compound was purified 
by column chromatography using silica gel with 5:1 (vol/vol) CHCl3:MeOH as the eluent. 
Each fraction collected was checked by TLC (Rf for N3-PEG-NH2 = 0.28; Rf for HOOC-
PEG-N3= 0.56) and the fractions containing the pure desired product were combined. 
After removal of the solvent, 1.271 g of the pure product was obtained (97 % yield). The 
1H NMR spectra of the purified compound is shown in Figure 2-8. HOOC-PEGn-N3: 1H 
NMR (400 MHz,   ppm): 7.27 (CDCl3 solvent peak); 3.65-3.70 (m,-CH2- in PEG repeat 
units, 4), 3.55 (m, 2H, -CH2- in PEG unit, 3), 3.48-3.50 (t, 2H, J = 4.8 Hz, -CH2-N3, 2), 












Figure 2-8. (A) 1H NMR spectrum for HOOC-PEGn-N3 in CDCl3 (n = ~23). (B) The 
enlarged 2.0-3.6 ppm region showing proton assignment.  
 
The chemical structure of HOOC-PEG-N3 linker was further characterized by MS. The 
general molecular formula of NH2-PEG-N3 is C4H5O3(C2H4O)nC2H5N4: 
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~209.16 + 44 𝑛 
Equation 2-5 
The mass spectra of NH2-PEG-N3 and the assignment of the corresponding EG chain 
length for each molecular ion peak is shown in Figure 2-9. 
 
 
The molecular formula for N3-PEGn-COOH with 23 EG units and sodium is 
C52H102O26N4Na. Therefore, the measured accurate mass (from the mass spectra) and 
monoisotopic calculated exact mass are 1221.6665 and 1221.6685 respectively. The 
mass error in ppm = -1.63. The same calculation can be carried out to calculate the 
mass error of an assignment with the other mass spectral peaks in Figure 2-9 (C).  
 
 Synthesis of NHS-PEG-N3 ligand 
 
HOOC-PEG–N3 (0.76 g, 0.62 mmol), N-hydroxysuccinimide (0.143 g, 1.24 mmol), and 
4-dimethylaminoyridine (0.076 g, 0.615 mmol) were dissolved in 10.0 mL of dry DCM in 
a 3-necked round bottom flask. The mixture was stirred under a N2 atmosphere for 30 
minutes and maintained at 0 oC using an ice bath. Dicyclohexyl-carbodiimide (0.225g, 
1.24 mmol) dissolved in 10.0 mL of dry DCM was added dropwise to the mixture while 
keeping the temperature at 0 oC. After the addition, the reaction mixture was allowed to 
gradually warm up to room temperature and stirred for 48 hours. The crude compound 
was purified by column chromatography using silica gel with 5:1 (vol/vol) CHCl3:MeOH 
as the eluent. Each fraction was checked by TLC (Rf for NHS-PEG-NH2 = 0.66; Rf for 
COOH-PEG-N3= 0.56) and the fractions containing the desired pure compound were 
combined. After removal of the solvent, 0.695 g of the pure product was obtained (91 % 
 
Figure 2-9. Typical mass spectra of HOOC-PEG-N3. The ion peaks are reported 
as (MW + Na1+) and the corresponding ethylene glycol chain lengths were 











































yield). The 1H NMR spectrum of the purified compound is shown in Figure 2-10. The 
product was dissolved in dry DMSO and stored in a freezer in aliquot till further use.  
NHS-PEGn-N3: 1H NMR (400 MHz,   ppm): 7.27 (CDCl3 solvent peak); 3.65-3.70 (m,-
CH2- in PEG repeat units, 4), 3.55 (m, -CH2- in PEG unit, 3), 3.48-3.50 (m, 2H,-CH2-N3, 
2), 3.30-3.42 (m, 2H,-CH2-NH-,1), 2.90-3.00 (m, 2H, -CH2-C(O)-,5) 2.78-2.82 (s, broad, 





Figure 2-10. (A) 1H NMR spectrum for NHS-PEGn-N3 in CDCl3 (n = ~23). (B) The 
enlarged 2.0-3.6 ppm region showing proton assignment.   
 
The chemical structure of NHS-PEG-N3 linker was further characterized by MS. The 































The MW peaks [MW + K+, H+] for NHS-PEGn-N3 was estimated using the following 
formula: 
~323.23 + 44𝑛 
Equation 2-6 
The mass spectra of NHS-PEGn-N3 and the assignment of the corresponding EG 
chain length for each molecular ion peak is shown in Figure 2-11. 
2.3.8 Surface Functionalization of MNP-NH2 and Preparation of 
MNP-DNAss-HRP Design-1 and Design-2 
 
The MNP-NH2 used in the succeeding experiments were the ones obtained from section 
2.2.5.5. The amine content were determined using ninhydrin assay to be ~ 760 nmol·mg-
1
. The MNPs were conjugated with 1% NHS-PEG~23-N3 and 99% NHS-PEG~17-OCH3. 
The amine content were determined for every new batch of MNP-NH2 prepared and the 
amount of the PEG linkers were adjusted accordingly. The azide modified MNP were 
then modified with the DBCO modified capture-DNA strands via copper-free click 
chemistry. Zeta potential measurements were carried out after each functionalization 
step. The incorporation of PEG linkers and DNA molecules onto the MNPs would 
change the surface charge thus, implying the success of the functionalization steps.  
 
Figure 2-11. Typical mass spectra of NHS-PEGn-N3. The ion peaks are reported 
as (MW + K+ + H+ ) and the corresponding ethylene glycol chain lengths were 
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 Surface Functionalization with NHS-PEG~23-N3 and blocking 
with NHS-PEG~17-OCH3 
An ~ 15 mg of MNP-NH2 (contains ~ 1.14 x10-5 mol amine) was washed with dry DMF 
three times and dispersed in 500 µL dry DMF. A 0.1216 g of NHS-PEG-N3 (0.094 mmol) 
was dissolved in 1000 µL dry DMF to yield a final concentration of ~ 94 mM. Then, ~1.5 
µL of the NHS-PEG-N3 solution was added to the MNP-NH2 and incubated for ~72 hrs 
at room temperature, leading to MNP surface being functionalized with azide. 
Thereafter, the MNPs were washed again with dry DMF and added with 45 µL of 250 
mM NHS-PEG~17-OCH3 and incubated for another 72 hrs at room temperature to 
passivate unreacted surface amine. The MNPs were washed by ultrapure water five 
times and dispersed in 1.0 mL PBS (pH 7.4) and stored in the fridge till use. 
 
  Conjugation of DBCO- DNA-Biotin to azide modified MNP 
and linking with NAV-HRP  
500 L of the MNP-PEG~23-N3 (~ 8 mgmL-1) and 50 L of 85 M DBCO-DNA-Biotin 
were mixed and incubated for 72 hrs. The MNPs were washed with ultrapure water three 
times and finally dispersed in PBS containing 1 mgmL-1 BSA. This yielded a final MNP 
concentration of ~ 4 mgmL-1 and the DNA loading per mg MNP was determined to be 
~ 0.36 nmolmg-1. The conjugation of the NAV-HRP to MNP-PEG~23-DNA-Biotin  was 
carried out  in a 1:1 mol ratio of NAV-HRP to DNA-Biotin. A 200 L aliquot of the MNP-
PEG~23-Biotin was mixed with 28 L of 10 M NAV-HRP in an eppendorf tube and 
incubated overnight and subsequently washed 5 times with PBS. Finally, the MNP-
DNAss-Biotin probe  (Design 1) was dispersed in 1.0 mL PBS. 
 
 Conjugation of DBCO-DNA-SH to azide modified MNP 
~ 15 mg of  MNP-PEG-N3 was washed with 1.0 mL ultrapure water and dispersed in 100 
µL of pure water. A 100 µL of ~200 µM capture DNA-SH was added and incubated for 
72 hrs at room temperature, leading to the DBCO-DNA-SH being covalently conjugated 
to the MNP surface via copper free click chemistry. The MNPs were subsequently 
washed three times with PBS. All the original and washing supernatants were collected 
for UV-Vis measurement at =260 nm to determine the amount of free-unbound DBCO-
DNA-SH, allowing the estimation of the DBCO-DBA-SH conjugation efficiency. Finally, 
the MNP-DNA probes were treated with 1 mL PBS buffer containing 1 mg/mL BSA to 




block MNP surface and reduce non-specific absorption of HRP in the subsequent steps. 
The MNP-DNA-SH were kept in the fridge till further use.  
 
The amount of the DBCO-DNA-SH loading was determined by comparing the 
concentration of the DBCO-DNA-SH before and after conjugation. The conjugation 
efficiency was computed using Equation 2-7: 
 
𝑪𝒐𝒏𝒋𝒖𝒈𝒂𝒕𝒊𝒐𝒏 𝒆𝒇𝒇𝒊𝒄𝒊𝒆𝒏𝒚𝑫𝑵𝑨 =  
𝑪𝒊 − 𝑪𝒙
𝑪𝒊
 𝒙 𝟏𝟎𝟎 
Equation 2-7 
 
where 𝐶𝑖 is the intial concentration of the DBCO-DNA-SH and 𝐶𝑥 is the remaining 
concentration of the DBCO-DNA-SH in solution after conjugation taken into account of 
the dilution factor. The absorbance of the DNA solutions were determined at =260 nm 
using nanodrop UV-Vis and the corresponding concentrations were calculated from the 
molar extinction coefficient (3.86 x 105 M-1 cm-1). This conjugation protocol afforded a 
DNA loading of 0.64– 0.70 nmolmg-1 with conjugation efficiency ranging from 35% -
72%.  
 
 TCEP treatment of MNP-DNA-SH 
The MNP-DNA-SH obtained from section 2.3.8.3 were treated with TCEP to reduce any 
disulphide bonds and to allow the conjugation of the maleimide modified HRP via 
Michael addition. This reduction step was simultaneously carried out while labelling HRP 
with NHS-PEG12-Maleimide linker as mentioned in section 2.3.8.5. Specifically, 1.0 mL 
of the MNP-DNA-SH was washed with once with PBS and dispersed in 200 µL PBS. 
This was added with 30 µL of 350 µM TCEP and incubated for 1 hr at room temperature. 
The MNP-DNA-SH(reduced) was washed once with 1.0 mL PBS to remove by-products 
from TCEP reduction.  
 
 HRP labelling with NHS-PEG12-Maleimide 
A 200 µL of 100 µM  HRP (dissolved in PBS) was mixed with 10 µL of NHS-PEG12-
Maleimide (10 µg·mL-1) and incubated for 1.5 hrs at room temperature. The maleimide 
labelled HRP was transferred to a centrifugal filter (MW cut off 10 kDa) and washed 




twice with 1.0 mL PBS. The volume of the HRP was adjusted to 100 µL by adding PBS.  
Then, 80 µL of the labelled HRP was mixed with 100 µL MNP-DNA-SH and was 
incubated for 3 hrs at room temperature and was left in the fridge overnight. The 
remaining 20 µL portion of the labelled HRP was used to determine the HRP 
concentration. The MNP-DNA-HRP were separated from the unreacted HRP by 
centrifugation at 10,000 rpm for 5 min and the supernatant was collected for UV-Vis 
measurement. Thereafter, the MNP-DNA-HRP were purified by repeated 5 cycles of 
centrifugation and washing with 1.0 mL PBS containing 0.1 % Tween-20 and once with 
1.0 mL PBS to remove any excess Tween-20. The final MNPs were dispersed in 1.0 mL 
PBS and kept in the fridge till further use.  
 
The amount of the labelled HRP conjugated to the MNPs were determined by comparing 
the concentration of the labelled HRP before and after conjugation. The percent 
conjugation efficiency was computed using Equation 2-8. 
 
𝑪𝒐𝒏𝒋𝒖𝒈𝒂𝒕𝒊𝒐𝒏 𝒆𝒇𝒇𝒊𝒄𝒊𝒆𝒏𝒚𝑯𝑹𝑷 =  
𝑪𝒊 − 𝑪𝒙
𝑪𝒊
 𝒙 𝟏𝟎𝟎 
Equation 2-8 
 
where 𝐶𝑖 was the initial HRP concentration and 𝐶𝑥 was the free unconjugated HRP 
concentration in solution after conjugation, taken into account of the dilution factor. The 
absorbance of the HRP solutions were measured at = 403 nm on a nanodrop UV-Vis 
and the corresponding concentrations were calculated using the molar extinction 
coefficient (1.0 x105 M-1 cm-1) 138. This conjugation protocol afforded efficiencies from 14 
– 27 %.  
 
2.3.9 General Experimental for detection of ECOR-I and DNA 
The general biosensing procedure was summarized in Scheme 2-4. Twice the amount 
of target DNA to that on the MNP beads was added to ensure efficient hybridisation. 
The capture-DNA loading used in the study ranged from 0.66 to 0.70 nmolmg-1 MNP 
unless otherwise stated. The MNP probe Design-1 and Design-2 were incubated with 
the target DNA then with ECOR-I. The MNPs were magnetically separated from the 
solutions and a portion of the clear supernatant was used for colorimetric detection 




reaction using amplex red and H2O2 with 1 hr incubation and then quenched by NaN3. 
The absorbance of the solutions were determined by using UV-vis at =572 nm.   
 
 
 Optimization of incubation temperature with ECOR-I 
 12 L (~ 60 g) MNP-DNAss-HRP in PBS was mixed with 10 L of (5 M) target DNA 
and incubated at room temperature for 1 hr. After that, 148 L water, 20 L Cutsmart® 
buffer and 10 L of 200 UmL-1 ECOR-I were added and incubated at different 
temperatures from 4C - 40C for 1 h. The final volume of the reaction was 200 L with 
10 UmL-1of the ECOR-I.  A control experiment was also carried out in which all reaction 
components were mixed except the target DNA. The experiment was conducted in 
triplicates. The MNPs were separated by centrifugation at 4000 rpm for 5 min. 150 L 
of the clear supernatant were transferred to a clean Eppendorf tube and added with 750 
L PBS, 50 L of 0.40 mM amplex red and 50 L of 0.40 mM hydrogen peroxide and 
was incubated at room temperature for 1 hr. The chromogenic reaction was stopped by 
addition of  100 L of 1.0 M NaN3 to the samples and the absorbance was recorded 
using Cary UV-Vis 50 spectrophotometer. 
 
 Optimization of incubation time with ECOR-I 
12 L (~60 g) MNP-DNAss-HRP in PBS was mixed with 10 L of (5 M) target DNA 
and incubated at room temperature for 1 hr. Then 148 L water, 20 L Cutsmart® buffer 
and 10 L of 200 UmL-1 ECOR-I were added and incubated at 30 C for 1  and 2 hrs. 
The final volume of the reaction was 200 L and the concertation of the ECOR-I was 10 
 
Scheme 2-4. Schematic illustration of the biosensing steps for the detection of 
ECOR-I and DNA. 




UmL-1. The same procedures mentioned in section 2.2.9.1 were followed in the 
succeeding steps. 
 
 Endonuclease Activity Assay with MNP-DNAds-HRP probes 
5 L (~ 60 g) MNP-DNAss-HRP in PBS was mixed with target 10 L of 5 M target DNA  
and incubated at room temperature for 1hr. Then, 155 L water, 20 L Cutsmart® buffer 
and 10 L  ECOR-I were added and incubated at 30 C  for 1 h. The final volume of the 
reaction mixture was all 200 L and the final ECOR-I concentration varied from 1x10-5 
to 10 UmL-1. All experiments were done in triplicates along with a control experiment 
(i.e. without target DNA, WOT). The same procedures mentioned in section 2.3.9.1 were 
followed in the succeeding steps. 
 
 DNA Detection with MNP-DNAds-HRP probes 
5 L (~ 60 g) MNP-DNAss-HRP in PBS was  were mixed with target 10 L of target 
DNA and incubated at room temperature for 1hr. After that, 155 L water, 20 L 
Cutsmart® buffer and 10 L of 10 UmL-1 ECOR-I were and incubated at 30 C  for 1 h. 
The final volume of the reaction mixture was 200 L. The final concentrations of DNA 
varied from 1 x 103 to 1 x 10-3 pM. Each samples were done in triplicates along with a 
control experiment (WOT; without target DNA). The same procedures mentioned in 
section 2.3.9.1 were followed in the succeeding steps.  




2.4 Results and Discussion  
2.4.1 Synthesis of Fe3O4 nanoparticles using co-precipitation and 
preparation of SiO2 capped Fe3O4 MNPs 
 
Iron oxide MNPs were successfully synthesized as black precipitates by using the co-
precipitation method. Co-precipitation is the simplest synthesis method for iron oxide 
MNPs. There are several chemical reaction steps known to take place in the Fe3O4 MNP 
formation, including the formation of some iron complexes as shown below 130: 
 
1.  Fe3+ + 3 OH- → Fe(OH)3 
2.  Fe(OH)3 → FeOOH + H2O 
3.  Fe2+ + 2 OH- → Fe(OH)2 
4.  2 FeOOH + Fe(OH)2 → Fe3O4 (MNP) + 2H2O 
 
Based on the above equations, the Fe2+ and Fe3+ molar ratio must be controlled to 1:2 
to form the magnetite (Fe3O4) MNPs. Since the Fe(OH)2 intermediate is susceptible to 
rapid oxidization by O2 under basic conditions, the entire synthesis vesicle was protected 
by an atmosphere of N2. The reaction was carried out under basic conditions (pH 11) by 
adding NH4OH. The nature of the alkali precipitator has known to play an important role 
in the reaction. Several studies reported that the use of strong base NaOH abruptly 
increased the OH- concentration in the solution, leading to rapid precipitation reaction 
and the formation of large Fe3O4 MNPs 131, 139. In contrast, ammonia is a weaker base 
than NaOH, and hence the pH of the reaction media would be lower, leading to smaller 
particle sizes. Magnetite (Fe3O4) is also known to be susceptible to oxidation in air, 
although this happens much slower than Fe(OH)2 does. Hence, purging with nitrogen 
was used during the reaction to prevent magnetite oxidization to maghemite (Fe2O3). 
Figure 2-12 (A) showed that the as synthesized Fe3O4 MNPs were homogeneously 
dispersed in an aqueous solution and remained stable up to 9 months without visible 
signs of precipitation. These Fe3O4 MNPs were found to adhere to the side wall of the 
Eppendorf tube when placed near a magnet within ca. 1 min of magnetic contact, leaving 
a clear supernatant solution as shown in Figure 2-12 (B). The Fe3O4 MNP concentration 
was 4.3 mg·mL-1. 





The MNPs were easily coated with amorphous silica via a sol–gel process because the 
iron-oxide surface has strong affinity for silica 140. The silica surface is terminated by 
silanol (Si-OH) groups which can easily couple to organosilanes by the formation of Si-
O-Si covalent bonds. Moreover, the silica coating can also protect the Fe3O4 MNPs from 
further oxidation and prevent direct interactions with biomolecules 140. In this study, silica 
coating was achieved by reacting Fe3O4 MNPs with tetraethylorthosilcate (TEOS) in a 
sol-gel reaction 134, 141, 142 in the presence of water and NH4OH catalyst. The hydrolysis 








Scheme 2-5. (A) Hydrolysis, and (B) condensation reaction of TEOS 
 
The hydrolysis of TEOS in a basic medium is associated with the formation of a 
supersaturated solution of silicic acid [SiOx(OH)4-2x]n. Subsequent condensation of 
TEOS results in the formation of siloxane bonds (-Si-O-Si-) and the loss of the 
protonated NH4+ 143-145. Sol-gel silica coating of iron oxide nanoparticles often leads to 
particle agglomeration and a significant increase of the overall particle size 140, 146-150 
 
Figure 2-12. The as-synthesized Fe3O4 MNPs as, (A) a homogeneous dispersion 
just being placed in the magnet prior to photo taken, and (B) after magnetic 
retrieval for 1 min with an external magnet. 
(B) (A) 




which can be a disadvantage for some biomedical applications. In this view, a careful 
control on the amount of TEOS and Fe3O4 particles must be considered in order to 
achieve a homogeneously dispersed Fe3O4-SiO2 in aqueous solution. Table 2-4 
summarizes the observations when different amounts of Fe3O4 were treated with the 
same volume of TEOS. 
 
In general, a stable homogeneous dispersion of Fe3O4-SiO2 MNPs was achieved by 
controlling the TEOS:Fe3O4 molar ratio. Under the present experimental conditions, 
MNP-SiO2 prepared at a TEOS:Fe3O4 molar ratio of < 12.5 gave a stable MNP-SiO2 
dispersion. Increasing the ratio of TEOS:Fe3O4 to above this threshold generally resulted 
in the precipitation of  nanoparticles. This observation highlighted the critical ratio to 
make stable dispersion. Table 2-4 shows the list of samples that exhibited a 
homogeneous dispersion. In comparison to uncoated Fe3O4, the Dh of the most samples 
were increased by ca. 20 nm after reaction with TEOS, suggesting a successful silica 
coating on the MNP. The zeta potential was used to measure the dispersion stability of 
the silica coated MNP 135, 151 because colloidal stability is important for biomedical 
applications. A high zeta potential (> 30 mV, either positive or negative) characterises a 
stable system due to strong electrostatic repulsion, while a low zeta potential value is 
typical of unstable ones. The zeta potentials for SiO2 coated and uncoated Fe3O4 MNPs 
Table 2-4. Parameters for synthesizing Fe3O4-SiO2 core-shell MNPs using 
different amounts of Fe3O4  (MW = 231.5 g·mol-1) and 0.100 mL (0.448 mmol) 














uncoated 4.30 - dispersed 147.0 -29.3 
A 4.30 24.11 precipitated - - 
B 8.27 12.54 precipitated - - 
C 12.39 8.37 dispersed 178.6 -41.9 
D 16.52 6.28 dispersed 165.3 -38.0 
E 20.65 5.01 dispersed 160.0 -37.3 
 




were all negative due to the ionized silica hydroxyl groups at pH 7.0 as shown in  Table 
2-4. In comparison to the uncoated Fe3O4 nanoparticles, the silica coated Fe3O4 MNPs 
exhibited higher negative zeta potentials, suggesting that silica coating may render the 
MNPs better colloidal stability to than the uncoated ones. 
  
2.4.2  Synthesis of amine modified Fe3O4-SiO2 MNPs 
 
3-(aminopropyl)triethoxysilane (APTES) was used to introduce functional amine groups 
to the Fe3O4-SiO2 MNPs as shown in the schematic diagram in Figure 2-13. The driving 
force here was the in situ formation of polysiloxane, which bond the MNP surface silanol 
groups (Si-OH) through the formation of Si–O–Si bonds 149. The synthesis was done in 
ethanol which provided an appropriate polarity to reduce the attractive force between 
APTES and the surface of Fe3O4-SiO2 147.  
 
 
Figure 2-13. Schematic diagram for the synthesis of MNP-NH2 nanoparticles 
 
Several trials were done to modify the Fe3O4-SiO2 surface silica at room temperature, 
but all attempts gave negative results in the qualitative test for amines. The low 
concentration of ammonia used in the experiment might lead to a slow hydrolysis of 
APTES, leading to the very low quantity of amines to deposite on the MNP-SiO2 surface. 
Increasing temperature (to i.e. 65 oC) would accelerate the hydrolysis and condensation 
of APTES on the MNP-SiO2 particle surfaces.147. However, aggregation was observed 
upon treatment of the Fe3O4-SiO2 particles with large amounts ( > 2.137 x 10-3 mol) of 




APTES, possibly due to that the negatively charged MNPs were attracted to the positive 
charge of the amine on APTES or its hydrolysed aggregates.  The Dhs of the amine 
modified Fe3O4-SiO2 core-shell nanoparticles were determined by DLS and shown in 
Table 2-5. Amine modification led to a large increase in the Dh, possibly due to 
aggregation or cluster formation during amine coating. This behaviour was also 
observed in another study wherein the introduction of a greater amount of aminosilane 
increased the tendency of agglomeration 147. Moreover, the irregular shapes of the 
Fe3O4 MNPs synthesized by the co-precipitation method might also have contributed to 
its large Dh. Zeta potential of the MNP-NH2 dispersions in water at pH 7.0 was shown in 
Table 2-5. The Fe3O4-SiO2 MNPs showed a more negative zeta potential than the earlier 
examples, suggesting that the citrate treatment increased the MNP stability via 
adsorption of negatively charged citrates on the MNP surface, strengthening the 
electrostatic repulsions among the MNPs. 
Table 2-5 Chemical and physical parameters of the prepared MNP-NH2. The  
Fe3O4-SiO2 nanoparticles treated with 350 µL , 500 µL, 750 µL, and 1000 µL 
APTES were labelled as NH2-350, NH2-500, NH2-750, NH2-1000 respectively. 
 




Zeta potential (, 
mV) 
Fe3O4-SiO2 none 188.6 -36.4 
NH2-1000 4.3 3747 + 0.134 
NH2-750 3.2  5212  -2.50 
NH2-500 2.1 1869 -11.2 
NH2-350 1.5 2854 -14.4 
 
In general, the high negative zeta potential of Fe3O4-SiO2 was significantly reduced or 
turned into slightly positive after amine modification, suggesting poor colloidal stability 
of the MNPs-NH2 dispersions. The positive charge of the amine groups at pH 7 reduced 
the overall negative charge of the SiO2 coated MNP, thereby decreasing their 
electrostatic stabilization. The samples treated with high amounts of APTES (i.e. NH2-
1000 and NH2-750) had very low zeta potential values, suggesting easy particle 
aggregation to form large particles. The results clearly demonstrated that the amount of 
APTES directly affected the colloidal stability of MNP-NH2. Several attempts were 
carried out to improve the water stability and to reduce the size of the MNP-NH2. Figure 




2-14 shows a facile approach to functionalise the Fe3O4-SiO2 MNPs with a cationic 




Figure 2-14. Schematic diagram for the synthesis of MNP-NH2 with a PDDA 
pretreatment of Fe3O4-SiO2 nanoparticles. 
 
PDDA contains quaternary ammonium functional groups which adsorb strongly to the 
negatively charged silica surface via electrostatic attraction, reducing the possibility of 
charge reversal induced particle aggregation upon APTES coating. It was mentioned 
that increasing the MNP-SiO2 with APTES temperature (i.e. 65 oC) accelerated the 
condensation of APTES on the surface of silica particles and effectively modifies the 
MNPs surface with the desired amine functionality. However, one consequence of heat 
treatment was that it led to agglomerated particles, due to the electrostatic attraction 
between the APTES (hydrolyzed and aggregated) and the surface silanolate. We 
hypothesized that a PDDA coating would block the negatively charged silanolate (-Si-
O-), reducing the interaction between the hydrolysed APTES and silica surface thereby 
giving to smaller amine-modified nanoparticles. The Dh and zeta potentials of MNP-NH2 
prepared with a PDDA pretreatment were determined and compared to those without a 
PDDA pretreatment and shown in Figure 2-15 .  





The PDDA treatment reduced the particle size of MNP-NH2. However, the results also 
clearly indicated the particle aggregation even with the PDDA pretreatment judging from 
their large Dhs  (i.e. > 1 m). The zeta potentials of the PDDA treated MNP-NH2 (Figure 
2-15 (B)) were all >15 mV, suggesting good water stability. 
 
2.4.3 Amine Quantification using Ninhydrin Assay 
Ninhydrin was used to quantify the MNP surface primary amines by forming 
Ruhemann’s purple which absorbed at 560 nm as shown in Figure 2-16 (A)135. The 
absorbance  v.s. concentration calibration plot gave a high linear correlation (R2 
=0.9805, Figure 2-16 (B)). The molar concentrations of the free amines on the amino-
modified MNPs were determined and converted to the molar quantity of amine in mol·g-
1 for comparison. 
 
Figure 2-15. (A) Hydrodynamic size and (B) Zeta potential with (red) and without 
(black) PDDA treatment prior to amine modification. 






























































Figure 2-16. (A) Schematic Diagram for the reaction of NH2-MNPs with 
ninhydrin, (B) absorbance versus APTES concentration calibration curve. 




Using Equation 2-1, the amounts of the amine grafted on the surface of MNPs were 
calculated and shown in Table 2-6. The addition of 350 μL (1.50  x10-3 mmol) and 500 
L (2.137 × 10-3 mmol) of APTES afforded a large amount of accessible (or reactive) 
amines on the MNP surface. Moreover, comparing the DLS sizes of the NH2-MNPs, 




A possible explanation here is that the use of high concentration of APTES may form 
thicker shells where not all amines are exposed on the surface. Moreover, bigger 
particles have smaller surface-to-volume ratios and hence lower amount of exposed 
surface amines. In addition, aminosilanes can undergo self-catalysis, leading to the 
formation of polymerized products at high concentrations 148. The electrostatic attraction 
between amine and silanolate groups on the MNP surface may lead to amino groups 
being oriented towards the silica surfaces as well as self-polymerization of aminosilane 
groups in the solvent. Both phenomena can adversely affect the efficiency of the surface 
functionalization by aminosilane molecules 150. At low amounts of APTES, hydrolyzed 
APTES molecules tend to diffuse to the MNP surface to form a well ordered monolayer 
with amine head groups exposed on the silica surface as shown in Figure 2-17  (A). 
However, at high amounts, some APTES molecules may be hydrolysed and 
polymerised in the solution before diffusion to the silica surfaces Figure 2-17 (B)), 
leading to poor surface functionalization and reduced surface reactive amines. 
  
Table 2-6 Molar quantity of amine (AM) grafted on the surface of MNP-SiO2 
Sample APTES (mmol) AM (mol/g) 
NH2-1000 4.52 x10-3 5.27 x10-4 
NH2-750 3.21 x10-3 1.08 x10-3 
NH2-500 2.14 x10-3 2.61 x10-3 
NH2-350 1.50 x10-3 2.06 x10-3 
 





2.4.4 Characterization of Fe3O4 –SiO2 nanoparticles. 
 
Transmission electron microscopy (TEM) imaging was done to determine the size and 
morphology of the F3O4-SiO2 core-shell nanoparticles. Figure 2-18 (A-C) revealed 
nearly spherical F3O4 particles of ca. 18 nm but with poor size and shape uniformity, and 
high degree of aggregation. The poor control of particle size distribution was due to the 
lack of robust surface protecting ligands that can prevent aggregation and limit growth 
speed. Moreover, the kinetic factors like nucleation and growth of crystals also affected 
shape homogeneity. When the concentration of the precursors reached supersaturation, 
the nucleation occurs instantly to form “seeds”. Then a slow process of crystal growth 
via diffusion of precursors on the surface of the “seeds” takes place. The key to produce 





Figure 2-17. Schematic diagram of APTES hydrolysis and condensation under 
(A) low concentrations and (B) high concentrations of APTES. Reprinted from 
reference (33)  
 




images (Figure 2-18 (B) and (C) inset) show that the nanoparticles poses core-shell 
structures with a high tendency of aggregation, consistent to their relatively large Dh 
measured by DLS. Moreover, silica coated samples showed an amorphous silica shell 







Figure 2-18. TEM images of (A) uncoated F3O4 nanoparticles, (B) Fe3O4-SiO2 
core-shell nanoparticles sample Cx, and (C) F3O4-SiO2 core-shell 
nanoparticles sample Ez. The Figure insets show the magnified images of 
Fe3O4 and the silica coatings for B and C, and (D) X-ray diffractograms of 
MNPs prepared using co-precipitation method. 
 
The structural information of the MNPs is collected by powder X-ray diffraction. Figure 
2-18 (D) shows the XRD patterns of the coated and uncoated MNPs. All the major peaks 
were indexed to the standard pattern for Fe3O4 (JCPDS No. 19-0629). The Fe3O4 




showed peaks at Bragg angles 2 ~30.2°, 35.5°, 43.0°, 53.1°, 57.0°, 62.5° and 74.2° 
corresponding to Miller indices (220), (311), (400), (422), (511), and (440) respectively, 
suggesting that Fe3O4 MNPs were in inverse spinel structure [JCPDS card no. 19-0629].  
 
The XRD pattern for MNP-SiO2 showed  weakening Fe3O4 peaks together with the 
occurrence of a broad peak 23° associated with amorphous silica 134. This implied that 
a thin coating on the Fe3O4 MNPs was achieved. The peaks associated with Fe3O4 were 
not observed after the further treatment with APTES. For robust biomedical applications, 
every MNP, regardless of size, must be coated with a homogeneous silica shell - which 
the co-precipitation route appeared to be lacking even after several optimization steps. 
In view of this, thermal decomposition was seen as a more viable route to prepare more 
uniform MNPs for biosensing applications. 
 
2.4.5 Synthesis of Fe3O4 nanoparticles using thermal 
decomposition method 
 
Thermal decomposition route is known to yield nanoparticles with narrow size 
distribution, high crystallinity, and excellent shape control  118, 119, 132, 133. In this study, an 
organic precursor ferric acetylacetonate [Fe(acac)3] was decomposed at high 
temperature inside a high boiling point non-polar solvent phenyl ether (bpt. 290°C) in the 
presence of capping agent (oleic acid) and a reducing agent (1,2-hexadecanediol). This 
approach can achieve high monodispersity of the final nanoparticles because the 
nucleation and growth steps occur at different temperatures. The precursor was heated 
up to 200 oC to decompose the precursor and was kept at that temperature for 2 hrs to 
initiate the nucleation process. It was reported that increase the temperature directly to 
reflux could result in poor particle monodispersity 153. The temperature was then 
increased to 300 °C for the growth process. The final nanoparticles were coated with 
oleic acid to impart hydrophobicity and solubility in non-polar solvents like hexane. 
Zhang and colleagues showed that that the oleic acid molecules were chemisorbed on 
the MNP surface and formed a single layer structure 154.  
 
Figure 2-19 (A) showed a TEM image of Fe3O4 MNPs prepared by thermal 
decomposition. The MNPs were mostly monodisperse, non-aggregated and had an 




average diameter of 6.4 ± 0.72 with a narrow size distribution (polydispersity  11%, 
Figure 2-19 (B), in good agreement with literature. The as-synthesized nanoparticles 
were subjected to one round of seed mediated growth to increase particle size. The 
Fe3O4 nanoparticles after seeded growth appeared to be spherical with an average size 


































Figure 2-19. Representative TEM micrographs of (A) the Fe3O4 MNP seeds 
prepared by thermal decomposition (B) Corresponding particle size 
distribution histogram of MNPs, (C) Fe3O4 MNPs after one round of seed 
mediated growth, and (D) Magnetization of the Fe3O4 MNP in (C) as a function 
of magnetic field obtained by VSM. 
 
The Fe3O4 MNPs obtained after 1 round of seed mediated growth were coated with silica 
and subsequently modified with APTES to impart amine functional groups. Silica coating 



















was carried out using reverse micro-emulsion method due to the ability of generating 
narrow size distribution and an ability to coat hydrophobic nanoparticles via ligand 
exchange mechanism. Reverse or water-in-oil micro-emulsion means that the water 
phase covered with a surfactant is dispersed in a non-polar media. In a sense, the “water 
droplets” act as constrained nanoreactors which are the key to attain narrow size 






Figure 2-20. Schematic illustration of the mechanism of silica coating on Fe3O4 








First, the IGEPAL CO-520 spontaneously forms micelles structures in cyclohexane 
because of its hydrophilic groups. As the Fe3O4 nanoparticles are added to the solution, 
a ligand exchange between oleic acid and IGEPAL CO-520 takes place. However, 
fractions of IGEPAL CO-520 molecules still adsorbs on the surface of the iron oxide 
nanoparticles with part of the IGEPAL CO-250 micelles still in the micelle form. Addition 
of ammonia fills and enlarges the size of IGEPAL CO-250 micelles and forms stable a 
reverse micro-emulsion system. Subsequently, the added TEOS hydrolyses at the 
oil/water interface and perform the ligand exchange with IGEPAL CO-520 adsorbed on 
the iron oxide surface and then transfer the nanoparticles to the water phase. Ultimately, 
the hydrolysed TEOS on the Fe3O4 surface undergoes a condensation process and 
forms a silica shell. The obtained MNP-SiO2 core-shell nanoparticles display uniform 
dispersion and the thickness of SiO2 shell can be tuned easily and precisely by changing 
the quantity of TEOS. Using this strategy I was able to obtain monodisperse and size-
tuneable Fe3O4-SiO2 core-shell nanoparticles with MNPs located at the centre. As 
shown in Figure 2-21 (A), MNP-SiO2 NPs were successfully synthesized through one-
step TEOS addition (75 µL) using IGEPAL CO-520 as surfactant; more that 95 % of the 
SiO2 beads contained only one MNP at the centre.  
  













Figure 2-21. MNP-SiO2 core-shell nanoparticles prepared using different 
amount of TEOS. (A) 75 µL, (B) 150 µL, (D) 300 µL, and (D) 450 µL TEOS. The 
scale bars are all  20 nm. 
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The particles were roughly spherical with some degrees of inhomogeneity and 
aggregation. Increasing the amount of TEOS (from 75 to 450 µL) allowed to obtain MNP 
with thicker SiO2 shell (from 7 nm  to 15 nm ). Figure 2-21 (A – D) showed that the 
addition of more TEOS improved, in general, the particle morphology to more spherical 
with higher degree of particle homogeneity and less aggregation. A close examination 
of different TEM images showed the occurrence of single core, multi-core, and core-free 
silica NPs. Table 2-7 showed the percentages of the different types of MNP-SiO2 
nanoparticles. 






















1.3 0.50 75 100 96 1 3 
1.3 0.50 150 100 92 6 2 
1.3 0.50 300 100 89 4 8 
1.3 0.50 450 100 84 5 10 
 
The high (>84 %) occurrence of single-core MNP indicates that MNP acts as 
heterogeneous nucleation points for SiO2 deposition, consistent  with the mechanism 
elucidated by Meijerink and colleagues 155. In general, a decrease of the single-core 
nanoparticles together with an increase of core-free silica was observed with the 
increasing TEOS amount. This observation highlights the role of TEOS in the stability of 
the microemulsion which is sensitive to the alcohol content generated in TEOS 
hydrolysis: a high concentration of TEOS will produce more ethanol, leading to 
increased MNP-SiO2 polydispersity 156. With all other experimental conditions held 
constant (i.e. weight of MNP, weight surfactant, volume NH3), the increased 
concentration of TEOS may destabilise the micelle systems, leading to the formation of 
core-free SiO2 NPs. Nevertheless, the MNP-SiO2 particles prepared by micro-emulsion 
are more homogeneous than those prepared by co-precipitation and mostly single-
cored. Although, a detailed analysis also reveals the existence multi-core nanoparticles 
albeit at relatively small proportions (< 6 %). The unequal core number and silica shell 
thickness can result in an irregular magnetic field causing uneven heating in 
hyperthermia and tissue distribution108, 157. However, for biosensing applications, multi-




cored nano-composites can be an advantage because it will allow easier and faster 
magnetic retrieval after target capture in solution. 
 
To clarify the effect of the amount of MNP, different amounts of MNP (e.g. 1.4, 4.0 and 
10 mg) were added to the reverse emulsion while the volume of TEOS was held 
constant. The corresponding TEM images were presented in Figure 2-22 (A) – (C). The 
particles appeared as non-aggregated spherical core-shell nanoparticles when 1.4 mg 
of Fe3O4 MNPs was used (Figure 2-22 (A)). However, a gradual deviation from spherical 
core-shell nanoparticles was observed as the amount of Fe3O4 MNPs was increased to 
4.0 mg  (Figure 2-22  (B)). Increasing the weight of MNP to 10 mg destabilised the 
micelle  system, resulting in serious particle aggregation (Figure 2-22 (C)). Thus, the 
preparation of multiple MNP cored particles cannot be achieved by simply increasing 





Figure 2-22. MNP-SiO2 prepared using different amount of MNPs. The scale bars 
are all 20 nm. 
 
 
The silica coated nanoparticles were treated with APTES to introduce amine groups for 
further conjugation as before. Initial attempts to modify the Fe3O4-SiO2 with amine were 
done by addition of APTES on the same reaction flask containing the Fe3O4 and TEOS 
using the fractionated drop method. However, it was observed that the particles 
gradually settled down after the addition of APTES. With this observation, the amine 
modification was done using the same method used in the earlier part of the study. The 
silica coated Fe3O4 nanoparticles were washed three times by ethanol to remove excess 
20 nm 20 nm 20 nm 




surfactant, dispersed in ethanol and was modified with APTES at 65 oC. Under these 
experimental conditions, the final amine-modified nanoparticles were stable in ethanol, 
but became flocculated when being transferred to water. The aggregation of the amine 
modified MNPs in water might be due to the formation of hydrogen bonds between 
amino groups of the MNPs 147. Shown in Figure 2-23. is a TEM image of the amine 
modified Fe3O4 nanoparticle which clearly exhibits a distinct core-shell structure. The 
average size of the nanocomposite was determined to be 32 ± 4.2 nm (polydispersity = 
13 %) and an average shell thickness of  10 nm. The overall silica coating is composed 
of two shell layers, from hydrolysis and condensation of TEOS and APTES respectively, 
thus, giving a thick shell coating. Note that the 10 nm shell thickness was not directly 
measured due to shell inhomogeneity, but was derived from the overall particle size 
increase compared with the seed mediated growth MNPs and MNPs coated with silica 
shell. Moreover, there was no crystallinity of the silica shell was observed.  
 
 
2.4.6 Surface Functionalization of MNP-NH2  
The MNP-NH2 were functionalized with by NHS-PEG~23-N3 and NHS-PEG~17-OCH3. The 
NHS ester moiety specifically reacted amino groups, thus, covalently linking the PEG 
linkers onto the surface of the MNP. The unreacted  surface amines were further blocked 
 
Figure 2-23. TEM images of amine-modified Fe3O4 core-shell nanoparticles 
synthesized at 65 oC using 350 µL of APTES. 
 
50 nm 




with NHS-PEG~17-OCH3. The PEG group functioned to stabilize the MNP dispersion in 
aqueous solutions and provided a protective layer against non-specific adsorption of 
horse radish peroxidase in biosensing assays. The functionalization of the bifunctional 
PEG linker introduced surface azide groups for further conjugation to the DBCO 
modified  DNA via click chemistry. The conjugation steps were monitored by zeta 
potential measurement as shown in Figure 2-24 .  
 
 
The MNP-NH2 surface showed a positive zeta potential (+20.2 mV), implying  that the 
silica coated MNPs were modified with amino groups. The introduction of the PEG 
linkers decreased the zeta potential to  +2.63 mV, suggesting most amino groups have 
been converted to neutral PEGs. A negative zeta potential  (-3.70 mV) was observed 
after conjugation of the DBCO-DNA-SH, due to the anionic nature of the DNA backbone. 
The changes in surface charge of the MNP after each surface functionalization step 
confirmed the attachment of the desired molecules. 
  
 
Figure 2-24. Zeta potential of the MNP-NH2 and after functionalization of PEG 









2.4.7 Biosensing Principle 
The general biosensing approach using MNP-DNAds-HRP probes is shown in Figure 
2-25. HRP is conjugated to the MNP-capture DNA via biotin-neutravidin interaction 
(Design 1) or covalent linkage (Design 2). In both designs, the HRP  enzyme that acts 
to amplify the signal produced. The capture DNA contains a sequence 5-…G/AATTC…-
3 while the other (i.e. target DNA) contains a sequence 3-…CTTAA/G…-5. The 
capture DNA is complimentary to target DNA and forms a palindromic sequence that 
can be recognized by ECORI endonuclease. Incubation with ECORI cuts the specific 
double strand DNA sequence and releases the DNA-HRP fragments into the solution. 
The MNP can be conveniently retrieved by centrifugation and a magnet. The 
supernatant containing thousands of HRP molecules can catalyse the conversion of 
amplex red in the presence of H2O2 to a highly coloured product resorufin. The 
absorbance was determined spectrophotometrically at  = 570 nm. The simple 
biosensing strategy is easy to carry out and does not require any rigorous washing 
steps, thus, shortening the assay time to ~ 4 hours.  
 
 
Figure 2-25. Schematic illustration for the MNP based colourimetric biosensor 
for detection of ECOR-I and DNA. The blocking of MNP with PEG~17-OCH3 was 
omitted for simplicity. The MNP PEG and capture DNA strand are shown in 
green and red colours respectively. 




2.4.8 ECOR-I Detection with MNP-DNAds-HRP Design-1 
The MNP-DNAds-HRP Design-1 probes were incubated with different concentrations of 
ECOR-I from 10 to 0.01 UmL-1 at 37 C and 2 hrs. The production of resorufin was 
monitored by recording the time-dependent absorbance at 572 nm for 30 min (Figure 
2-26 (A)). The samples were mixed using a pipette at several stages of the 
measurement because the formation of a non-homogeneous coloured solutions was 
observed. Figure 2-26 (A) showed an increase in the solution absorbance with time, 
suggesting that DNA-HRPs were released into the solution after ECOR-I incubation. 
Based from the slope shown in Figure 2-26 (B), 10 UmL-1 ECOR-I gave the highest 
signal, and the signal decreased with the decreasing ECOR-I concentration as 
expected. This observation suggested that  ECOR-I was able to cut and release DNA-





Figure 2-26. ECOR-I detection using MNP-DNAds-HRP Design-1 after incubation with 
ECOR-I at 37 C for 2 hrs. (A) Time dependent absorbance of the samples at  = 572 
nm. (B) The corresponding slopes from the linear fit plots in (A). 
 
Although a general trend of increasing absorbance of the samples with the increasing 
ECOR-I concentration was observed, the rate of resorufin production was slow. This 
could be due to the difficulty of the ECOR-I accessing the nicking site of the DNA. The 
control experiment (without target, WOT) also showed high background absorbance, 
possibly due to non-specifically adsorbed NAV-HRP detaching from the MNP probe 
surface or the dissociation of the biotin– NAV-HRP complex. Several experimental 
parameters were changed to improve the current design of the MNP probes and obtain 


































































greater signal. Specifically, the capture DNA was re-designed to introduce a longer oligo 
thymine spacer at the 5’ end and a covalent linkage between the HRP and  the MNP-
DNA probe, resulting in Design-2. We hypothesised that the use of a longer spacer 
would improve the accessibility of the ECOR-I to recognise and cleave the specific DNA 
sequence. A covalent linking of the enzyme should be able to lower the background 
signal by avoiding the biotin-NAV dissociation. The incubation temperature and time 
with ECOR-I were also optimised to get a more reliable  biosensor.  
 
2.4.9 ECOR-I and DNA detection with MNP-DNAds-HRP Design-2 
 Optimization of incubation temperature and time  
The effect of incubation temperature and time of MNP-DNAds-HRP Design-2 probes with 
ECOR-I were investigated to determine the optimum condition for ECOR-I to cut the 
DNA strand and release DNA-HRP to the solution. Firstly, the MNP-DNAds-HRP Design-
2 were incubated with ECOR-I from 4 to 40 oC for 1 hr. A high ECOR-I concentration of 
10 UmL-1 was used to ensure efficient cut all the DNA linkage and release  DNA-HRP 
into the solution to generate a high signal. The amplex red-H2O2 amplification  was 
carried out in 1 hr and stopped with addition of 100 L of 1 M NaN3. This method 
provided a better alternative to the real time monitoring of the solution absorbance 
because the colour was homogenously dispersed. Figure 2-27 (A) showed the average 
absorbance of assay solutions incubated at different temperatures.  
 
A higher absorbance was observed at 37 C than that obtained with Design-1 at the 
same ECOR-I concentration (10 UmL-1). Moreover, a lower background signal was also 
observed. Thus, the use of longer spacer length and the covalent linkage of the HRP to 
the DNA successfully improved the assay signal and also reduced the background. The 
sample incubated at 4 oC  gave a low signal that was almost comparable to the control 
experiment. This observation implies that ECOR-I activity is almost negligible at this 
temperature. Increasing incubation temperature resulted to an increase in the signal and 
the highest signal was observed  at  30 oC together with a low background. Further 
increasing temperature resulted in a decrease in signal, suggesting a reduced ECOR-I 
activity. Thus 10 UmL-1 ECOR-I can effectively cut the specific DNA sequence and 
release a large amounts DNA-HRP fragments in solution. Moreover, the use of a high 
activity HRP is important because it can catalyse the fast conversion of amplex red to 
resorufin. Hence, all succeeding experiments were conducted at 30 oC.  






The effect of ECOR-I incubation time was also investigated. The MNP-DNAds-HRP 
Design-2 probes were incubated with 10 UmL-1 ECOR-I at 30 oC for 1,  2 and 4  hours. 
It was expected that the longer the incubation, the more cutting and release of DNA-
HRP fragments to the solution, leading to a higher signal generation. Figure 2-27(B) 
showed that the signal showed no  significant difference for 1, 2 and 4 hr incubation, 
suggesting that 1 hr was enough for ECOR-I to cut most of the specific DNA sequence. 
Furthermore, the control sample (WOT) also showed a slight increase of the background 






Figure 2-27. (A) Effect of incubation temperature (indicated underneath each 
bar) using Design 2 probes incubated with 10 UmL-1 ECOR-I, (B) Effect of 
incubation time on assay performance using MNP-DNAds-HRP Design 2 and 
10 UmL-1 ECOR-I at 30 C. The blue and red  bar indicates the experiment 
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 ECOR-I and DNA detection  
Initial ECOR-I detection experiments were carried out by incubating the MNP-DNAds-
HRP Design-2 probes at 30 oC for 1 hr with different concentration of the ECOR-I (10– 
1x10-5 UmL-1). The enzymatic amplification with amplex red and H2O2 was carried out 
for 1 hr and were terminated with the addition of NaN3. The absorbance of the solutions 
were recorded as shown in the Figure 2-28 inset.  Each sample were done in triplicates 
and  the average absorbance was calculated and plotted in Figure 2-28. The incubated  
with 10 UmL-1 showed the highest absorbance signal while those incubated with 1 
UmL-1 and lower concentrations ECOR-I showed very low signal and almost 
comparable to the controls.   
  
 
Figure 2-28. ECORI detection using MNP-DNAds-HRP Design-2. The MNP 
probe samples were incubated with different concentrations of ECORI for 1 
hr at 30 C. The term WOT refers to the control experiment without target DNA. 
Inset: absorbance wavelength scan of the test solutions. The blue and red 
 bar indicates the experiment containing the target DNA and control 
experiment (i.e. without the target DNA) respectively. 
 
The incubation time was prolonged to 2 hrs to allow low concentration ECOR-I to cut 
more dsDNA strands and release more HRPs hence to provide better signal to 
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and release more of the DNA-HRP fragments in the solution. Prolonging the ECORI 
incubation will release enough DNA-HRP fragments and give appreciable difference in 
the absorbance of the solutions. The absorbance of the solutions were recorded after 1 
hour  reaction with amplex red and H2O2 and shown in Figure 2-29.  A control 
experiment was carried out alongside with the MNP probes incubated with the target 
DNA. This was done to see whether the absorbance of solutions from MNP Design-2 
probes incubated with the target DNA significantly differ than  those  MNP Design-2 
probes without the target DNA.  
 
 
The signal was again the highest at 10 UmL-1 ECOR-I  as expected. However, those 
incubated with ECOR-I concentrations at ≤ 1 UmL-1  still gave low signal and comparable 
with the negative controls, implying that most of MNP-dsDNA-enzyme probes were still 
 
Figure 2-29. ECORI detection using MNP-DNAds-HRP Design-2. The MNP probe 
samples were incubated with different concentrations of ECORI for 2 hrs at 30 
C. The term WOT refers to the control experiment without target DNA. Inset: 
absorbance wavelength scan of the test solutions. The blue and red  bar 
indicates the experiment containing the target DNA and control experiment (i.e. 
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intact. Given the assay signal was slightly higher than the control at 10  UmL-1, the 
MNP-DNAds-HRP Design-2 probe can detect ECOR-I down to ~1  UmL-1.  
 
The feasibility of the MNP-dsDNA-HRP Design-2 probe to detect target DNA was also 
investigated. The MNP probes were incubated with different concentrations of the target 
DNA with a fixed ECOR-I concentration of 10 UmL-1.Figure 2-30 showed the results 
after 1 hr of enzymatic amplification with amplex red and H2O2.  
 
 
Figure 2-30 DNA detection using 10 UmL-1 ECOR-I with 1 hr incubation at 30 C. 
The term WOT refers to the experiment without target DNA. Inset: absorbance 
wavelength scan of the test solutions. The blue and red  bar indicates the 
experiment containing the target DNA and control experiment (i.e. without the 
target DNA) respectively. 
 
The assay with 1000 pM target DNA showed the highest signal with an appreciable 
difference form its control experiment. The MNP probes incubated with lower 













































































target DNA. Under this protocol, the MNP-DNAds-HRP Design-2 can positively detect 
1000 pM of target DNA. 
 
In summary, we have developed a MNP-SiO2 core-shell nanoparticles for detection of 
ECOR-I and DNA. However, the current results for the biosensing is uncompetitive 
against several reported ECOR-I biosensors with similar detection strategy and DNA 
biosensors based on nicking endonuclease. These observations highlight an important 
aspect for the improvement of the biosensor, which is to control the surface chemistry 
of the MNP. Specifically, it is important to reduce non-specific adsorption of NAV-HRP 
in order to decrease the background signal. In this direction, a new MNP platform based 
on the polymer encapsulated MNP was carried out. Similarly, the PEG units will be used 
to graft to the polymer forming a thick brush like structure. This is expected to 
dramatically reduce background signal and contribute to a more sensitive biosensor. 
The details  of the preparation of polymer encapsulated MNP and its application towards 
DNA biosensing is presented in Chapter 3.  
 
2.5 Conclusion  
Two different methods have been successfully employed to make Fe3O4 MNPs, 1) co-
precipitation, and 2) thermal decomposition. Fe3O4 MNPs synthesised by co-
precipitation generally yielded stable and water-dispersible MNPs. XRD analysis 
confirmed the identity of the MNPs being Fe3O4. However, TEM analysis revealed that 
the as-synthesized MNPs were ~18 nm in size but with poor size and shape uniformity. 
As a result, the thermal decomposition of Iron (III) acetylacetonate was used to 
synthesise aggregation-free MNPs with narrow size distribution and uniform spherical 
morphology. However, this synthesis process was more complicated and having lower 
yield than the former, and moreover the oleic acid capping ligands on the MNPs also 
rendered them hydrophobic and water in dispersible. Nonetheless, these negative 
features were easily outweighed by the formation of high quality MNPs, crucial for 
biomedical applications. The average particle size of the MNPs synthesised by thermal 
decomposition was 6.4 ± 0.72 nm and increased to 12.6 ± 2.0 nm after 1 cycle of seed 
mediated growth. Silica coating has been successfully applied to both types of MNPs, 
allowing for effective protection of the MNPs from oxidation, aggregation at physiological 
pH and also transfer the hydrophobic MNPs (prepared via thermal decomposition) to 




the aqueous media. A sol-gel method was employed to coat the MNPs prepared by co-
precipitation with a silica shell using base catalysed hydrolysis of TEOS in an aqueous 
solution. The successful silica coating was confirmed by XRD and TEM analysis. 
However, DLS measurements and TEM image analysis revealed significant 
agglomeration with poorly defined Fe3O4–SiO2 core-shell nanostructures with co-
precipitation prepared MNPs. For MNPs synthesised by thermal decomposition, the 
silica coating was achieved by a reverse micro-emulsion method. After several attempts, 
monodisperse core-shell hydrophilic nanoparticles were successfully synthesized as 
revealed by TEM imaging. The core-shell Fe3O4-SiO2 nanoparticles were further 
functionalized with amine groups in a base catalysed hydrolysis and condensation of 
APTES on the silica surface at 65 oC. The overall silica shell thickness was estimated 
to be ~10 nm. The surface reactive amine groups were  quantified using the ninhydrin 
assay.  
 
The MNP were functionalised with PEGylated heterobifunctional linkers and passivation 
reagents (i.e. NHS-PEG~23-N3 and NHS-PEG~17-OCH3) to improve water stability and 
provide functional group for further conjugation with  DBCO modified-DNAs. The results 
of each surface functionalization step were monitored by zeta potential measurement. 
The DNA modified MNPs were conjugated with HRP via biotin-Neutravidin interaction 
(with NAV-HRP) or covalent thiol-maleimide reaction to yield MNP-DNAss-HRP Design-
1 and Design-2 probes respectively. The MNP probe Design-2 offered better signal to 
background ratio in ECOR-I detection than   Design-1. A high ECOR-I activity was 
observed at 30 C and incubation with the MNP probe Design-2 at 1 hr was enough to 
generate appreciable signal. The MNP-DNAds-HRP Design-2 can detect 10 UmL-1 
ECOR-I and 1 nM target DNA. Although this biosensing protocol is simple and easy to 
carry out, it can only offer limited sensitivity.  
 
In general, the biosensor sensitivity can be improved  by reducing the non-specific 
adsorption of the NAV-HRP on the MNP surface. This can be done by using a more 
effective surface passivation method such as coating the MNP with a PEGylated 
polymer. In addition, magnetic micro beads (typical size 0.5 – 500 µm) would be an ideal 
candidate to use for biosensing applications. Magnetic microbeads have inherent 
advantages over magnetic nanoparticles in biosensing protocol. The magnetic 
microbeads have the tendency to interact with each other in the presence of external 
magnetic field and this significantly reduces the timescale of  separating the beads from 




the rest of the solution. Moreover, magnetic microbeads have lower surface area to 
volume ratio as compared to their nanoparticle counterparts. This means that the 
surface have fewer adsorption sites for NAV-HRP, thus, leading to a reduction of 
background signals due to non-specific adsorption. These changes are expected to 
contribute to a better assay sensitivity and would lead to a more reliable biosensor.
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Chapter 3  
Ultrasensitive Detection of Cancer Related Single Nucleotide 
Polymorphisms by Combining Magnetic Nanoparticle 
Capture and Poly-enzyme Nanobead Amplification 
 
3.1 Introduction 
The development of sensitive DNA detection and quantification method has attracted 
significant research efforts due to importance in biomedical research 158-160 and 
clinical diagnosis 161-163. In particular, ultrasensitive detection of single nucleotide 
polymorphisms (SNPs) in genetics has great potential to diagnose life-threatening 
illnesses (i.e. cancer, diabetes, vascular diseases, etc.), prediction of patient’s 
response to treatments and risk of possible relapse, and therefore has been of great 
interest for both scientists and clinicians164, 165. However, disease related SNPs are 
often found in extremely low concentrations in an overwhelming background of 
wildtype gene, which can only be detected reliably after substantial amplification, 
making them challenging targets to detect reliably 166. Among the many techniques 
that have been used for DNA amplification, polymerase chain reaction (PCR) remains 
the gold standard. However, PCR requires the use of multiple primers, DNA 
polymerases and high precision thermal cycling which can limit its use in resource 
poor countries. Moreover, PCR is also susceptible to contamination. Hence, 
considerable efforts have been focused to develop ultrasensitive DNA sensing 
methods that can provide rapid SNP detection without the need of target 
amplification. This is particularly important for the early non-invasive detection of 
tumours before they metastasize uncontrollably and become incurable.  Over the 
past two decades, several methods capable of SNP detection and discrimination 
have been reported. These include high resolution DNA melting 167-169, single 
molecule fluorescence 170, molecular beacons 38, 171, hybridization chain reactions 85, 
172, surface enhanced Raman scattering 173-176, and electrochemical detection 43, 177. 
Despite well-designed strategies, most of these methods displayed either relatively 
low SNP discrimination ratio and/or insufficient sensitivity, limiting their potential in 
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real-world applications. While methods based on nicking endonucleases 47 or 
restriction enzymes 178 can offer high levels of SNP discrimination, these methods 
however, are not general and limited to targets containing the specific enzyme 
recognition site only. On the other hand, ligase-based approaches are general and 
can work with any target of interest and offer high SNP discrimination 75, 78. Moreover, 
it can be coupled to various signal amplification strategies, e.g. rolling circle 
amplification 76, 179, 180, polymerase mediated target displacement, 181-183 as well as 
different nanomaterials to further improve the SNP detection sensitivity. In particular, 
coupling enzymes to magnetic nanoparticles (MNPs) are highly attractive because 
they form stable, homogenous dispersions in the absence of an external magnetic 
field, allowing for rapid target capture and high enzymatic activity 41; yet they are 
readily retrieved from the media by applying an external magnetic field, allowing for 
efficient and rapid removal of contaminants and reducing background. Indeed, by 
combining target recycled ligation, MNP capture and enzymatic signal amplification, 
the Zhou group has previously developed a simple MNP-enzyme sandwich assay 
and demonstrated the successful detection of specific target-DNAs down to the sub-
pM level with high SNP discrimination 52, 56, although their absolute sensitivities are 
still uncompetitive against some of the most recent ultrasensitive DNA detection 
methods 92, 184-186 . Building upon the previous MNP-enzyme sandwich assay 
developed in the Zhou group 52, herein we have further introduced a direct MNP-
signal-DNA ligation strategy to increase the target-DNA to enzyme conversion 
efficiency. Moreover, we have developed a new poly-enzyme nanobead signal 
amplification strategy which can covert each captured target-DNA into thousands of 
copies of active enzymes for greatly enhanced signal amplification power, allowing 
us to realise ultrasensitivity and excellent SNP discrimination simultaneously. Using 
the KRAS somatic mutations (codons 12/13) which are widely found in human 
cancers, (e.g. colorectal, pancreas, ductal, and lung) as model examples 56,  we show 
this new sensing strategy allows for rapid, ultrasensitive detection of cancer specific 
SNPs down to the low aM level. 
3.2  Experimental  
3.2.1 Reagents 
Dry powders of manganese iron oxide magnetic nanoparticles (MnFe2O4 MNPs, 
nominal diameter ~50 nm), poly(ethylene glycol) (Mn ~1000), poly-(maleicanhydride-
alt-1-octadecene) (PMAO, Mn = 30k-50k), dicyclohexylcarbodiimide (DCC), 
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dimethylaminopyridine (DMAP), NaN3, and bovine serum albumin (BSA) were 
purchased from Sigma Aldrich (UK). Amine modified polystyrene nanobead aqueous 
dispersion (~180 nm diameter, containing 2.54% solid by weight) was purchased 
from Bangs Laboratories, Inc. (USA). HABA Biotin Quantitation kit was purchased 
from Cambridge Bioscience (UK). Sterilized ultra-pure water (18.2 M) generated 
by ELGA Purelab flex purification system was used throughout the experiments and 
to make buffer solutions (PBS: 20 mM phosphate, 150 mM NaCl, pH 7.4; PBS-tween: 
PBS containing 0.1% of tween 20). 
 
3.2.2 DNA Probes and Reagents 
All DNA probes used in this study were purchased from IBA GmbH (Germany). Their 
abbreviations and sequences are shown in Table 3-1. High activity neutravidin-HRP 
conjugate (NAV-HRP) and amplex red were purchased from Thermo Scientific (UK) 
and Invitrogen Life Technologies (UK), respectively. Taq DNA ligase (40,000 U/mL) 
and 10× ligation buffer were purchased from New England Biolabs (UK). Methoxy-
polyethylene glycol amine (NH2-PEGn-OCH3, MW ~1000, n = ~23) was purchased 





Capture-DNA PO4- - 5'- TGGCGTAGGCAAGAG TT8 - 3' – DBCO * 
Signal-DNA Biotin-5'-T5GTGGTAGTTGGAGCTGG- 3' 
Wild type DNA:  
(T1) 
5'-ACTCTTGCCTACGCCACCAGCTCCACCTACCAC-3' 
Cancer SNP1: (T2) 5'-ACTCTTGCCTACGCCATCAGCTCCACCTACCAC-3' 
Cancer SNP2: (T3) 5'-ACTCTTGCCTACGCCAACAGCTCCACCTACCAC-3' 
3.2.3 Polymer Modification and Characterization 
Figure 3-1 shows the steps for the modification of PMAO with amino-PEG linkers to 
yield an amphiphilic polymer.  
 
Table 3-1. The name and sequences of DNA oligonucleotides. 




PMAO was modified with NH2-PEGn-N3 (n = ~23) and NH2-PEGn-OCH3 (n = ~23) in 
30% and 70% grafting ratios (based on the PMAO monomer molar amount) 
respectively to form an amphiphilic PEG-PMAO polymer. This polymer grafting ratio 
was chosen primarily to control the amount of capture-DNA that will be further 
conjugated. The large amount of azide groups in the surface will lead to high capture-
DNA loading and can eventually lead to high background signals as seen in our 
earlier studies. The long PEG chain (n= ~23) also confers the resulting grafted 
 
Figure 3-1. Synthetic route to PEG modified PMAO amphiphilic polymer. DCC: 
N,N’-dicyclohexylcarbodiimide, DMAP: 4 - dimethylaminopyridine 
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polymer with good hydrophilicity and steric stabilisation. In the first step of the 
reaction, the lone pair of electrons from the amine group of NH2-PEGn-N3 was utilized 
in the nucleophilic ring opening of succinic anhydride yielding the carboxylic acid-
PEG-azide derivative. The remaining intact succinic anhydride rings were reacted 
with NH2-PEGn-OCH3. The DCC/DMAP coupling step was used to convert the 
carboxylic acids formed during the anhydride ring opening to amide linked-PEGs to 
increase PEG grating density. 
 
The number of moles of the amino-PEG reagents were twice that the PMAO 
monomer unit.  First, PMAO (0.250 g, 0.66 mmol monomer unit) was reacted with 
NH2-PEGn-N3 (0.396 g, 0.396 mmol) in dry CHCl3 under a N2 atmosphere for 12 h. 
The remaining unreacted anhydride groups were reacted with NH2-PEG-OCH3 
(0.923 g, 0.923 mmol) for 24 h. The solvent was removed and the crude polymer was 
dried under vacuum. The reaction flask was then sealed, purged with N2 and placed 
in an ice bath. Dry CHCl3 (5 mL) was added to dissolve the polymer followed by DCC 
(0.164 g, 0.792 mmol) and DMAP (0.014g, 0.11 mmol) dissolved in dry CHCl3 at 0 
ºC. The reaction mixture was allowed to gradually warm up to RT and stirred for 72 
h. The reaction mixture was filtered and concentrated under vacuum to give a 
yellowish oil (~1.5 g). It was dissolved in CHCl3 to make a ~100 mg·mL-1 stock 
solution and was used directly to encapsulate hydrophobic MnFe2O4 MNPs without 
further purification, taking the full advantage of MNP’s ease of magnetic retrieval for 
efficient removal of undesirable impurities. For NMR characterisation, a 5 mL of the 
crude polymer was transferred to a round bottom flask and the solvent was removed 
by rotary evaporation. The polymer was then dissolved in 10 mL of ultrapure water 
and was dialysed (MW cut-off 30,000 Da) versus water for 24 hours. The polymer 
solution was dried by rotary evaporation and further lyophilized for 48 hours, yielding 
a white solid. The purified polymer was characterized using 1H-NMR spectroscopy 
as shown in Figure 3-2. The 1H NMR (400 MHz, CDCl3);  ppm, 0.88 (t, 3 H, J = 6.7 
Hz, -(CH2)15CH3, 1), 1.45-1.14, (18H, -(CH2)14-CH2-CH3, 2,3),  1.50-1.70 (52H, -CH2-
CH-, *contains H2O impurity), 3.41-3.33 (m, 2H, C(O)-CH-CH-, 6,7), 3.49-3.43 (-CH2-
N3,10), 3.72-3.55 (m, 57H -(CH2-O-CH2)n where n ~ 14 units),  3.80 (m, 2H, -NH-
CH2). The presence of a broad singlet peak at ~1.60 ppm which corresponds to a 
water peak have obscured the correct integration of protons in the 1.50-1.70 ppm 
region. 
 







Figure 3-2. (A) Enlarged 1H-NMR spectra from region 4.0-3.0 ppm (B) 
Enlarged 1H-NMR spectra  from region 2.0 – 0.0 ppm. The characteristic 
peaks of alkyl chains (C16) in PMAO were observed at ~0.89 – 1.50 ppm, 
The peak of amide bond was weak due to low abundance as compared to 
the protons of the alkyl chain and the PMAO backbone, and (C) Proton 
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3.2.4 MNP Encapsulation and Stability Evaluation 
A 5.0 mg of dry MnFe2O4 MNPs were dispersed in 1.0 mL CHCl3 through sonication, 
then different amount of the PEG-PMAO polymer was added (MNP:polymer weight 
ratio = 1:5, 1:10 and 1:15) and stirred overnight at RT. After that, ethanol was added 
to reach a 1:1 volume ratio with CHCl3 and then CHCl3 was slowly removed by rotary 
evaporation. The resulting MNP dispersion was transferred to a centrifugal filter 
(10000 MW cut-off) and water was added to a 1:1 v:v ratio and then centrifuged at 
4000 rpm for 10 min. The MNPs were washed five times by centrifugation with water 
and finally dispersed in sterilized water to give a black solution. The solution was 
filtered through a 0.45 µm syringe filter to remove any large aggregated particles. 
The MNPs were further centrifuged (14000 rpm, 15 min) and washed with water 3 
times to remove any unbound polymers and other contaminants, and finally 
dispersed in pure water. Combining several different batches, a final MNP stock 
solution of ~10 mg·mL-1 was obtained. The MNP colloidal stability and hydrodynamic 
sizes at different temperatures (25-75 ºC) and salt contents were determined by 
dynamic light scattering (DLS) 187. 
 
3.2.5 MNP-capture-DNA Conjugation 
The copper-free “click” reaction between the MNP surface azide and DBCO-modified 
capture-DNA was employed for the capture-DNA-MNP conjugation. Figure 3-3 
shows the mechanism for the copper- free click chemistry. This reaction does not use 
relies on the use of strained cyclooctynes that possess a decreased activation energy 
as compared to terminal alkynes, thus, do not require an exogenous catalyst such as 
copper (I) ions. The conjugation chemistry based on the strain promoted 
cycloaddition reaction between a dibenzocylcooctyne (DBCO) with an azide which 
readily occurs under normal conditions without the use of reagents such as copper 
or microwave heating. The resulting  MNP-capture DNA conjugate are crosslinked 
via a stable triazole moiety highlighted in yellow in  Figure 3-3. The PEG-PMAO 
encapsulated MNPs (10 mg) were mixed with the DBCO capture-DNA (100 µL, 100 
µM) and incubated for 48 h at a constant 600 rpm vortex. After that, the MNPs were 
centrifuged and washed three times with pure water to remove any unbound capture-
DNA. The clear supernatants were collected and used to determine the amount of 
unbound DNA. The capture-DNA loading was calculated from the difference between 
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Figure 3-3 Mechanism for the copper free click chemistry between DBCO-
capture DNA and the azide moiety of the polymer encapsulated MNP. 
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3.2.6 Target Ligation and Enzymatic Assay 
All sample tubes were pre-treated with PBS containing 1.0 mg·mL-1 of BSA to 
minimise any possible non-specific adsorption. All ligation experiments were done 
with the MNP having a capture-DNA loading of ~0.35 nmol.mg-1 (MNP). All ligation 
experiments were performed by dispersing 30 g of the MNP-capture-DNA (10 L) 
to a tube containing 15 L ultrapure water, 5 L ligase buffer (10×), 10 L target-DNA 
(different concentration), 10 L signal-DNA (500 pM), and 1 µL Taq DNA ligase (10 
U/L). The samples were incubated at 45 oC in a dry heating block for 60 min, after 
which they were cooled to RT naturally. The MNPs were centrifuged (3000 rpm) for 
1 min and pulled to the tube wall via a permanent magnet. The clear supernatant was 
carefully removed, and the MNPs were washed twice with PBS-Tween. NAV-HRP 
(50 L, 100 pM) was then added and incubated for 60 min, after which the samples 
were centrifuged to remove the clear supernatant. The MNPs were washed four times 
with PBS-Tween, once with PBS and finally dispersed in PBS (80 L) and transferred 
to 96 microplate wells. Each well was added amplex red (300 M, 10 L) and H2O2 
(300 M, 10 L) to initiate enzymatic assays which was monitored by fluorescence 
time traces on an Envision® plate reader using BODIPY TMR FP 531 excitation filter 
and Cy3 595 emission filter. Ligation assays for SNP discrimination were performed 
in the same way by changing the target-DNAs.  
 
3.2.7 Preparation of polymer nanobead (PB)-EG12-Biotin 
Figure 3-4 shows the steps for the preparation of the polymer nanobead signal 
amplifier. The signal amplifier was prepared by tagging several thousand copies of 
Neutravidin-HRP on the surface of a polymer bead. This greatly improved the assay 
sensitivity by dramatically increasing the number of enzymes that could be converted 
from each ligated DNA sandwich. An aqueous suspension of amino-functionalized 
polymer nanobeads (100 µL, 2.54 % weight) was centrifuged for 1 min at 15,000 g 
and the clear supernatant was discarded. The beads were washed twice with sodium 
bicarbonate buffer (20 mM NaHCO3, pH 8.3), and then dispersed in 1.0 mL of sodium 
bicarbonate buffer (pH 8.3). NHS-EG12-Biotin (100 µL, 250 mM) was added to the 
nanobeads and the resulting suspension was incubated overnight at a rotor at 600 
rpm at RT. The unreacted surface amino groups were further passivated by treatment 
with NHS-PEG17-OMe (containing on average 17 PEG units, 100 µL, 100 mM) to 
minimize non-specific adsorption. The resulting biotinylated polymer nanoparticles 
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were centrifuged at 20,000 g and washed twice with PBS and finally dispersed in 5 
mL of PBS.  
 
 
3.2.8 Determination of polymer nanobead biotin valency and 
tagging with NAV-HRP 
The amount of biotin attached to the polymer beads was determined using HABA 
assay. An assay solution was prepared by adding avidin to HABA solution following 
the kit instruction and mixed for 5 min. 900 µL of the HABA/Avidin solution was added 
to a cuvette and its absorbance at 500 nm was measured. Then, a 100 µL biotin-
modified polymer nanobeads was added and mixed by inversion. After centrifugation 
to remove the polymer beads, the absorbance of the supernatant at 500 nm was 
measured. The biotin valency was determined as ~104 per nanobead. An equimolar 
amount of NAV-HRP to the bead surface biotin was added to make the poly-enzyme 
nanobead signal amplifier with a stock concentration of 0.50 µM (based on the NA-
HRP concentration, CHRP). 
 
 
Figure 3-4. Schematic process used for the preparation of the poly-enzyme 























(pH 8.3), 12 hrs. 
PBS (pH 7.4) 
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3.2.9 Biosensing via poly-enzyme nanobead amplification   
The MNP-capture-DNA and signal-DNA was ligated under the same procedures as 
above except with much lower target-DNA concentrations (e.g. 0.001, 0.02, 0.1, 1, 
10, 100 and 1000 fM). After ligation, the samples were washed twice with PBS-Tween 
and then dispersed in 100 µL of the poly-enzyme nanobead signal amplifier in PBS 
(final CHRP = 1.0 pM) and incubated for 60 min at RT. The samples were washed 
twice with PBS-tween and then transferred to a 96 well plate to initiate enzymatic 
assays as described above. 
 
3.3 Results and Discussion 
3.3.1 Biosensing Principle.  
The  sensing principle is illustrated schematically in Figure 3-5. It uses a pair of DNA 
probes, one covalently linked to a MNP for target capture (i.e. capture-DNA, 5’ 
phosphorinated), and the other (i.e. signal-DNA) is biotinylated for NAV-HRP binding 
and signal amplification. The capture- and signal- DNA sequence are complimentary 
to each half of the target-DNA, allowing them to hybridize with a target-DNA to form 
nicked double-stranded DNA sandwich. The signal-DNA-Biotin was used to hybridize 
with half of the sequence of the target-DNA rather than an enzyme labelled signal-
DNA (i.e. signal-DNA-HRP). The small biotin moiety in the signal-DNA would allow 
efficient hybridization with the target-DNA without complications that might arise if a 
bulky HRP group is at the terminal of the signal DNA. Moreover, a smaller biotin end 
group would allow the Taq ligase to reach the nick site during ligation step without 
being sterically restricted by HRP for a signal-DNA-HRP probe design. 
 
A ligation step using Taq DNA ligase then covalently links the biotinylated signal-DNA 
to the capture-DNA (templated by a full-match, but not a SNP target-DNA), ensuring 
that it will not detach from the MNP surface in the subsequent washing steps, thereby 
increasing the target-DNA to enzyme conversion efficiency (the nicked double-
stranded DNA sandwich may dissociate during the washing steps). It is important 
that a single-base mismatch in the target-DNA probe must be at the nick site to 
prevent ligation, thus, capture-DNA and target-DNA (i.e. SNP) remain unlinked. In 
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this manner, the biosensor can effectively discriminate a perfectly matched target 
and a SNP target DNA.  
 
After washing to remove any unbound species, excess NAV-HRPs (Route a) are 
added to bind to the MNP surface biotin, converting each MNP-ligated signal-DNA 
into a MNP-linked HRP for enzymatic signal amplification by converting the non-
fluorescent substrate, amplex red, into a strongly fluorescent product, resorufin 41. 
The rate of fluorescence production is linear to the number of the HRPs bound to the 
MNP surface, which is directly correlated to the full-match target-DNA concentration. 
To further improve sensitivity, a more powerful signal amplification strategy using 
poly-enzyme nanobeads, each tagged with about ten thousand copies of NAV-HRP, 
is designed (Route b). It can convert each successfully ligated signal-DNA into 
thousands of copies of HRPs for greatly improved sensitivity, allowing us to detect 
ultralow levels of target-DNA directly without the need of PCR target amplification. 
Moreover, the strict requirement of perfect-match to produce successful ligation also 
enables our approach to effectively discriminate between wildtype and cancer 
specific SNPs: a single base mismatch at the nicking double-stranded site can 
prevent covalent ligation 56.  
 
 






Figure 3-5. Schematic Illustration of our DNA sensing strategy. A MNP linked 
capture-DNA and a biotinylated signal-DNA are used to sandwich hybridize 
with the target-DNA followed by ligation. Only the perfect-match target-DNA, 
but not the SNP target, can template the covalent ligation of the MNP-
capture-DNA and signal-DNA, producing a MNP-linked biotin for binding to 
NAV-HRP (Route a) or poly-NAV-HRP polymer nanobead (Route b) for HRP 
catalysed enzymatic assay. 
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3.3.2 MNP dispersion and stability 
The dispersion of hydrophobic MNPs in water was achieved via PEG-PMAO-
amphiphilic polymer encapsulation. PEG was used owing to its ability to resist the 
non-specific adsorption of biomolecules (i.e. proteins) and excellent 
biocompatibility.188-190 Its flexible ether backbone utilizes hydrogen bonding and steric 
stabilization, and not electrostatic interactions, to achieve stable water dispersion. 
This confers PEG encapsulated or modified nanoparticles excellent colloidal stability 
in aqueous media over a wide range of pH and even with high salt contents. The 
maleic anhydride ring in PMAO was opened by reacting to an amino-PEG molecule 
(i.e. NH2-PEG-N3), forming a carboxylic acid and an amide linked-PEG-N3. The 
generated free carboxylic acid group was further reacted with NH2-PEG-OCH3 via a 
DCC/DMAP mediated amide coupling to increase the PEG graft density, forming a 
dense, brush like PEG structure to offer excellent hydrophilicity and resistance 
against non-specific adsorption. 
 
Figure 3-6 showed the FT-IR spectra of the unmodified PMAO and PMAO-PEG 
copolymers. The original PMAO gave a strong peak at 1775 cm-1, assigning to the 
C=O stretching of the anhydride ring 191. This peak was completely diminished after 
modification, indicating a complete reaction of the anhydride functional groups. The 
opening of the anhydride ring was also confirmed by the appearance of the amide 
C=O stretching peak at 1655 cm-1 and amide N-H bending peak at 1514 cm-1. 
Moreover, the appearance of the azide stretching peak at 2100 cm-1 as well as the -
C-O-C- absorption at 1060 cm-1 clearly demonstrated the successful grafting of the 
NH2-PEG-N3. The -C-H stretching peaks of the alkyl chains at 2882 and 2930 cm-1 
remained unchanged. These alkyl chains can interact with the hydrophobic ligands 
on the MNP surface via van der Waals interactions, leaving the hydrophilic PEG 
moieties exposed to the aqueous media to confer particle water-dispersity.  
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Figure 3-6. FT-IR spectra of the unmodified (top) and azide-PEG-modified 
(bottom) PMAO polymers. 
 
The prepared PMAO-PEG copolymer was used directly to water-disperse 
hydrophobic MnFe2O4 MNPs using a modified solvent exchange method first 
reported by Bao and colleagues 192. First, ethanol was added to a chloroform solution 
containing the MNP and PMAO-PEG polymer in 1:1 volume ratio. Then chloroform 
was selectively removed by rotary evaporation, and finally, ethanol was replaced by 
water using centrifugal filter tubes (10000 MW cut off). During this process, the 
solvent polarity was increased gradually from chloroform to water which has shown 
to improve the encapsulation efficiency. The amphiphilic PMAO-PEG encapsulates 
the hydrophobic MNPs via multiple hydrophobic-hydrophobic interactions between 
the polymer alkyl chains and the MNP surface hydrophobic ligands, leaving the 
hydrophilic PEG arms exposed to the aqueous environment to provide stable 











Figure 3-7. (A) Schematic diagram of polymer encapsulation and 
stabilization of MNPs in an aqueous solution.  (B) Photographs of polymer 
encapsulated MNPs dispersed in water under different polymer:MNP 
weight ratios after standing for 24 h. The 5:1 sample is mostly precipitated 
but the 10:1 and 15:1 samples show good water-dispersability. (C) 
Hydrodynamic sizes of the MNP-polymer suspensions determined using 
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The amounts of the PMAO-PEG for MNP encapsulation was optimized by varying 
the polymer:MNP weight ratios from 5:1 to 15:1. MNP dispersed at 5:1 gave a much 
fainter colour as compared to those prepared at 10:1 or 15:1 as shown in Figure 3-7 
(B). This indicates that 5:1 ratio was insufficient to promote high MNP water-
dispersion. In contrast, those dispersed at 10:1 and 15:1 were similar in colour and 
both were much darker than that of 5:1, suggesting these ratios provided high MNP 
encapsulation efficiency. Furthermore, the  percentage encapsulation efficiency for 
each polymer: MNP ratio was also determined. After removing the supernatant 
containing polymer encapsulated MNP, the precipitated MNPs were washed 3 times 
with water to remove excess polymer. The MNPs were dried in an oven for 3 days 
and their weights were determined. The weight difference between the initial MNP 
and that remained in the precipitate was considered as polymer encapsulated. Using 
this method, the polymer encapsulation efficiency was calculated as 39 , 56 and 53 
% for the 5:1, 10:1, and 15:1 polymer: MNP ratio, respectively.  
 
The polymer:MNP ratio of 5:1 gave the lowest encapsulation efficiency which was 
also visually confirmed by the faint brown colour of the supernatant. However, more 
than 50 percent of the MNPs were successfully encapsulated as the amount of the 
polymer was increased and an optimum coating efficiency was observed for a 
polymer:MNP ratio of 10:1. Further increase in the amount of polymer did not 
decrease in encapsulation efficiency. The primary goal here was to make stable MNP 
dispersions in high yields using the minimal amount of polymer possible, hence 10:1 
was determined to be optimal. The <100% encapsulation efficiency was due to that 
the MNP powders were heavily aggregated prior to polymer encapsulation: they 
could not be fully dispersed in CHCl3 even after extensive sonication. The 
hydrodynamic diameters (Dhs) of the polymer encapsulated MNPs were found to be 
~230 nm by dynamic light scattering as shown in Figure 3-7 (C). Such relatively large 
Dh sizes were likely due to MNP clustering as revealed by TEM imaging as shown in 
Figure 3-8 and bilayer formation: the polymer alkyl chains interact with the 
hydrophobic ligands on the MNP surface via hydrophobic interactions 193.  







Figure 3-8. (A) TEM image of the polymer coated MnFe2O4 nanoparticles 
showing a clustered morphology of smaller MNPs with an overall magnetic 
core size of ~90 nm (scale bar 50 nm). (B) Elemental mapping of a MNP 
cluster (scale bar 50 nm) using high angle annular dark field (HAADF) for 
elemental analysis showing the presence of Mn (red dots) and Fe (green 
dots) atoms. The Energy Dispersive X-ray (EDX) spectrum of the same MNP 
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The colloidal stability of the MNPs under different pH, temperature, and salt content 
were further investigated. Figure 3-9 (A) showed that the MNPs did not display any 
significant Dh size variations over a wide pH range (i.e. 2-12). Since the ligation step 
will be carried out at 45 oC, the thermal stability of the MNPs was further tested. As 
shown in Figure 3-9 (B) no significant MNP size changes were found as temperature 
was increased from 25 to 70 oC, suggesting that the PMAO-PEG provided a stable 
coating on the MNP surface, presumably via multiple hydrophobic interactions 
between the polymer alkyl chains and MNP surface hydrophobic ligands 194.  
 
Moreover, the polymer encapsulated MNPs were found to be stable under different 
salt contents (e.g. 100, 300 mM NaCl) with similar Dhs as those dispersed in pure 
water as shown in Figure 3-9 (C). Together, these results suggested that the MNPs 
were not mainly stabilized by electrostatic repulsion, otherwise significant Dh increase 
would have been expected in high salt media which are efficiently in screening the 
electrostatic repulsion. The high MNP colloidal stability was attributed to effective 
steric stabilisation afforded by a thick amphiphilic polymer coating with extended PEG 
graphs which can prevent the MNPs from interaction with each other 195-197. The 
stability of the polymer encapsulated MNPs was further confirmed by comparing the 
hydrodynamic size of the same batch of polymer encapsulated MNP after 6 months 
storage as shown in Figure 3-9 (D). The DhS of the freshly prepared MNP-polymer 
taken as 0 month is 204.9 nm and increased to 244.6 nm after 6 months of storage. 
The ~ 40 nm change in Dh suggests slight aggregation of polymer encapsulated 
MNP. However, visual inspection of the solution gave no signs of precipitation. The 
increase in size can be taken to have an insignificant effect  for use of these polymer 
encapsulated MNP for biosensing applications.  Overall, these results suggests that 
the attachment of the PMAO-PEG co-polymer to the MNP surface can be viewed as 
“irreversible” in an aqueous environment, making such MNPs capable of 
withstanding relatively harsh conditions. 
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Figure 3-9. Comparison of the hydrodynamic diameters of the polymer 
encapsulated MNPs in water at different (A) pH, (B) temperature (C) different 
salt concentration, (D) Dynamic Light scattering measurements were 
performed on the sample at two time points after coating. Dh histograms of 
freshly prepared and after storage for 6 months. 
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3.3.3 Optimization of capture-DNA loading 
The Zhou group has previously found that increasing capture-DNA loading on silica 
coated MNPs could increase the target-DNA capture efficiency, presumably via 
enhanced binding affinity.52 However, too high a capture-DNA loading could also lead 
to high background signals, possibly due to non-specific interactions.52 Therefore, the 
MNPs with different capture-DNA loading (e.g. 0.04, 0.10, 0.20, and 0.35 nmol·mg-1) 
were prepared to investigate the optimal loading. The MNPs (30 µg each) were mixed 
with the signal-DNA and full-match target-DNA (10 pM each) followed by ligation and 
then NAV-HRP binding. A control without the target-DNA (WOT) was also prepared 
under identical conditions. The typical time-dependent fluorescence response curves 
and the corresponding slopes were shown in Figure 3-10.  
 
Figure 3-10. Comparison of fluorescence response (slopes of fluorescence 
response curves shown in figure inset) for MNP-DNA conjugates with 
different capture DNA loadings (n =3). Figure inset: typical time-dependent 
fluorescence intensity profiles for detecting perfect match T1 for MNP-
capture DNA with different capture DNA loading. 
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The highest signal was obtained for the MNP having the highest capture-DNA loading 
(e.g. 0.35 nmol·mg-1), while those having the capture-DNA loading of 0.04 and 0.10 
nmol·mg-1 were rather low and comparable to the WOT control. Unfortunately, we 
were unable to prepare MNPs with the capture-DNA loadings higher than 0.35 
nmol·mg-1 despite several tries, including the use of higher amounts of capture-DNA, 
possibly limited by the amount accessible PEG-azide on the MNP surface. Therefore 
MNPs with this capture-DNA loading was used in all subsequent sensing 
experiments. 
 
All subsequent DNA sensing experiments via the Route (a) were carried out with a 
fixed 100 pM signal-DNA in PBS. The assay gave a steady increase of fluorescence 
with time Figure 3-11 (A). The signal was highest for the highest target-DNA 
concentration (10 pM) and decreased with the decreasing target-DNA concentration 
with the control giving the lowest signal as expected. The slopes were determined 
and plotted versus the DNA target concentration as shown in Figure 3-11(B). The 
limit of detection (LOD) based on three times the standard deviation plus the negative 
control signal (i.e. LOD = 3 WOT + IWOT) 180, 198 was determined as 1.0 pM. This LOD 
was comparable to many previously reported DNA sensors which typically offered 




Figure 3-11. (A) Representative time-dependent fluorescence responses 
curves for detecting different concentrations (0.01 - 10 pM) of the full-match 
target-DNA (T1). (B) Typical fluorescence response rates for T1 detection (n 
=3). 
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Traditional DNA hybridization assays are usually performed using “sandwich-type” 
detection designs that is suitable for the detection of label-free target DNA. The 
unlabelled target DNA is bordered by a nanomaterial tagged with capture-DNA 
probes and a biotinylated signal-DNA reporter probe that can bind with NAV-HRP. 
Interestingly, our simple approach MNP based DNA sandwich assay is comparable 
in terms of its LOD to a more intricate electrochemical DNA sensing using a DNA 
tetrahedron structure 160 In general, one of the major drawback often encountered in 
surface –based (flat and spherical) biomolecular detection is the limited accessibility 
of target molecules to the probes immobilized on heterogeneous surface as 
compared to the probe-target binding events in solution phase which is often specific 
and fast. Thus, addition of inert linkers are often added to the surface to passivate 
vacant spaces and allow the capture-DNA probes to adopt an upright surface position 
that will favour hybridization with the target DNA. In this study, the long chain PEG 
backbones (n~23 ethylene glycol units) can be thought of stretching outward the 
nanoparticle surface. Moreover, the addition of the inert linker (-PEG~23-OCH3) might 
have forced the PEG-capture-DNA strands to adopt a rod-like spatial orientation with 
the capture-DNA oriented toward the solutions in order to readily hybridize with the 
target-DNA. This requirement is imperative in order to increase probe-target affinity 
and increase DNA hybridization efficiency. In addition, the polyethylene glycol units 
imparted the nanoparticle surface with non-specific adsorption properties. In this 
manner, the target-DNA does not adsorbed on the nanoparticle surface and allows 
more target DNA to hybridize with the capture-DNA, thus, leading to more efficient 
hybridization. Interestingly, this simple design of polymer encapsulated MNP coupled 
to traditional DNA sandwich hybridization can achieve LOD comparable to many 
previously reported DNA sensors which typically offered nM-pM sensitivity without 
the need of several DNA primers or the use of more sophisticated instruments. 
However, this 1 pM level of sensitivity was still uncompetitive against some of the 
recent ultrasensitive DNA assays 63, 90, 94, 199. Therefore a more powerful signal 
amplification strategy using poly-enzyme nanobead was designed to further improve 
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Table 3-2 Comparison of the sensing performances of some sensitive DNA 






Photonic crystal hydrogel beads 0.66 
200 
Electrochemical detection based on bar-coded GNPs ~4 
161 
MNP-dye sandwich assay 100 
163 








Microcantilever array based nanomechanical sensing 10 202 
Silver particle amplified dual-wavelength surface enhanced 
Raman scattering 
1-33 203 
Graphene quenched fluorescent DNA nanoprobes ~100 
204 




Zn(II)-porphyrin/G-quadruplex complex with Exo III-
assisted target recycle 
200 
205 




Electrochemical DNA sensing using a DNA tetrahedron 
structure 
1 160 
Gold nanoparticle amplified surface Plasmon resonance 
sensing 
10 206 
Electrochemical sensing via a DNA Super-sandwich 
Assembly 
0.1 159 
Enzyme-Based Electrochemical DNA Sensing 0.01 207 
MNP-sandwich + ligation with single-enzyme amplification ~1 
This 
work 
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3.3.4 SNP discrimination 
The sensor was further evaluated for its ability to detect specific SNPs in the KRAS 
gene associated with many human cancers (e.g. colorectal, pancreas, ductal and 
lung). Here three target-DNAs (all 10 pM) were employed: wild-type T1 (counting 
from 5’, base 17 C), two cancer mutants: T2 (17C  T) and T3 (17C  A). The 
sensing was done in PBS and PBS containing 10% human serum to mimic clinical 
assay conditions. Figure 3-12 (A) revealed that only the full-match target-DNA (T1) 
produced a high fluorescence response, the signals for both SNP targets (T2, T3) 




Figure 3-12. Discrimination of the perfect-match (T1) against other SNP 
targets (T2 and T3). (A) Comparison of average fluorescence production 
rates (slopes of fluorescence response curves shown in inset) for different 
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The SNP discrimination ratio for T1 against the SNP targets before background 
correction was determined as ~14.3 and ~16.8 for T2 and T3, respectively. This level 
of SNP discrimination was comparable or better than many other assays reported in 
the literature 163-165, 208, 209. More importantly, even higher SNP discrimination ratios 
(ca. 33) were obtained when the detection was carried out in clinically relevant media 
(e.g. PBS containing 10 % human serum, see Figure 3-12 (B), demonstrating that 
our sensor was highly robust and could work effectively under clinical relevant 
conditions. 
 
3.3.5 Poly-enzyme nanobead amplification  
A more powerful signal amplification strategy using poly-enzyme nanobeads each 
tagged with ~104 copies of NAV-HRPs was designed to further improve sensitivity 
(Scheme 1, Route b). We first prepared NHS-PEG12-biotin modified polymer 
nanobeads, determined its biotin valency as ~104 per bead, and then conjugated the 
nanobead with NAV-HRP by incubating with 1:1 mole ratio of NAV-HRP to the bead 
surface biotin. The MNP-capture-DNA, signal-DNA and different amounts of target-
DNA were mixed, ligated as above and then treated with poly-enzyme nanobead. 
The resulting fluorescence response curves were shown Figure 3-13 (A) inset. Each 
sample was done in triplicates and the average of the slopes were calculated and 
plotted in Figure 3-13. The highest signal was observed for the 1 pM target-DNA 
sample as expected. Very low fluorescence signals were observed from the controls 
(no target-DNA), suggesting that the polymer encapsulated MNP was highly effective 
in resisting non-specific adsorption. Here a low background was critical to achieve 
high sensitivity, allowing for unambiguous detection of weak signals arising from 
ultralow levels of target molecules.  
 
The fluorescence intensity was plotted against the logarithm of the target DNA 
because at lower concentration, the fluorescence intensity approaches a linear 
expression according to the equation: 
𝐹 = 𝑘′ 𝐼𝑜(𝑙𝑜𝑔10 ε𝑙𝑐) 
Equation 3-1  
 
- 132 - 
 
 
Where F refers to fluorescent intensity, k’  is a rate constant that takes quantum yield 
into account, Io intensity of the incident radiation, ln is the natural logarithm,  ε is the 
extinction coefficient, l is the path length and c is the concentration. A linear 
dependence between the fluorescence intensity and the logarithm of the target DNA 
concentration was obtained in the range from 0.001 fM to 1000 fM.  As shown in 
Figure 3-13 (B), our sensing strategy provided a rather wide linear dynamic range of 
6 orders of magnitude (e.g. 1 aM to 1 pM, R2 = 0.966) with a LOD of as 1.6 aM based 
on the interception point between the linear fit and the background + 3 level. Such 
levels of sensitivity place it among the most sensitive DNA biosensors reported in the 
literature as shown in Table 3-2.  We attributed the ultrasensitivity here to the greatly 
increased signal amplification power of the poly-enzyme nanobead, each carrying 
~104 copies of HRPs. As a result, it was able to covert each captured full-match 
target-DNA into ~104 copies of HRPs (versus 1 in the traditional sandwich assay) for 
greatly enhanced sensitivity.   
 
In general, the use of MNP for efficient target capture and enzyme-tagged polymer 
beads were of great significance to this work. This study illustrates its novelty on the 
simple design and universality of signal amplification approach. The signal 
amplification mechanism only requires an enzyme (i.e. HRP) immobilized on polymer 
beads. The signal amplifier can be reliably and easily prepared by incubating NAV-
HRP on a biotinylated polymer nanobeads and has the potential to be scaled up. 
Furthermore, the beauty of using such powerful signal amplification approach is that 
it only requires incubation step with MNP-DNAds- Biotin, thus, eliminating the use 
DNA primers and time consuming steps as in RCA or the use of sophisticated thermal 
cyclers in LCR-based signal amplification strategies. Moreover, the poly-NAV-HRP 
nanobead also offers a new and powerful signal amplification strategy that can be 
adopted in any bioassay formats because it only needs a free biotin for binding (e.g. 
ELISA). To the best of our knowledge this is the first report that utilized a poly-enzyme 
nanobead as signal amplifier for SNP detection.  
 
 







Figure 3-13. (A) Comparison of the average fluorescence increase rate 
(cps·min-1) for assays containing 0-1000 fM of T1 (inset show the 
corresponding time-dependent fluorescence responses, n=3). (B) 
Relationship between the fluorescence increase rate and the log(CDNA, in fM) 
fitted by a linear function (y = 153x + 592, r2 = 0.966). The blue line shows the 
background + 3 level which intercepts with the linear fit at x = -2.788, 
corresponding to CDNA = 1.6 aM. 
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Besides high sensitivity, the ability of accurate and reliable detection of low abundant 
specific SNPs in a background of wildtype genes is of great importance for the non-
invasive diagnosis of cancer and other diseases.24 Therefore the ability to detect low 
abundance full-match target-DNA (T1) in large excess of SNP targets (T2 and T3) 
was also investigated. The final DNA concentrations were 1 fM for the full-match T1 
and 10 fM (i.e.10-fold excess) or 100 fM (i.e. 100-fold excess) for each SNP target 
(T2 and T3). Figure 3-14 revealed that, increasing the SNP:T1 ratio led to a 
decreased fluorescence signal, presumably because the large excess of SNP targets 
(T2 or T3) could compete with T1 to sandwich hybridize to the capture- and signal- 
DNAs, reducing the chances of a successful ligation templated by the full-match T1. 
Nevertheless, the signal of samples containing just 1 fM T1 (1% of the T2/T3 SNP 
target concentration) was clearly higher than those of the SNP targets only, 
suggesting that our sensor can specifically detect 1 fM T1 even in the presence of 
100 fold excess of SNP targets. This level of specificity for the perfect-match target-





Figure 3-14. Detection of 1 fM perfect-match T1 in the presence of large 
excess (10 or 100 fold) of the SNP targets (T2, T3). A control with 100 fM of 
T2 and T3 each. 























We have shown that encapsulation of hydrophobic MNPs with an azide-PEG 
functionalised amphiphilic polymer not only produces stable, well-dispersed MNPs 
that effectively resist non-specific adsorption, but also enables the convenient DNA 
conjugation via the Cu-free “click” chemistry. A new strategy based on sandwich 
hybridisation followed by ligation to introduce biotins on the MNP surface for 
enzymatic signal amplification has yielded excellent SNP discrimination. Moreover, 
a new powerful signal amplification strategy using poly-enzyme nanobead which can 
convert each captured target-DNA into thousands of copies of active enzymes has 
been developed, enabling the direct detection of target-DNA down to 1.6 aM with a 
linear dynamic range of 6 orders of magnitude, placing it among the most sensitive 
PCR-free DNA sensors. Furthermore, this sensor is highly robust (works effectively 
in clinical relevant media) and specific (can positively detect 1% of the full-match 
target in a background of 100 fold excess SNP targets), suggesting that it may have 
broad applications in biosensing and clinical diagnostics. 
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Chapter 4  




Colloidal inorganic nanoparticles (NPs) are tiny objects sized between 1 to 100 
nanometres (nm) and can form stable dispersions in a solvent 210. The NPs can be 
made of a noble metal,  metal or non-metallic oxides, semiconductors, magnetic 
compounds and a hybrid of them 210, 211. Over the past years, scientists have 
developed new methodologies to synthesise colloidal NPs and unravelled their 
unique physical and chemical properties that are different or absent from their bulk 
counterparts. Colloidal NPs have been utilised in various biomedical and 
technological applications 210-212. In terms of biomedical applications, the 
development of inorganic antimicrobial nanoparticles have a profound impact in the 
healthcare industry because of their ease in synthesis, stability, and nanoparticles 
tend to show a broad spectrum of bactericidal and fungicidal activities 213. 
Furthermore, with emergence of antibiotic resistant bacterial strains, it is imperative 
to develop new antimicrobials that can offer better therapeutic property and less 
toxicity to mammalian cells 214. In this regard silver nanoparticles (Ag NPs) are one 
of the most well studied nanomaterials that show outstanding antimicrobial activities 
over wide range of bacteria, viruses, and fungal strains 215, 216. The antimicrobial 
properties of Ag NPs are dependent on its size, shape, and the presence of oxidizing 
agents such as molecular oxygen 217.  
 
Recently, metallic nanoclusters (e.g. Pt, Au, Ag, Cu) with all three spatial dimensions 
below 2 nm have emerged as a new class of nanomaterials and have drawn research 
interests due to distinctive optical and chemical properties which differ significantly 
and unavailable from their nanoparticle counterparts 218-220. In particular, water 
soluble silver nanoclusters (Ag NCs) have received considerable attention in the past 
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few years owing to the plethora of potential  applications 221. However, synthesis of 
water soluble Ag NCs is challenging because few-atom silver nanoclusters are highly 
reactive and tend to form large nanocrystals 221. Hence, more research must be done 
to improve the stability of Ag NCs in aqueous solutions. Having luminescent 
properties, Ag NCs are being investigated for its applications in biological imaging 222, 
223, catalysis 224, 225, and biological 226 and chemical 227, 228 sensing. It is surprising that 
only a few studies have reported the antibacterial properties of Ag NCs and more 
research has to be done to determine its antibacterial properties 229-232. It is 
hypothesised that Ag NCs may have a stronger interaction with the bacterial cells 
than its larger NP counterpart due to their ultra-small sizes, leading to more effective 
antimicrobial potency.  
 
This chapter will give an introduction on the electronic structure and optical properties 
that differentiate Ag NPs and Ag NCs. Moreover, the synthetic approaches to water-
dispersible Ag NPs and Ag NCs will be discussed. This chapter will also highlight the 
current understanding of the antimicrobial mechanisms of Ag NPs against selected 
microbial strains.  
 
4.2 Electronic Structures in Nanoparticles and 
Nanoclusters 
 
Bulk metals are good electrical conductors and optical reflectors because of the free 
movement of delocalized electrons in the conduction band as shown in Figure 4-1. When 
the size is reduced to 2– 100 nm, metal nanoparticles display characteristic colours due 
to surface plasmon resonance (SPR) which is a result of the collective oscillation of 
conduction electrons at their surfaces upon interaction with light 233, 234. When the size of 
these  metals is further reduced to  2 nm or less (down to 300 atoms or less) 235, 236 , these 
particles are too small to support surface plasmon resonance. Moreover, at this sub-
nanometre size scale, the band structure becomes discontinuous and is broken down into 
discrete energy levels 219. This electronic structure is somewhat similar to the energy 
levels of molecules. Hence, metal nanoclusters are said to have “molecule-like” properties 
and do not exhibit plasmonic properties 219, 237. Metallic nanoclusters are seen as 
materials that bridge the gap between plasmonic nanoparticles and individual atoms. 
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Nonetheless, metal nanoclusters can still interact with light via electronic transitions 
between energy levels, resulting in light absorption and emission. A prominent feature 
that makes metallic nanoclusters particularly attractive in biomedical applications is 
their strong photoluminescence, good quantum yields, tuneable fluorescence 




Figure 4-1. Whereas bulk metal and metal nanoparticles have a continuous 
band of energy levels, the limited number of atoms in metal nanoclusters 
results in discrete energy levels, allowing interaction with light by electronic 
transitions between energy levels. Metal nanoclusters bridge the gap 
between single atoms and nanoparticles. Reprinted from reference 239. 
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4.3 Optical Property of Metallic Nanoparticles 
 
Noble metal NPs such as Gold (Au) and Silver (Ag) exhibit a unique optical property 
originating from their surface plasmon resonance (SPR) that can be conveniently 
detected by UV-Visible spectrophotometry. Au NPs typically display a strong the SPR 
band peaking in the range of 520 nm to 580 nm 240, depending on the particle size as 
demonstrated by  El-Sayed and colleagues  in 1999 241. Increasing the Au NP size 
resulted in a red shift of the SPR peak absorption in the UV-Vis spectrum 241. Ag NP’s 
SPR band appeared at  the region of 420 nm to 450 nm 242, 243. Moreover, a similar 
behaviour was observed for differently sized Ag nanoparticles, wherein the 
characteristic SPR peak position shifted to longer wavelengths with increasing  
particles size 244. The SPR absorption is caused by the interaction between incident 
light and electrons on the surface of NPs as shown in Figure 4-2. The free electrons 
(s electrons) in the metal are free to move through the material. An incident light with 
wavelength greater than the diameter of the particle can lead to standing resonance 
conditions. As the wave front of incident light passes, the electron density in the 
nanoparticle is polarized to one surface and oscillates in resonance with the light’s 
frequency causing a standing oscillation234.  
 
 
Figure 4-2. Basics of localized surface plasmon resonance (LSPR) of gold 
nanoparticles due to collective oscillation of surface electrons with incident 
light at a specific wavelength. Reprinted from www.cytogenetics.com 
 
The Mie theory can be used to describe the response of spherical NPs whose 
diameter is smaller than the wavelength of incident light 245. As shown in Equation 
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4-1, the extinction cross section of a single particle (Cext) defines the energy loss in 
the direction of incident light due to both absorption and scattering. The Cext is 
described in terms of dielectric function of the metal (ε() = ε’() + iε” ()) and 
dielectric constant of the medium εm. From the equation, Cext of the particle is 
dependent on the dielectric function of the metal of which the particle is composed. 
Hence, this give rise to the unique absorption and scattering profiles for different 
metal nanoparticles. For small nanoparticles compared to the wavelength of incident 
light (e.g. Au < 25 nm), only the dipole absorption of the Mie equation contributes to 
the extinction cross section Cext of the nanoparticles 241. The Mie theory then reduces 
to the following relationship: 
 
 






(ε′ () + 2ε𝑚)2 + ε′′ ()2 
 Equation 4-1 
 
 
where ε() = ε’() + iε” () is the wavelength-dependent, complex dielectric function 
of the NP material, εm is the dielectric constant of the surrounding or embedding 
medium and R is the radius of the particle. The frequency of SPR is also dependent 
on the size and composition of NPs, as well as the dielectric constant of medium 241. 
As the shape or size of the nanoparticle changes, the surface geometry changes 
causing a shift in the electric field density on the surface. This causes a change in 
the oscillation frequency of the electrons, generating different cross-sections for the 
optical properties including absorption and scattering 234. The change in SPR 
frequency yields the change of NPs colour that can even be observed with bare eyes 
234. Zhong and colleagues 246 showed the  size correlation with SPR properties and 
UV-vis absorption spectra for Au nanoparticle with diameters ranging from 10 to 100 
nm as shown in Figure 4-3.  
 
 










Figure 4-3. (A) TEM images of Au NPs of different sizes: 10 nm (A); 20 nm (B); 
30 nm (C); 40 nm (D); 50 nm (E); 60 nm (F); 70 nm (G); 80 nm (H); 90 nm (I); and 
100 nm (J). The size distributions of Au NPs: (a) 12.31.3 nm; (b) 20.6 1.5 nm; 
(c) 30.01.1 nm; (d) 40.31.7 nm; (e) 51.62.0 nm; (f) 61.31.5 nm; (g) 70.62.0 
nm; (h) 78.32.7 nm;(i) 88.1 2.0 nm; (j) 102.2  2.6 nm. The y-axis represents 
normalized frequency. (B) Photo showing the colours of Au NPs with different 
particle sizes, and (C) The UV-vis spectra (normalized) for Au NPs with different 
particle sizes in aqueous solution. Reprinted from reference 246. 
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4.4 Optical Property of Metallic Nanoclusters 
 
 
Figure 4-4. Schematic representation of the optical properties of 
nanoclusters and nanoparticles. Reprinted from reference 247. 
 
The UV-Vis absorption spectra for nanoparticles and nanoclusters are shown in 
Figure 4-4. The absorption spectra of metallic nanoclusters do not show the typical 
surface plasmon resonance (SPR) feature of nanoparticles (Figure 4-4 (A)). Instead, 
NCs display a “molecule-like” optical characteristics due to their discrete electronic 
energy levels. This gives rise to size tuneable HOMO-LUMO gap that in turn can lead 
to size-dependent luminescence 248. For larger NCs (those formed by a number of 
atoms N  10-15 atoms), the UV-Vis absorption spectra  consists of a continuous 
increase of absorbance with decreasing wavelength  (Figure 4-4 (B)). However, for 
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smaller metallic nanoclusters (those formed by a number of atoms N  10-15 atoms) 
display molecule bands (Figure 4-4 (C)) instead of collective plasmon excitations. As 
the size of the nanoclusters decreases, the spacing’s between the discrete states in 
each band increases, leading to a blue shift in the absorption peaks. For example, 
Dickson and colleagues 249 reported Ag NC made of  Ag1–Ag4 core showed 
absorption peaks at 440 nm and 357 nm 249. Recently, the UV-Vis absorption spectra 
of DHLA-stabilized Ag4 and Ag5 NCs were found to exhibit peaks at 435 nm and 
335 nm and a shoulder peak at 500 nm 227. These observations clearly indicate that 
discrete electronic transitions in few atom metal NCs exhibit molecular like  
behaviour. 
 
Luminescence of metals (e.g. bulk and nanoparticles) is extremely weak for any 
practical applications due to the efficient non-radiative decay channels and lack of 
energy gap 250. Interestingly, metallic nanoclusters were reported to exhibit strong 
luminescence which can have ~ 9 orders of magnitude higher than bulk gold (QY = 
10-10). Unfortunately, there is no general mechanism that explains the emission from 
all metal NCs as compared to the well-established emission mechanism in quantum 
dots (QDs). Instead, several studies have shown that the luminescence mechanism 
of metal NCs may vary with sizes, coating ligands, and their synthesis routes. For 
instance, Huang and Murray suggested the visible light emission from monolayer-
protected metal NCs is due to the interband transitions between the filled d band and 
the conduction band 238, 251. Whetten and colleagues attributed the infrared luminesce 
of glutathione protected Au25 NCs to the relaxed radiative recombination across the 
HOMO-LUMO gap within the sp conduction band (intra-band transition) 252. Zheng 
and colleagues proposed that luminescent nanoparticles synthesized by dissociation 
of polymeric Au(I) thiolates can actually be considered as intermediate between 
luminescent Au(I) complexes/clusters and non-luminescent gold nanoparticles 253. 
Very recently, Wu and Jin 254 reported that the surface ligands have a profound effect 
on the fluorescence of thiol-protected Au NCs. In summary, these studies suggest 
that fluorescence emission from nanoclusters may originate from (a) the metal core 
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intrinsic quantization effects and (b) the property of nanocluster surface determined 
by the chemical interactions between the surface ligands and the metal core. 
 
4.5 Synthesis of Ag NPs and Ag NCs 
A variety of methods have been developed for the synthesis of water-soluble Ag NPs 
and Ag NCs since most applications their applications involve aqueous conditions 
(e.g. chemical and biological sensing, imaging, etc.). Various synthetic approaches 
involve the reduction of silver salts in the presence of suitable stabilizers which can 
be accomplished by physical methods (e.g. radiolytic 221, 255-259, photochemical 260-270, 
sonochemical 271-281, and microwave 281, 282), and chemical methods.  
 
The synthesis of water-soluble Ag NPs via chemical reduction typically involves the 
reduction of AgNO3 solution in the presence of an appropriate stabilizer (i.e. capping 
agent) with an effective reducing agent. The stabilizer is necessary to avoid particle 
aggregation by shielding the growth of the particles 210, 211. The final particle size and 
aggregation state of Ag NPs strongly depend on experimental parameters such as 
the initial AgNO3 concentration, reducing agent, Ag:ligand, and  Ag:reducing agent 
molar ratios, and stabilizer concentrations. Several reducing agents are suitable for 
the synthesis. As for any redox reactions, the standard reduction potential (E) of the 
reaction determines a successful chemical conversion (i.e. Ag+  Ag0). Furthermore, 
the Gibbs free energy change (G) in the reaction must be negative. Note that G 
= -nFEcell, where n is the number of electrons involved, F = Faraday constant (96485 
coulombs/mole) and E0cell is the standard potential of the redox reaction. If  E0cell > 
0, then G would be negative and hence reaction can happen. In case of Ag NP 
synthesis, the large reduction potential for Ag+ → Ag0 in water  (E= +0.799 V, 283) 
permits the use of several reducing agents such as sodium citrate (E = −0.180 V,284), 
sodium borohydride (E = −0.481 V, 283), hydrazine (E = −0.230 V, 285) and 
hydroquinone (E = −0.699 V, 286). Strong reductants usually generate small and 
monodisperse Ag NPs but it is difficult to produce larger size Ag NPs. Weak 
reducing agents lead to slower reduction reactions and more polydisperse Ag NP 
sizes 287. Size controlled Ag NP synthesis can be achieved in a two-step method 
involving two reducing agents, where nuclei particles are prepared using a strong 
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reducing agent and then enlarged by a weak reducing agent 288, 289. Capping agents 
also play an important role in the final outcome Ag NP size and shape because they 
can constrain the growth of distinct crystal faces by preferential adsorption. Weak 
capping agents such as surfactants 290, ligands 291, polymers 290, and dendrimers 292 
commonly produce spherical nanoparticles. However, capping ligands were also 
found to allow the formation of other nanoparticle shapes by controlling the growth 
rates for {111} and {100} crystallographic planes and thus determining the final shape 
of the nanoparticles 293. A good example is the selective adsorption of both poly(vinyl 
pyrrolidone) (PVP) and bromide ions (Br-) to {100} facets of Ag to slow down their 
growth rate resulting in the formation Ag nanocubes and nanobars 294, 295. 
Furthermore, citrate has been shown to bind more strongly to {111} than {100} facets, 
favouring the formation of Ag nanoplates 296, 297. 
 
The typical synthesis of Ag NCs also involves the reduction of an aqueous solution 
of AgNO3 with NaBH4 in the presence of stabilizing agents with high affinity for Ag+. 
Common stabilizers reported include DNA 249, peptides 298, 299, proteins300, and 
polythiol 301, 302 or polyethyleneimine appended molecules 303. Dickson and 
colleagues first reported the synthesis of Ag NC using DNA as template and reported 
that silver ions have strong interactions with oligonucleotide bases (N3 in the 
pyrimidines and N7 in the purines) but not with the negatively charged phosphate 
backbone. Mass spectral analysis of the synthesized Ag NCs further revealed ~ 4 Ag 
atoms are contained in a single DNA  template 249. Single stranded DNA consisting 
mostly of 12 cytosine bases were found to generate near-IR emitting Ag NC with a 
high quantum yield ~ 17 %. The resulting Ag NCs exhibit excellent photostability and 
show no photoblinking at 0.1 to > 1000 ms time scales 304.  
 
Lipoic acid and polyethylene glycol appended lipoic acid ligands were also used to 
synthesize water-soluble and stable Ag NCs. Usually, a strong reducing agent 
(i.e.NaBH4), was used to reduce the lipoic acid to dihydrolipoic acid ligands, so they 
chemisorb on the Ag NC surface and make the Ag NCs water-dispersible. Banerjee 
and colleagues prepared Ag NCs with  Ag:L ratio of  1:10 and high resolution mass 
spectral analysis revealed that Ag NC consisted of Ag4 and Ag5 227. Using the same 
synthesis  method but with an Ag:L ratio 1:5, Meijerink and colleagues reported a 
larger Ag25 cluster. It is highly likely that the smaller cluster size (Ag4 and Ag5) resulted 
from the fragmentation  of Ag25 clusters 305. Interestingly, size control of Ag NCs can 
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be achieved using polyethylene glycol modified lipoic acid by simply varying the molar 
ratio of Ag+ ions to the ligand 306. Ag NPs were formed when Ag:L ratio is between 
1:0.001 to 1:0.2, while Ag NCs were formed when Ag:L ratio were 1:1 and 1:10 as 
shown in Figure 4-5 306. The use of PEG molecules with different terminal functional 
groups (-OCH3, -NH2, -COOH) gives the Ag NCs different surface property that can 
be used  in various biological applications. 
 
 
Figure 4-5.  (A) synthetic strategy of NPs/NCs of various core sizes. (B) and 
(C)  Photographs of aqueous dispersions of the particles synthesized at 
various Ag:L ratios under room light and UV light irradiation. The Ag:L ratio 
for NP1, NP2: NP3, NP4, NP5, NP6, NC1 and NC2 were 1:0.001,1:0.01, 1:0.02, 
1:0.04, 1:0.1, 1:0.2, 1:1 and 1:10 respectively. Images were collected from a 
set of freshly prepared dispersions, without filtration or adjustment of the 
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4.6 Antimicrobial  Mode of Action  
A number of paper has studied the anti-bacterial properties of Ag NPs over the past 
years 217, 307, 308. However, the exact mechanism of action remains a hot debating 
topic. Currently, there is a wealth of experimental evidence that supports the different 
antimicrobial mechanisms of Ag NPs. Ag NPs can cause cell lysis or inhibit bacterial 
growth through several mechanisms which include silver ion release from Ag NPs, 
cell membrane damage, DNA interactions and generation of reactive oxygen species 
(ROS). 
 
Silver ions has been previously shown to cause considerable morphological changes 
in bacterial cell membrane and cause S. aureus and E. coli to reach an “active but 
non culturable” (ABNC) state and eventually die 309. Hence, researchers have 
correlated the release of silver ions from Ag NPs as a possible mechanism for its 
antimicrobial property. Silver (E°= +0.799 V) as a noble metal, is not attacked by 
water or acid but Ag metal and Ag NPs continuously release small amounts of silver 
ions under aerobic conditions 310, 311. These silver ions are biochemically active and 
can interact with thiol and nitrogen groups of many enzymes, thus, interfering in many 
biochemical process inside bacterial cells. The highest concentration of released 
silver ions was observed in the case of the highest surface area of Ag NPs (e.g. 
smallest NPs). While the lowest concentration of released silver ions was observed 
for the biggest Ag NPs with the lowest surface area, resulting in weak antimicrobial 
properties 312. Interestingly, Alvarez and colleagues excluded the “particle-effect” as 
a mechanism for the antimicrobial effects of Ag NPs. They prepared and stored Ag 
NPs under anaerobic conditions and the effect on E.coli was studied under the 
exclusion of oxygen. The results showed a direct correlation with the amount of 
released silver ion to the toxicity of Ag NPs. Moreover, Ag NPs alone were found to 
be not toxic up to 200 mgL-1 313. 
 
Another antimicrobial mechanism of Ag NPs involves the anchoring and penetration 
of Ag NPs to bacterial cell wall. Electron microscopy imaging of  Ag NPs treated E.coli 
and S. aureus have revealed the formation of ‘pits’ in the cytoplasmic membrane and 
accumulation of Ag NPs on the cell surface 314. The Ag NPs anchored on the bacterial 
surface can cause pronounced defects in the cell membrane which can lead to 
changes in the permeability of the cell membrane and eventually to death of the cell. 
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Silver can interact with the protein portion of the bacterial membrane to form 
complexes with electron donors that contain oxygen, phosphorus, nitrogen or sulphur 
atoms 215, 307, 315. Several bacterial membrane proteins are known to contain sulphur 
which can interact with silver, leading to the inactivation of membrane-bound 
enzymes and proteins 242, 316. Alternatively, Ag NPs can chemically interact with the 
lipid portion of the bacterial membrane317, 318. It has been reported that silver ions and 
Ag NPs are able to increase the trans/cis ratio of unsaturated membrane fatty acids 
319. Moreover, silver species were also observed to cause modifications in fatty acid 
composition in bacterial cell wall 320. Taken together, these reactions (e.g., cis to trans 
isomerization and modifications in lipid composition) can affect membrane fluidity and 
hinder normal membrane function by inducing an increase in permeability and loss 
of membrane integrity 314, 321, 322.  
 
The production of free radicals by the Ag NPs  is another possible mechanism by 
which bacterial cells die. These highly reactive species have the ability to damage 
the cell membrane, making it porous which can ultimately lead to cell death. Electron 
spin resonance spectroscopy (ESR) was used to investigate if free radical generation 
from Ag NPs  is related to the observed antimicrobial effect. The results showed that 
microbial growth inhibition may be caused by the formation of free radical species 
from the surface of Ag NPs, and led to radical-induced membrane damage 323. In 
another study, Soo-Hwan and colleagues showed the antibacterial activities of Ag 
NPs against S. aureus and E.coli generate ROS that lead to protein breaks, 
increased cell membrane permeability and inactivation of lactate dehydrogenase 324. 
The toxicity of Ag NPs was significantly higher in aerobic conditions than in anaerobic 
conditions 325. Moreover, loss of Ag NP toxicity was observed upon addition of an 
antioxidant, N-acetylcysteine 325. These results clearly suggests that ROS formation 
plays a key role on the toxicity of Ag NPs. 
 
Several investigations have demonstrated the lethal DNA damage caused by 
interaction of silver ions with DNA. Experimental evidence based on a combination of 
FTIR spectroscopy and capillary electrophoresis revealed that Ag+ ions have optimal 
binding sites at guanine N7 and adenine N7 326. Vishnupriya and colleagues 327 studied 
the interaction between E. coli and citrate-reduced Ag NPs  (size 25 nm) through 
Raman spectroscopy in conjunction with plasmon resonance imaging of single 
bacterial cells. The technique of hyperspectral imaging showed Ag NPs inside the E. 
coli cells and Raman spectroscopy showed that the bacterial DNA was degraded 
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after 1 hour, causing a decrease in the nucleotide-specific Raman signals. This result 
suggested that Ag NPs interacted mainly with DNA. In another study, Ouda and 
colleagues 328 studied the antibacterial effect of Ag NPs (38 nm) against  Proteus sp. 
and Klebsiella sp.. Growth in both bacterial strains were inhibited, cellular 
components became disorganized, and bacterial cell wall was ruptured. The reported 
an MIC value of 10 μgmL-1 for both bacterial strains. Furthermore, agarose gel 
electrophoresis images showed the destruction of both pathogenic bacteria 
genomes. In effect, this resulted in a loss of DNA replication and promoted 
degradation, thereby inhibiting bacterial growth 328.  
 
4.7 Overview of the Project 
Ag NPs and NCs are interesting silver nanomaterials with unique optical properties. 
An increasingly common application of Ag NPs are their incorporation to consumer 
based products 329, 330 and as surface coatings to medical implants and equipment 331 
primarily to provide protection against bacteria. On the other hand, Ag NCs are a new 
class of silver nanomaterials that are composed of several to a few hundred Ag atoms 
and exhibit a strong and tuneable photoluminescence224, 236. With their unique optical 
properties, it is also interesting investigate and compare the antibacterial activities of 
Ag NPs and Ag NCs. The ultra-small size of Ag NCs could have a “scaling effect” in 
biological systems over their larger NP counterparts. Thus, it is of paramount 
importance to clarify and gain a better understanding of the antimicrobial properties 
of Ag NPs and Ag NCs.  
 
There is a large volume of work that demonstrated the antibacterial property of Ag 
NPs are dependent on shape and size, where smaller Ag NPs displayed better 
antimicrobial properties over bigger Ag NPs 215, 332. In terms of shape, cubic Ag NPs 
exhibited greater antibacterial efficacy over nanospheres and nanowires due to the 
exposed (111) facet of the nanocubes having greater surface energy than facet of 
nanospheres 333. The antibacterial properties of Ag NCs have also been recently 
investigated and showed potent antibacterial action against several bacterial strains 
229 and even with the multi-drug resistant bacteria P. Aeruginosa 334. Interestingly, Jin 
and colleagues (2017) 231 were able to show that Ag NCs can be internalized into E. 
coli DH 5 and E.coli DSM 4230 cells via different mechanisms and the silver ions 
inside the cells were assumed to contribute to the bacterial growth inhibition and 
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death 231. It has been hypothesized that the ultra-small size of Ag NCs might have a 
better interaction with cellular components, thus, penetrated through cell membranes 
and exerted in their antibacterial action. This raises an important fundamental 
question whether “particle size effect” is a predominant factor that can differentiate 
the antimicrobial efficiency between Ag NPs and Ag NCs. Current literature provide 
sufficient but separate information about the antimicrobial properties of Ag NPs 287 
and Ag NCs 237. However, a direct comparison between the silver nanomaterial 
systems is difficult because of the difference in the preparation of silver nanomaterials 
and the different bacterial strains and growth medium used in these studies. To 
address these challenges, Ag NPs and Ag NCs were prepared in the same chemical 
synthesis protocol, thus, allowing direct comparison of their antimicrobial properties 
without any of the aforementioned complications.  
 
A topic that deserves further investigation is the effect of the zeta potential of Ag NPs 
and Ag NCs on their antibacterial activities. Capping ligands which provide surface 
charge and stability to Ag NPs also play an important role in their use as antimicrobial 
agents 335. This was exemplified in a study of Enteroccocus faecalis that were 
incubated with chlorhexidine (control), neutral, negative and positively charged Ag 
NPs (size 10 nm). The results showed that that positively charged Ag NPs were more 
toxic to E. faecalis (>106 fold) than negatively charged nanoparticles 336. 
Unfortunately, experimental evidence regarding the effect of surface charge to the 
antibacterial properties of Ag NCs is still lacking in the literature. Furthermore, a direct 
comparison of surface charge between Ag NPs and Ag NCs with regard to their 
antimicrobial activities remains unknown. To address these issues, the project aims 
to prepare polyethylene glycol appended lipoic acid based ligands with different 
terminal functional groups (e.g. zwitterion, –NH2, -OH, -OCH3) and use them to 
prepare Ag NPs and Ag NCs. 
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Chapter 5  
Ligand Synthesis and Preparation of Silver Nanomaterials as 
Antibacterial Agents 
This chapter describes the synthesis of thioctic acid–PEG based (TA-PEG-X, X refers 
to the different functional groups) ligands, zwitterion–appended thioctic acid ligand, 
and the preparation of water-soluble silver nanoparticles (Ag NPs) and silver 
nanoclusters (Ag NCs). Each TA-PEG-X based ligand contains a thiotic acid head 
group that provides strong binding to the metallic silver surface by bidendate 
chelative binding; PEG moiety which provides good water dispersion stability and 
terminal functional group such as (-OCH3 and NH2). The chemical structures of these 
ligands are shown in Figure 5-1.  
 
 
Figure 5-1. Chemical structures of thioctic acid and thioctic acid based 
ligands for the synthesis Ag nanomaterials. The EG and PEG refers to the 














 ~  750 and ~1000 
TA-Zwitterion 
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These ligands were prepared and purified by following the literature procedures 337, 
338 and the purity and structure of the products were confirmed by thin layer 
chromatography (TLC), proton nuclear magnetic resonance (1H NMR) spectroscopy, 
and mass spectrometry (MS). The spectroscopic data of the ligands were found to 
be consistent with those reported in the literature.  
 
Note: Undergraduate students Alexandra Gummer and Wei Ng in Dr. Dejian Zhou’s 
group contributed to the results in this chapter. The author of this Thesis (L. Lapitan) 
contributed in the planning of the experiments, synthesis and purification of the 
ligands, preparation of the Ag nanomaterials and co-supervision of the students. The 
antibacterial properties (i.e. MIC experiments) of the Ag nanomaterials were carried 
out by Dr. Christopher Randall from Antimicrobial Research Centre, School of 
Molecular and Cellular Biology, University of Leeds. The silver concentration ion were 
determined using ICP-Ms analysis and conducted by Dr. Karen Arnes Thorne from 
the Faculty of Engineering, University of Leeds. The TEM imaging was carried out by 
Dr. Nicole Hondow and Dr. Michael Webb from the Faculty of Engineering, University 
of Leeds. The data presented in this chapter are taken from the undergraduate thesis 
of A. Gummer and W. Ng and were re-formatted by L. Lapitan to suite the 
explanations made in the text. The contributions of the students and collaborators 
were specified in the captions of relevant figures.  
 
5.1 Materials and Methods 
 Equipment 
Fluorescence and UV-Vis measurements were recorded using Cary 
Eclipse®Spectrofluorimeter and Varian Cary 50 Bio® Ultraviolet -Visible 
spectrophotometer respectively. The silver ion concentration were determined using 
Perkin Elmer ELAN DRC-e Inductively Coupled Plasma / Mass Spectrometry. Proton 
NMR (1H NMR) and Mass spectrometry (MS) data were collected using BRUKER 
DPX400®, 400 MHz nuclear magnetic resonance spectrometer and high resolution 
BRUKER Maxis Impact® mass spectrometer respectively. Hydrodynamic size and 
zeta potential measurements of Ag nanomaterials  were measured using Malvern® 
zetasizer-nano with BI-APD detector using a He-Ne laser at 633 nm (scattering angle: 
90, temperature, 25C). Transmission electron microscopy (TEM) images were 
- 153 - 
 
 
taken using the FEI Titan Themis G2 300 Analytical transmission electron 
microscope. The specimen for TEM study was prepared by depositing a drop of the 
MNP solution onto a carbon-coated TEM grid. Ultrapure water (resistance >18.2 
M·cm) was purified by ELGA Purelab classic UVF system, was used for all 
experiments. Ultracentrifugation was carried out using Thermo Scientific Heraeus 
Fresco 21 and agarose gel electrophoresis was carried out using Bio-Rad HU6 Mini 
Horizontal Gel Unit. 
 
 Materials 
Flash column chromatography using silica gel 60 A (Merck grade 9385) was used to 
purify the ligands. Thin layer chromatography was done on a  silica gel-60 F254 on 
aluminium plates. Quartz cuvette was used for UV-Visible spectroscopy (1 mL, 10 
mm optical path length) and fluorescence spectroscopy (0.7 mL, 10 mm optical path 
length). Centrifugal filtration (Amicon- Vivaspin® MW cut-off 5000 Da and 10 000 Da) 
was used to concentrate and purify the Ag nanomaterials.  
 
 Reagents 
Thioctic acid (TA,>98+%), Triethylamine (>99%), Triphenylphosphine (>99%), 
Polyethylene glycol methyl ether (MWave ~ 750 g·mol-1) and sodium hydrosulfide 
hydrate were purchased from Acros Organics. Silver nitrate, sodium borohydride, 
ammonium hydroxide, and agarose purchased from Fisher Scientific. 
Methanesulfonyl chloride (>99.7%), N,N-dimethyl-1,3-propanediamine (>99%), 1,3-
propanesultone (>99%), sodium azide (>99.5%), dicyclohexylcarbodiimide 
(DCC,>99%), dimethylaminopyridine (DMAP, >99%), anhydrous magnesium 
sulphate (>99%), Methanol (>99.9%), potassium hydroxide, ethyl acetate (>99.0%), 
methylene chloride (>98%) sodium bicarbonate (>99.5%), Rhodamine 6G, 
chloroform-d (99.8%), and sodium carbonate (>99.5%) were purchased from Sigma-
Aldrich. Hydrochloric acid, dichloromethane, chloroform and methanol are analytical 
grade and were purchased from VWR Chemicals. Amino polyethylene glycol methyl 
ether (H3CO-PEG~23-NH2) (MW ~1000 g·mol-1) was purchased from Alfa Aesar and 
Azido dodcylethylene glycol amine (N3-EG12-NH2) and triethylene glycol amine (N3-
EG3-NH2) were purchased from Polypure Inc. 
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5.2 Ligand Synthesis  
5.2.1 Synthesis and Spectroscopic Analysis of TA-PEG~17-OCH3 
The chemical structures and synthetic route for the synthesis of TA-PEG~17-
OCH3 are shown in  
Scheme 5-1. The starting material is a mixture of polyethylene glycol methyl ether 
with an average molecular weight of 750 g·mol-1. This PEG molecular weight 
corresponds to ~ 17 ethylene glycol units.  
 
 
 Synthesis of H3CO-PEGn-N3 (n ~17) 
Polyethylene glycol methyl ether (MW ~750 g·mol-1) (37.5 g, 50 mmol), dry THF (150 
mL) and methanesulfonyl chloride (11.45 g, 100 mmol) were added in a 500 mL two-
necked round bottomed flask equipped with an addition funnel, septa and a magnetic 
stirring bar. The reaction mixture was purged with N2 and cooled to 0 °C in an ice 
bath. Triethylamine (Et3N, 15 mL, 111 mmol) was then added dropwise to the reaction 
mixture through the addition funnel (total addition time ~30 min). After that, the 
reaction mixture was allowed to warm up gradually to room temperature (~20 °C) and 
stirred for 12 hrs. The product was checked by TCL on silica gel with CHCl3:MeOH = 
10:1 (vol/vol) as elution solvent, Rf (MsO–PEG17–OMe) = 0.65, Rf (HO–PEG~17–OMe) = 0.35. The 
mixture was then diluted with H2O (50 mL) and NaHCO3 (3.125 g, 37 mmol) was 
added. The mixture was transferred to a separatory funnel and extracted with CHCl3 
 
 
Scheme 5-1. The synthetic route to TA-PEG17-OMe. The reaction conditions 
are: (ia) MsCl, Et3N, THF; (ib) NaN3, NaHCO3, H2O; (ii) PPh3, EtOAc and 1 M 
HCl; (iii) thioctic acid, DCC/DMAP, CH2Cl2. 
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(60 mL × 3). The combined organic layer was concentrated on a rotary evaporator, 
yielding slightly yellowish oil, 40 g (48.3 mmol) and 96.6% yield. The product (40 g), 
sodium azide (7.75 g, 120 mmol), THF (50 mL), H2O (50 mL) and NaHCO3 (3.125 g, 
37 mmol) were then added to 500 mL two-necked round-bottomed flask equipped 
with a distilling head with a round-bottomed flask as a solvent trap. The solvent trap 
was cooled with an ice-bath. The biphasic reaction mixture was heated under N2 to 
distill off the THF. The reaction mixture was then refluxed for ~12 hrs. After the 
reaction mixture was cooled to room temperature, it was transferred to a separation 
funnel and extracted with CHCl3 (100 mL × 5). The product was checked with TCL 
using CHCl3: MeOH =10:1 (vol/vol) as elution solvent, Rf (N3-PEG~17-OMe) = 0.75. The 
combined organic layers were dried over MgSO4 with stirring for 30 minutes. The 
MgSO4 was filtered and the combined organic layer was concentrated on a rotary 
evaporator. A pale brown oil (24.93g, yield: 66.7%) was obtained and its 1H NMR was 
shown in Figure 5-2. H3CO-PEGn-N3: 1H NMR (400 MHz, ppm): 7.27 (CDCl3  
solvent peak); 3.65-3.60 (m, -CH2- in repeated EG groups, 4), 3.56-3.52 (t, 2H, J = 







Figure 5-2. (A) The 1H NMR spectrum of H3CO-PEGn-N3 from 2.0-8.0 ppm. (B) 
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The chemical structure of H3CO-PEGn-N3 was further characterized using high 
resolution mass spectrometry. The chromatogram of the purified compound is shown 
Figure 5-3 (A). The general molecular formula used to calculate the MW peaks 
[MW+Na+] of H3CO-PEGn-N3 is shown in Figure 5-3 (B). The mass spectra of H3CO-
PEGn-N3 and the assignment of the corresponding EG chain length for each 










Figure 5-3 (A) Chromatogram of N3-PEGn-OCH3 (PEG MW ~750 g·mol-1). (B) 
The structural and molecular weight equation used to estimate for the 
ethylene glycol chain lengths. (C) Accurate mass spectra of H3CO-PEGn-N3. 
The ion peaks are reported as (M+Na+) abduction and the corresponding 
ethylene glycol chains (n) lengths were assigned to each molecular ion peak. 
1






N3-PEG750-OMe_217440_BB3_01_37347.d: BPC 50.0000-1501.0000 +All MS
n 





































400 500 600 700 800 900 1000 1100 m/z
n=13                                
n=14                                
n=15                          
n=16                                
n=17                                
n=18                                
n=19                                n=20                                
n=12                                
n=11                                
n=10                                
n=9                                
n=8                                
- 157 - 
 
 
The mass error in ppm was calculated using the formula 339: 
 
𝑒𝑟𝑟𝑜𝑟 (𝑝𝑝𝑚) =  
𝑚𝑖 − 𝑚𝑎
𝑚𝑎
 𝑥 106 
Equation 5-1 
 
Where mi and ma refers to the measured accurate mass (experimentally observed 
m/z) and monoisotopic calculated exact mass (theoretical m/z) respectively. The ma 
was determined by summing the masses of the individual isotopes for a given ion. 
The molecular formula for H3CO-PEGn-N3 with 13 PEG units and a sodium atom is 
C29H59N3O14Na. Therefore, the measured accurate mass (from the mass spectra) 
and monoisotopic calculated exact mass are 696.3833 and 696.3900 respectively. 
The mass error in ppm = -9.62. The same calculation can be carried out to calculate 
the mass error of an assignment with the other mass spectral peaks in Figure 5-3 
(C).  
 
 Synthesis of H3CO-PEGn-NH2 (n ~17) 
N3–PEG~17–OCH3 (8.0 g, ~10 mmol), EtOAc (150 mL) and 1 M HCl (25 mL, 25 mmol) 
were added into a 500 mL two-necked round-bottomed flask equipped with an 
addition funnel, septa and a magnetic stirring bar. Triphenylphosphine (2.8 g, ~10 
mmol) dissolved in 100 mL EtOAc was transferred to the addition funnel. The reaction 
vessel was purged with N2 and cooled to 0 °C in an ice-bath while stirring. The 
triphenylphosphine solution was then added dropwise under N2. The temperature 
was maintained to below 5 °C with an ice bath during the addition. Once the addition 
was complete, the reaction mixture was gradually warmed up to room temperature 
and stirred overnight under N2. The reaction mixture was then transferred to a 
separatory funnel and the biphasic solution was separated. The aqueous layer was 
collected and washed with EtOAc (100 mL × 2) to remove the formed triphenyl-
phosphine oxide byproduct. The aqueous layer was transferred to a round bottom 
flask and cooled in an ice bath. KOH (13.5 g) was added slowly to the aqueous 
solution under magnetic stirring to adjust its pH to basic (pH > 10). The aqueous 
solution was transferred into a separatory funnel and extracted with CHCl3 (60 mL × 
5). The combined organic layer was dried over MgSO4 for 30 mins. The MgSO4 was 
filtered and the solvent was removed on a rotary evaporator. A light yellow oil was 
obtained, 4.58 g, yield: 59.2%. Rfs (CHCl3:MeOH = 10:1, vol/vol) for Rf (N3-PEG17-OMe) = 
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0.75, Rf (NH2-PEG17-OMe) = 0.25. The chemical structure of OCH3-PEGn-NH2 was 
determined by 1H NMR as shown in Figure 5-4. H3CO-PEGn-NH2 : 1H NMR (400 MHz, 
ppm): 7.27 (CDCl3 solvent peak);  3.65-3.60 (m, -CH2- in repeated EG groups, 4), 
3.56-3.52 (t, 2H, J = 4.8, -CH2-OCH3, 2), 3.38 (s, –OCH3-, 3H, 1), 3.10 (t, 2H, J = 4.8, 
-CH2-NH2,3), 1.61 (2H, broad s, -NH2, 5).  
 
 
The chemical structure of H3CO-PEGn-NH2 ligand was further characterized using 
mass spectrometry. The chromatogram of the purified compound is shown Figure 
5-5 (A). The general molecular formula used to calculate for the MW peaks [MW + 
Na+] for H3CO-PEGn-NH2 is shown in Figure 5-5 (B). The mass spectra of H3CO-
PEGn-NH2 and the assignment of the corresponding EG chain length for each 
molecular ion peak is shown in Figure 5-5 (C). 
 
The molecular formula for OCH3-PEGn-NH2 with 17 EG units and proton is 
C37H78N1O18. Therefore, the measured accurate mass (from the mass spectra) and 
monoisotopic calculated exact mass are 824.5267 and 824.5224 respectively. The 
mass error in ppm = 5.22. The same calculation can be carried out to estimate the 
mass error of an assignment with the other mass spectral peaks in Figure 5-5 (C). 
(A) (B)  
Figure 5-4.  (A)  The 1H NMR spectrum of  H3CO-PEGn-NH2 from 1.0-8.0 ppm 







































 Synthesis of TA-PEGn-OCH3 (n = ~17) 
NH2-PEG~17-OCH3 (3.75 g, ~5.0 mmol), 4-(N,N-dimethylamino)pyridine (0.12 g, ~1.0 
mmol), N,N’-dicyclohexylcarbodiimide (1.06 g, ~5.0 mmol) and CH2Cl2 (80 mL) were 
added into a 250 mL round-bottomed flask equipped with a magnetic stirring bar and 
an addition funnel. The mixture was kept at 0 °C in an ice bath. Thioctic acid (1.03 g, 
~5.0 mmol) dissolved in 30 mL of CH2Cl2 was added dropwise using an addition 
funnel over 30 min under N2 while stirring. The mixture was allowed to stir at 0 for 1 
hr and was allowed to warm up to room temperature and stirred overnight. The 
mixture was then filtered off through celite and the celite plug was rinsed with CHCl3. 
The solvent was then evaporated on a rotary evaporator, and the residue was added 
with saturated NaHCO3, The aqueous mixture was extracted with ether (100 mL x 2). 
The aqueous layer was transferred to a separate funnel, and extracted with CH2Cl2 






Figure 5-5. (A) Chromatogram of OCH3-PEGn-NH2 (PEG MW ~750 g·mol-1). (B) 
The structural and molecular weight equation used to compute for the 
ethylene glycol chain lengths. (C) Accurate mass spectra of H3CO-PEGn-NH2. 
The ion peaks are reported as proton (M+H+) abduction and the 
corresponding ethylene glycol chains (n) lengths were assigned to each 
molecular ion peak. 
1
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evaporated on a rotary evaporator a yellow solid was obtained, weight 2.30 g, yield: 
48.4%. TLC analysis (CHCl3: MeOH=10: 1 (vol/vol) as elution) results, Rf (TA-PEG17-OMe) 
= ~0.6, whereas Rf (NH2-PEG17-OMe) = 0.25. The 1H NMR spectra of TA-PEGn-NH2 is 
shown in Figure 5-6. H3CO-PEGn-TA: 1H NMR (400 MHz, ppm): 7.27 (CDCl3 solvent 
peak);  6.11 ppm (1H, broad s, amide NH, 6), 3.65-3.62 (m, -CH2- in repeated EG 
groups, 4), 3.60 (m, 1H, -CH-in the ring, 11), 3.56-3.52 (m, 2H, -CH2-OCH3, 2), 3.45 
(t, 2H, J = 5.0 Hz, -NH-CH2-, 5), 3.38 (s, –OCH3-, 3H, 1), 3.08 - 3.11 (m, 2H, 13), 2.47 
(m, 1H,-CH2- in the ring, 12), 2.18 (t, 2H, J = 7.4 Hz, -CH2-C(O), 7), 1.91 (m, 1 H, -




The chemical structure of TA-PEGn-OCH3 ligand was further confirmed by mass 
spectrometry. The chromatogram of the purified compound is shown Figure 5-7 (A). 
The general molecular formula used to calculate for the MW peaks [MW + NH4+] for 






Figure 5-6. (A) The 1H NMR spectrum of H3CO-PEGn-TA (n ~17) from 1.0-8.0 
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of TA-PEGn-OCH3 and the assignment of the corresponding EG chain length for each 









Figure 5-7.  (A) Chromatogram of TA-PEGn-OCH3. (n~17, PEG MW ~750 g·mol-1) 
(B) The structural and molecular weight equation used to compute for the 
ethylene glycol chain lengths. (C) Accurate mass spectra of TA-PEGn-OCH3. The 
ion peaks are reported as proton (M+H+) and ammonium (M+NH4+) abductions 
and the corresponding ethylene glycol chains (n) lengths were assigned to each 
molecular ion peak. 
1 2
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The molecular formula for OCH3-PEGn-TA with 14 PEG units and a NH4+ ion is 
C39H81N2O16S2. Therefore, the measured accurate mass (from the mass spectra) and 
monoisotopic calculated exact mass are 897.5044 and 897.5032 respectively. The 
mass error in ppm = 1.33. The same calculation can be carried out to estimate the 
mass error of an assignment with the other mass spectral peaks in Figure 5-7  (C). 
 
5.2.2 Synthesis and Spectroscopic Analysis of TA-PEGn-OCH3 (n 
= ~22) 
Monomethoxy polyethylene glycol amine (MWave ~ 1000 g·mol-1) (2.43 g, 2.43 mmol), 
4-N,N-dimethylaminopyridine (0.051g, 0.413 mmol), N,N’-dicyclohexylcarbodiimide 
(0.601 g, 2.92 mmol) were dissolved in 8 mL of dry CH2Cl2. The mixture was cooled 
to 0°C in an ice bath and under N2 gas. Thioctic acid (0.500 g, 2.43 mmol) dissolved 
in 2 mL dry CH2Cl2 was slowly added over a 20 minute period. The reaction mixture 
was stirred at 0°C for 1 hour before being allowed to gradually warm up to room 
temperature (27oC in oil bath) and stirred for 24 hours. The reaction mixture was 
filtered and the solvent was evaporated in vacuum giving an oily yellow substance. 
The by-products were first eluted by using 1:15 (v/v) methanol/chloroform, then the 
desired products were eluted by using 1:10 (v/v) methanol/chloroform. The reaction 
yield was ~33%. Figure 5-8 shows the 1H NMR spectra for TA-PEGn-OCH3.  
 
H3CO-PEGn-TA: 1H NMR (400 MHz, ppm): 7.27 (CDCl3 solvent peak); 6.11 ppm 
(1H, broad s, amide NH-, 6), 3.65-3.62 (m, -CH2- in repeated EG groups, 4), 3.60 (m, 
1H, -CH-in the ring, 11), 3.56-3.52 (m, 2H, -CH2-OCH3, 2), 3.45 (t, 2H, J = 5.0 Hz, -
NH-CH2-, 5), 3.38 (s, –OCH3-, 3H, 1), 3.08 - 3.12 (m, 2H, 13), 2.47-2.50 (m, 1H,-CH2- 
in ring, 12), 2.18 (t, 2H, J = 7.4 Hz, -CH2-C(O), 7), 1.91 (m, 1 H, -CH2- in ring, 12), 











The chemical structure of TA-PEGn-OCH3 ligand was further characterized using 
mass spectrometry. The chromatogram of the purified compound is shown Figure 
5-9 (A). The general molecular formula used to calculate the MW peaks [MW + Na+] 
for TA-PEGn-OCH3 is shown in Figure 5-9 (B). The mass spectra and the assignment 
of the corresponding EG chain length for each molecular ion peak are shown in 
Figure 5-9 (C).  
 
The molecular formula for OCH3-PEGn-TA with 17 PEG units and Na+ ion is 
C45H89N1O19S2Na1. Therefore, the measured accurate mass (from the mass spectra) 






Figure 5-8. The 1H NMR spectrum of H3CO-PEGn-TA from 1.0-7.5 ppm and (B) 
Enlarged region from 1.0 to 4.0 ppm. The data were collected by W. Ng in Dr. 
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The mass error in ppm = -1.54. The same calculation can be carried out to estimate 





5.2.3 Synthesis and Spectroscopic Analysis of TA-EGn-NH2 (n = 
3, 12) 
The synthesis of TA-PEGn-NH2 (n=3,12) is a two-step reaction involving amide 






Figure 5-9.  (A) Chromatogram of TA-PEGn-OCH3 (PEG MW ~1000 g·mol-1). (B) 
The structural and molecular weight equation used to compute for the 
ethylene glycol chain lengths. (C) Accurate mass spectra of TA-PEGn-OCH3. 
The ion peaks are reported as sodium (M + Na+) abductions and the 
corresponding ethylene glycol chains (n) lengths were assigned to each 
molecular ion peak. The data were collected by W. Ng in Dr. Zhou’s group. 
Reproduced from W. Ng’s BSc thesis (2015). 
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involves the reduction of the azide to amine. The chemical structure and synthetic 
steps to TA-PEGn-NH2 is shown in Scheme 5-2. 
 
 
 Synthesis of TA-EG3-N3 
Azido tri(ethylene glycol) amine (N3-EG3-NH2) (1.00 g, 4.58 mmol), 4-N,N-dimethyl-
aminopyridine (0.0895 g), N,N’-dicyclohexylcarbodiimide (1.0395 g, 5.04 mmol) were 
dissolved in 10 mL of dry CH2Cl2. The mixture was cooled to 0°C in an ice bath under 
dry conditions through purging N2. Thioctic acid (0.950 g, 4.60 mmol), which was 
dissolved in 2 mL dry CH2Cl2 was slowly added over a 20 minutes under nitrogen gas 
atmosphere. The reaction mixture was then stirred at 0°C for 1 hour before being 
allowed to gradually warm up to room temperature (27oC) and stirred for a further 24 
hours. The reaction mixture was then filtered and the solvent was removed in vacuum 
yielding yellowish oil. This crude product was purified via silica gel column 
chromatography using CH2Cl2: CH3OH (15:1 v/v) as eluting solvent. The product was 
a yellow oil, 1.48 g, yield ~ 80 %. ESI-MS (EI+) calculated for C16H31N4O4S2 (M+H+) 
= 407.18; found m/z = 407.17 (M+H+), mass error (ppm) = -24.5. 
 
 
Scheme 5-2. The synthetic route TA-EGn-NH2. The reaction conditions are, (i) 
DCC/DMAP, CH2Cl2, (2i) PPh3, dry THF, 27oC, 3 hrs, and (2ii) H2O work-up, 
27oC, 48 hrs. 
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 Synthesis of TA-EG3-NH2 
TA-EG3-N3 (1.482 g, 3.65 mmol) and triphenylphosphine (1.91 g, 7.3 mmol) were 
dissolved in 20 mL of dry THF in a round bottom flask and stirred at room temperature 
for 1 hour under N2. A 0.33 mL of de-gassed H2O (36.4 mmol) was added and stirred 
at room temperature for 20 hrs. The solvent was removed by rotary evaporation and 
purified by column chromatography. The by-products were first eluted out of the 
column using 1:9 (v/v) MeOH: CHCl3. The desired product was then eluted out of the 
column by using a 3:7 (v/v) MeOH: CHCl3. The fractions were combined and the 
solvent was removed on a rotary evaporator. A yellow oil was obtained with 0. 91 g 
and yield ~ 66%. Figure 5-10 shows the 1H NMR of TA-PEG3-NH2.   
 
TA-PEG3-NH2: 1H NMR (400 MHz, ppm): 7.27 (CDCl3 solvent peak); 6.78 (broad s, 
1H, amide NH, 6), 3.69-3.60 (m, 14H, m, -CH2- in repeated EG groups,4), 3.57-3.51 
(m, 2H,-O-CH2-, 3), 3.46-3.41 (m, 2H, -CH2- next to amide NH, 5), 3.21-3.08 (m, 2H, 
-CH2- in ring,13), 2.90-2.85 (m, 2H, -CH2- next to NH2, 2), 2.81 (br , 2H, NH2, 1), 2.41 
(m, 1H, -CH2- in the ring, 12), 2.24-2.16 (m, 2H, -CH2-C=O,7), 1.74-1.56 (m, 4H, -
CH2-CH2-8,9), 1.51-1.39 (m,2H, -CH2-, 10). ESI-MS (EI+) calculated for C16H33N2O4S2 
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 Synthesis of TA-EG12-N3 
Azido dodcylethylene glycol amine (N3-EG12-NH2) (1.8 g, ~3 mmol), 4-N,N-
dimethylaminopyridine (0.064 g, 0.5mmol), N,N’-dicyclohexylcarbodiimide (0.752 g, 
3.65mmol) were mixed and dissolved with 10mL of dry DCM in a three-necked 
bottom flask. The mixture was left to stir in an ice bath under N2 gas. Thioctic acid 
(0.65 g, ~3 mmol) dissolved in 2 mL of dry DCM was added slowly through a syringe 
over 20 minutes under N2 gas. After the addition of thioctic acid, the mixture was left 




Figure 5-10 (A) The 1H NMR spectrum of TA-PEG3-NH2 from 1.0-7.5 ppm. (B) 
Enlarged 1H NMR spectrum from 1.0 to 4.0 ppm. The (*) denotes a MeOH 
impurity peak. The data were collected by A. Gummer in Dr. Zhou’s group. 
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to stir a further 1 hour at 0°C before warming up gradually to room temperature to be 
left to stir for 24 hours. The insoluble solid was washed with CHCl3. The combined 
filtrate and washing solution was evaporated to dryness using a rotary evaporator, 
yielding the crude product as a yellow oil. The crude product was purified by using 
silica gel column chromatography using 1:10 (v/v) MeOH: CHCl3 as eluting solvent. 
The solvent was removed in a rotary evaporator yielding yellow oil, 2.2878 g, yield ~ 
93%. ESI-MS (EI+) calculated for C32H62N4O12S2 (M+Na+) = 781.3708; found m/z = 
781.3724 (M+Na+); mass error (ppm) = 2.04. 
 
 Synthesis of TA-EG12-NH2 
TA-EG12-N3 (2.3 g, ~3 mmol) and triphenylphosphine (1 g, ~4 mmol) was dissolved 
in 20 mL of anhydrous THF in a round bottom flask. The mixture was stirred at room 
temperature for 1 hour under N2 gas. 1.410 mL of degassed H2O was added to the 
mixture and stirred in room temperature for 24 hours. The by-products were first 
eluted out using 1:6 (v/v) MeOH: CHCl3. Then, the desired product was eluted out 
using 10:10:1 (v/v) MeOH: CHCl3:NH4OH. The solvent was removed in a rotary 
evaporator yielding a yellow oil, 1.2455 g, yield ~56%. The chemical structure of TA-
EG12-NH2 was determined using 1H NMR spectra shown in Figure 5-11.  
 
TA-EG12-NH2: 1H NMR (400 MHz, ppm): 7.27 (CDCl3 solvent peak); 6.11 ppm (broad 
s, 1H, amide NH-, 6), 3.70-3.64 (m, -CH2- in repeated EG groups, 4), 3.61 (m, 1H, -
CH- in the ring, 11), 3.51-3.49 (m, 2H, -O-CH2-, 3), 3.45 (m, 2H, -CH2- next to amide 
NH, 5), 3.08 - 3.12 (m, 2H, -CH2- in ring,13), 2.90-2.87 (m, 2H,-CH2- next to NH2, 2), 
2.70-2.65 (broad s, 2H, NH2, 1), 2.49-2.42 (m, 1H, -CH2- in the ring, 12), 2.18-2.27 
(m, 2H, -CH2-C=O, 7), 1.91-1.86 (m, 1 H, -CH2- in the ring, 12), 1.80-1.61 (m, 4H, -
CH2-CH2- 8,9), 1.49 (m, 2H, -CH2-,10). ESI-MS (EI+) calculated for C32H65N2O12S2 
(M+H+) = 733.39; found m/z = 733.38 (M+H+); mass error (ppm) = -13.63. 









Figure 5-11. The 1H NMR spectrum of NH2-EG12-TA from 1.0-7.5 ppm and (B) 
enlarged region from 1.0 to 4.0 ppm. The data were collected by W. Ng in Dr. 
Zhou’s group. Reproduced from W. Ng’s BSc thesis (2017). 
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5.2.4 Synthesis and Spectroscopic Analysis of TA-Zwitterion 
Scheme 5-3 shows the chemical structures and synthetic strategies of the zwitterion 
appended thioctic acid.  
 
 Synthesis of Thioctic acid-N,N-Dimethyl-1, 3-propanediamine 
Thioctic acid (3g, ~15 mmol), trimethylamine (1.47 g, ~15 mmol) and dichloro-
methane (30 mL) were added in a three-necked round bottom flask. The mixture was 
cooled to 0°C with an ice bath and stirred under N2 gas for 30 minutes. 
Methanesulfonyl chloride (1.67 g, ~15 mmol) was added dropwise by using a syringe. 
The mixture was stirred for a further 5 hours and then gradually warmed up to room 
temperature (25-27oC in oil bath). Triethylamine (0.61 g, ~6 mmol) and 20 mL of 
CH2Cl2 were added slowly into the mixture, which was left to stir overnight at room 
temperature under N2 gas. The reaction mixture was washed twice with 30 mL of 
water in a separatory funnel followed by 100 mL of saturated Na2CO3 solution. The 
organic layer was dried using Na2SO4 and the solvent was removed in a rotary 
evaporator. The compound, N,N-dimethyl-1,3-propanediamine was obtained as a 
yellow oil, 1.83 g, yield ~43%. Its chemical structure was confirmed by 1H NMR 
(Figure 5-12). N,N-dimethyl-1,3-propanediamine: 1H NMR (400 MHz, ppm): 7.27 
(CDCl3 solvent peak); 1H NMR assignment (400 MHz, CDCl3):  (ppm), 1H NMR (400 
MHz, CDCl3): δ (ppm): 6.91 (broad s, 1H, amide NH, 5), 3.55 (m, 1H, -CH- in the ring, 
10), 3.32 (m, 2H, -NH-CH2- 4), 3.21 - 3.10 (m, 2H, -CH2- in the ring,12), 2.49-2.45 
(m, 1H, -CH2- in the ring, 11), 2.37 (t, 2H, J=6 Hz, -CH2-C(O), 6), 2.23 (s, 6H, -N-
 
Scheme 5-3. The synthetic route to TA-Zwitterion. Reaction conditions are: i) 
Et3N, dry CH2Cl2, MsCl, (ii) N,N-dimethyl-1,3-propanediamine, and  (iii) CHCl3, 
H2O, 1,3-propanesultone. 
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(CH3)2,1), 2.17-2.13 (t, 2H, J = 6Hz, -CH2-N-,2), 1.90-1.83 (m, 1H, -CH2- in the  ring, 
11), 1.77 (m, 2H –CH2-,3), 1.72-1.62 (m, 4H,-CH2-CH2-, 7,8), 1.51-1.42 (m, 2H, -CH2-
,9). ESI-MS (EI+) calculated for C13H27N2OS2 (M+H+) = 291.1564; found m/z = 
291.1548 (M+H+); mass error (ppm) = -5.49.  
Figure 5-12. (A) The 1H NMR spectrum of TA-N,N-dimethyl-1,3-
propanediamine from 1.0-8.0 ppm and (B) enlarged region from 1.0 to 4.0 
ppm. The data were collected by W. Ng in Dr. Zhou’s group. Reproduced from 
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 Synthesis of TA- Zwitterion 
TA-N,N-dimethyl-1,3-propanediamine (1.8259 g, ~ 6.30 mmol) was dissolved in 20 
mL of dry THF and purged under N2 gas 30 minutes. 1,3-propanesultone (1.1488 g, 
~9.40 mmol) dissolved in 4 mL of THF was added and stirred for 3 days.  A gradual 
build-up of turbidity was observed as the reaction progressed due to the limited 
solubility of the TA-Zwitterion in THF. The solvent was evaporated in vacuum yielding 
a pale yellow solid. The crude product was washed with CHCl3 three times to remove 
any impurities followed by dying in vacuum to yield TA-Zwitterion as yellow solid in 
~48 % yield. Figure 5-13 shows the 1H NMR spectra for TA-Zwitterion.  
 
TA-Zwitterion: 1H NMR (400 MHz, ppm): 4.620 (D2O solvent peak); 3.79-3.70 (m, 
1H, -CH- in the ring 13), 3.55−3.48 (m, 2H, -CH2-SO3, 1), 3.42−3.38 (m, 2H, -CH2-
N(CH3)2-, 3), 3.35 − 3.31 (m, 2H, -CH2-N(CH3)2-, 5), 3.28-3.20 (m, 2H, -NH-CH2-, 7)  
3.14 (s, 6H, -N-(CH3)2, 4), 3.03-2.99 (t, 2H, J = 6Hz -CH2-C(O), 9), 2.57-2.49 (m, 1H, 
-CH2- in the ring, 14) 2.34−2.30 (t, 2H, J = 9 Hz, 15), 2.27-2.23 (m, 2H, -CH2-CH2-
CH2-,6)  2.07-2.03 (m, 2H, -CH2-CH2-CH2, 2), 2.03 −1.94 (m, 2H, -CH2- in ring, 14), 
1.72 − 1.62 (m, 2H, -CH2-CH2-CH2-, 10,11), 1.56−1.43 (m, 2H, -CH-CH2-, 12). ESI-
MS (EI+) calculated for C16H32N2O4S3 (M+H+) 413.16; found m/z = 413.15 (M+H+), 

















5.3 Synthesis of Ag NPs and Ag NCs 
Silver nanoclusters (Ag NCs) and silver nanoparticles (Ag NPs) were prepared in a 
single step via reduction of Ag+ ions by sodium borohydride in the presence of 
thioctic acid or zwitterion-/or PEG- appending thioctic acid ligands. The ligand:Ag+ 
molar ratio was controlled to generate different Ag nanomaterials. Specifically, the 
ligand:Ag+ molar ratio was varied from 1:1 – 5:1 to generate fluorescent Ag NCs 
and a lower ratio (e.g. 0.1-0.001:1) was used to obtain Ag NPs. Scheme 5-4 shows 
the synthesis route to generate of Ag NPs and Ag NCs. 
 
Figure 5-13. The 1H NMR spectrum TA-Zwitterion from 1.0-4.0 ppm. The 
data were collected by W. Ng in Dr. Zhou’s group. Reproduced from W. 



































5.3.1 Synthesis of Ag NC and Ag NP 
Ag NCs were synthesized according to the method reported by the Mattoussi group 
306 with several modifications. In detail, a 100 µL of 150 mM silver nitrate solution, 
water and the corresponding volume of 100 mM ligand were stirred for 60 minutes in 
the dark.  A 1000 µL of 50 mM freshly prepared and ice-cold sodium borohydride was 
added to the solution and the reaction mixture was stirred overnight at room 
temperature (25oC). Ultrafiltration was conducted with a centrifugal filters (MW cut-
off 5 000 Da membrane) to remove any unreacted silver ions and excess ligand and 
washed three times with water. The purified product was dried in vacuum, weighed 
and then re-suspended in deionized water to obtain the desired concentration (in 
mg·mL-1) for further experiments. Table 5-1 showed the different volume of the 




Scheme 5-4. Schematic representation of the synthetic route for the 
preparation of Ag NCs and Ag NPs stabilized by thioctic acid and thioctic 
acid based ligands.  
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Table 5-1 Reagent volumes to synthesize Ag NCs. The ligand concentration 
was 100 mM.  
 
Ag : L Ratio AgNO3  (µL) Ligand (µL) H2O (µL) NaBH4 (µL) 
1:1 100 150 1750 1000 
1:2 100 300 1600 1000 
1:3 100 450 1450 1000 
1:4 100 600 1300 1000 
1:5 100 750 1150 1000 
 
Ag NPs were synthesized in a similar manner but with a lower Ligand:Ag ratio was 








Table 5-2  Reagent volumes to synthesize Ag NPs.  The concentration of the 
ligand for Ag NPs at 1:0.1 is 100 mM. The concentration of the TA-Zwitterion 
ligand for the ratio 1:0.1 and 1:0.001 is 10 mM.  










Thioctic acid (TA) NP1 1: 0.1 100 15 1885 1000 
TA-Zwitterion  NP2 1: 0.1 100 15 1885 1000 
TA- EG3-NH2  NP3 1: 0.1 100 15 1885 1000 
TA-EG12-NH2  NP4 1: 0.1 100 15 1885 1000 
TA-PEG~17-OCH3 NP5 1: 0.1 100 15 1885 1000 
TA-PEG~23-OCH3  NP6 1: 0.1 100 15 1885 1000 
TA-Zwitterion NP7 1: 0.01 100 15  1885 1000 
TA-Zwitterion NP8 1:0.001 100 1.5  1898.5 1000 
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5.3.2 Quantum Yield Calculations for Silver Nanoclusters 
Quantum yield (QY) of the Ag NCs was determined using Rhodamine 6G in ethanol 
as the standard by the equation in Equation 5-2: 
 
QYAgNCs = QYS • (FAgNCs/FS) • (AS/AAgNCs)  
Equation 5-2 
 
Where QYAgNCs, FAgNCs and AAgNCs are the quantum yield, integrated fluorescent 
intensity and the absorbance at 480 nm of the Ag NC sample. QYS, FS and AS are the 
quantum yield, integrated fluorescent intensity and absorbance at 480 nm of the 
standard (Rhodamine 6G, which has a QY of 95% under 480 nm excitation). The 
silver nanoclusters and Rhodamine 6G were diluted and the solution with an 
absorbance of less than 0.1 (λ= 480 nm) was used as the first solution. Then, Beer 
Lambert Law (Equation 5-3) was used to calculate the absorbance of the other 
standard solution with lower concentrations.  
 
𝐴 = 𝜀𝑙𝐶   Equation 5-3 
 
Where A is the absorbance, 𝜀 is the molar extinction, 𝑙 is the path length and C is 
the concentration of silver nanoclusters or Rhodamine 6. 
 
5.3.3 Antimicrobial Test 
To examine the antibacterial property of the Ag NPs and Ag NCs, E. coli BW25113, 
S. aureus SH1000 were used as standard strains in this study. The procedure was 
conducted in accordance with reference methods for the determination of minimal 
inhibitory concentrations (MICs) of aerobic bacteria by broth microdilution from the 
NCCLS consensus process (Methods for Dilution Antimicrobial Susceptibility Tests 
for Bacteria that Grow Aerobically – approved standard Sixth edition, January 2003). 
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5.4 Results and Discussion 
5.4.1 Characterization of Ag NCs and Ag NPs 
 
The synthesis of the Ag NC involved the mixing of the ligand to the silver nitrate 
solution followed by the addition of freshly prepared and ice-cold NaBH4. The addition 
of the reducing agent immediately changed the colour of the solution to dark brown 
and finally to a yellow to reddish-orange colour after 12 hrs of mixing. These reddish-
orange solutions emitted a red fluorescence under UV-light lamp excitation at  = 365 





(A)  (B) 


















































Figure 5-14. (A) Photos of Ag NC-DHLA in normal daylight (top panel) and 
under UV-light illumination (bottom panel), and (B) Spectroscopic 
characterization of the synthesized Ag Nanoclusters. The absorption 
spectrum and their corresponding fluorescence spectra (exc = 480 nm) of Ag 
NCs dispersed in water. The Ag:L ratio was 1:3.  The data were collected by 
A. Gummer in Dr. Zhou’s group. Reproduced from A. Gummer’s BSc thesis 
(2016). 
1:2  1:3.3  1:6.7  1:13 
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Several synthesis parameters were investigated such as the amount of the reducing 
agent and ratio of silver ion to ligands. The amount of the NaBH4 is critically important 
because it not only reduces silver ions to Ag NCs but also thioctic acid to dihydrolipoic 
acid (DHLA) based ligand for Ag NC stabilisation. The Ag NCs were prepared with 
different molar ratio of NaBH4: Ag+. The optical properties of the as-synthesized Ag 
NCs were characterized by UV-Vis and fluorescence spectroscopy as shown in 
Figure 5-14 (B). The Ag NC-DHLA exhibited well-defined absorption peaks at  = 
335 nm, 429 nm, and 500 nm regardless of the amount of the NaBH4. The Ag NC 
showed a relatively broad emission peak centred at 660 nm (EX = 425 nm). These 
observations were consistent with the results previously reported for DHLA protected 
Ag NC305, 306. Furthermore, relatively high fluorescence emission was observed at an 
Ag:NaBH4 molar ratio of 1:3.33. Increasing the Ag:NaBH4  ratio to 1:7 to 1:13 did not 
resulted in a higher florescence emission. Hence, a Ag:NaBH4 ratio of 1:3.3 was 
chosen to synthesize Ag NCs. The same procedure was used to generate Ag NCs 
stabilized by different PEG-or zwitterion appending thioctic acid ligands. For 
simplicity, Ag NC will be denoted as Ag NC-PEG-X for PEG appended thioctic acid 
ligand and Ag NC-ZW for zwitterion appended thioctic acid ligand. The effect of  
concentration and nature of ligand on the spectral properties of the Ag NCs were 
investigated by varying the Ag:L  molar ratio from 1:1 to 1:5. In general, Ag NC  
solutions exhibited dark brown colour when the Ag:L ratio was 1:1 but showed a  
yellow to reddish-orange colour at.higher ligand concentrations (i.e. 1:2 – 1:5) in 
normal day light conditions. Excitation under UV lamp (exc = 365 nm) revealed that 
Ag NCs gave a red fluorescence emission in all Ag: L mole ratio (i.e. 1:1 – 1:5) tested 
as shown in Figure 5-15 (A)-(F).  
  




The fluorescence emissions were generally brighter for Ag NC-PEG-X as 
compared to Ag NC-DHLA and Ag NC-ZW. This observations suggests that the 
nature of stabilizing ligand also affects the not only the surface properties but also 
the optical properties of Ag NCs. The UV-Visible absorption and fluorescence 
spectra of the different Ag NC were given in Figure 5-16  (A) - (F). 
 
 
   
   
Figure 5-15. Photos of (A) Ag NC-DHLA, (B) Ag NC-ZW (C) Ag NC-PEG3-
NH2, (D) Ag NC-PEG12-NH2, (E) Ag NC-PEG17-OCH3 and (F) Ag NC-PEG23-
OCH3 under normal day light and UV–light illumination.  The data were 
collected by W. Ng in Dr. Zhou’s group. Reproduced from W. Ng’s BSc 
thesis (2017). 
1:1 1:3 1:4 1:5 
1:1 1:2 1:3 
1:1 1:2 
1:4 
1:4 1:5 1:3 
1:5 1:1 1:2 1:3 1:4 1:5 
1:2 1:1 1:3 1:4 1:5 
1:2 1:3 1:4 1:5  
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Figure 5-16. The UV-Vis absorption and Fluorescence (exc = 425 nm)  
spectrum of (A) Ag NC-DHLA, (B) Ag NC-ZW,  (C) Ag-PEG3-NH2, (D) Ag NC-
PEG12-NH2, (E) Ag NC-PEG~17-OCH3 and (F) Ag NC-PEG~23-OCH3. The data 
were collected by W. Ng in Dr. Zhou’s group. Reproduced from W. Ng’s BSc 
thesis (2017). 
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The UV-Vis absorption spectra revealed similar absorption features Ag NC-DHLA 
(Figure 5-16 (A)), Ag NC-EG12-NH2 (Figure 5-16 (D)) AG NC-PEG17-OCH3 (Figure 
5-16 (E)) and Ag NC- PEG23-OCH3 (Figure 5-16 (F)). The UV-Visible absorption 
spectra of Ag NCs stabilized by TA-Zwitterion (Figure 5-16 (B)), TA-EG3-NH2 (Figure 
5-16 (C)) and revealed the absence of the peak at  = 325 nm but the other main 
absorption peaks at  = 429 nm and  = 500 nm are present.  
 
The Ag NCs excited at = 425 nm gave broad emissions peaked at = 660 - 680 nm 
region. The fluorescence emission peak for each Ag NC was unaffected by the molar 
excess of ligands, although it was slightly affected by the different ligand as shown in 
Table 5-3. 
 
Table 5-3 Quantum Yield (F) of selected Ag NC. The data were collected by 
W. Ng in Dr. Zhou’s group. Reproduced from W. Ng’s BSc thesis (2017). 
 






Ag NC-DHLA  NC1 1:5 665 0.003 
Ag NC-ZW NC2 1:2 615 0.42 
Ag NC-PEG3-NH2 NC3 1:2 665 0.28 
Ag NC-PEG12-NH2 NC4 1:5 656 2.5 
Ag NC-PEG~17-OCH3 NC5 1:3 671 0.56 
Ag NC-PEG~23-OCH3 NC6 1:2 644 2.6 
 
The same procedure was used to generate Ag NPs stabilized by DHLA and DHLA – 
based ligands using lower ligand:Ag ratios which favoured the growth of larger 
nanoparticles as there were less ligands to passivate the nanoparticle. Figure 5-17 
showed the UV-visible spectra of Ag nanomaterials synthesized at Ag:L ratio of 1: 
0.10. All the solutions exhibited an absorption spectra characteristic of SPR band for 
Ag NPs. The measured absorption maxima were  = 391 nm for NP1,  430 nm for 
NP2, 403 nm for NP3, 386 nm for NP4, 404 nm for NP6, and 400 nm for NP5. 
 





 Particle Size and Surface Charge Measurements 
Table 5-4 showed the average hydrodynamic diameters (Dhs) with ± ½ full width at 
half height maximum (FWHM) of the purified Ag NCs. The Dh of Ag NC-DHLA was 
2.5  0.8 nm (average DhS ± ½ FWHM), and comparable to the earlier reports 340, 341. 
The Dhs of zwitterion stabilized Ag NCs were found to be 4.6  1.4 nm, in close 
agreement to those prepared using a phosphatidylcholine zwitterion ligand (i.e. 4.9  
2.9 nm) 229. The slightly bigger size as compared to Ag NC DHLA might be due to the 
longer length of the zwitterion ligand. In general, the Dhs of the Ag NCs prepared at 
Ag:L ratio of 1:1 were slightly bigger than those  of prepared at higher Ligand:Ag 
ratios. This observation may suggest that larger clusters are likely to be synthesized 
at lower ligand ratio. Moreover, larger DhS for Ag NC-EGn-NH2 (n =3, 12) were 
observed primarily due to the extended and longer ligand on the surface of the Ag 
NCs. The Dhs did not significantly differ for the Ag NCs synthesized at an Ag:L ratio 
of 1:2 and 1:5.  













































 Thioctic acid (TA)
 TA-Zwitterion
 
Figure 5-17. Normalized UV-Visible absorption spectra of the Ag NPs. The 
data were collected by W. Ng in Dr. Zhou’s group. Reproduced from W. Ng’s 
BSc thesis (2017). 




The Ag NC-PEG~17-OCH3 and Ag NC PEG~23-OCH3 gave interesting DhS sizes for 
NCs.  The nanocluster DhS at Ag:L is 1:1 and 1:2 can be explained by the longer PEG 
units compared to the other ligands. However, the Dhs of 53 nm to 59 nm when Ag:L 
ratio is 1:3 and 1:5 is too big for a nanocluster system. Surprisingly, even larger 
hydrodynamic sizes were recorded for Ag NC PEG~23-OCH3 when the Ag:L was > 
1:2. Two different batches of the Ag NCs were prepared and several repeat DLS 
measurements were carried out and results showed similar large Dhs.  A possible 
explanation to the observed large size could be due to the complexation of the PEG 
chains to Na+ ions 342, 343  causing NCs to agglomerate. 
 
Table 5-4 The average hydrodynamic diameters (Dh, in nm) of the Ag NCs ± ½ 
FWHM. The data were collected by W. Ng in Dr. Zhou’s group. Reproduced 
from W. Ng’s BSc thesis (2017). 
 
Ag NC 1:1 1:2 1:3 1:4 1:5 
Ag NC-DHLA  2.50.8 1.10.28 1.920.30 1.720.15 1.40.37 
Ag NC-ZW 4.61.4 4.11.3 4.41.3 3.91.3 3.81.2 
Ag NC-EG3-NH2 5.71.6 5.51.5 5.51.6 4.81.4 5.11.5 
Ag NC-EG12-NH2 4.81.4 4.41.6 4.41.3 5.11.3 4.51.2 
Ag NC-PEG17-OCH3 6.32.0 5.71.5 5319 5418 59.22 
Ag NC-PEG23-OCH3 5.21.4 13657 14366 15272 14668 
 
Another probable reason for the large DhS for the Ag NC-PEGn-OCH3 (n ~17, 18) 
system is due to the long PEG polymer. Although the size of a single Ag nanocluster 
unit is expected to be < 2 nm, it is possible that several Ag NCs can be embedded in 
the long PEG backbone making the movement of the nanoclusters in the surrounding 
medium slower, thereby increasing the hydrodynamic size.344 Large DhS sizes were 
also as previously reported using polymethylacrylic acid (PMAA) stabilized Ag NCs 
345. 
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The Dhs of the Ag NPs were shown in Table 5-5. Surprisingly, the size of the Ag NP 
were smaller than expected > 5 nm diameter for NP1, NP3, and NP4. The Ag NPs 
were synthesized in two batches and still showed almost the same Dhs. Considering 
that the Ag NPs were purified by centrifugal filtration, the DLS measurement should 
reveal the size of the nanoparticle without complication from the excess ligand. The 
Dhs for NP2, NP5, NP6 showed expected sizes for nanoparticles and were larger than 
their corresponding nanocluster counterparts. It is important to validate the size Ag 
NPs with additional technique such as TEM imaging. Nonetheless, the UV-Vis 
spectra in Figure 5-17 shows the characteristic SPR peak for Ag nanoparticles.  
 
Table 5-5 Hydrodynamic diameters (Dh) of the Ag NPs. The data were 
collected by W. Ng in Dr. Zhou’s group. Reproduced from W. Ng’s BSc 
thesis (2017). 
Ag NP Label Dh (nm) 
Ag NP-DHLA NP1 1.20  0.35 
Ag NP-ZW NP2 7.96  3.1 
Ag NP-EG3-NH2 NP3 2.18  0.63 
Ag NP-EG12-NH2 NP4 1.90  0.82 
Ag NP-PEG17-OCH3 NP5 9.32  3.4 
Ag NP-PEG23-OCH3 NP6 6.40  3.2 
 
 
Surface charge is an important property that affects the stability and antimicrobial 
property of the Ag nanomaterials. This surface charge was determined using zeta 
potential measurements and shown in Table 5-6. The Ag NCs and Ag NPs were 
washed three times with ultrapure water and finally dispersed in 1.0 mL water before 
zeta potential measurements. This was done to eliminate the possible complication 
of the excess ligands during the measurement. The zeta potentials for Ag NC-DHLA 
and Ag NC-ZW were - 23.1 mV and – 21.8 mV respectively, due to the deprotonated 
carboxylic acid. The Ag NC-ZW was slightly negative charged, consistent to the near 
charge neutral of the zwitterionic ligand. The surface charge for Ag NP-DHLA and Ag 
NP-ZW were the same compared to their nanocluster counterparts but differ in 
magnitude. Zeta potential measurements also revealed that PEG appended Ag NCs 
also differed in their surface charge. The PEG backbone is expected to be neutral 
thus, the terminal group (i.e. –NH2 and –OCH3) are expected to dictate the over-all 
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charge of the Ag NC. The PEG-amine terminated Ag NCs and Ag NPs showed 
positive zeta potentials as expected from protonated amines. Surprisingly, the PEG 
methyl ether terminated Ag NCs exhibited a negative surface charge, a sharp 
contrast to their corresponding NPs which appeared to be positively charged. These 
results were unexpected because the methyl moiety cannot undergo 
protonation/deprotonation reactions and should render the entire ligand neutral. 
Again these experiments were repeated twice with two different batches of the methyl 
ether-PEG appended Ag NCs and Ag NPs which both gave the same surface charge. 
However, several reports have shown that PEGylated nanoparticles can indeed 
exhibit a negative zeta potential 346-349 
 
Table 5-6 Zeta potentials for the Ag NC and Ag NPs in pure water. The data 
were collected by W. Ng in Dr. Zhou’s group. Reproduced from W. Ng’s BSc 
thesis (2017).  
 
Ligand NC Zeta Potential 
(, mV) 
NP Zeta Potential 
(, mV) 
Thioctic acid (TA) NC1 -23.7 NP1 -23.2 
TA-zwitterion NC2 -2.47 NP2 -10.4 
TA-EG3-NH2 NC3 +30.2 NP3 + 33.6 
TA-EG11-NH2 NC4 +7.69 NP4 + 34.6 
TA-PEG17-OCH3 NC5 -24.9 NP5 + 22.0 
TA-PEG23-OCH3 NC6 -23.1 NP6 + 16.3 
 
Agarose gel electrophoresis was conducted to further confirm the surface charge of 
the silver nanomaterials. The Ag NCs and Ag NPs were loaded in each lane and the 
gel was run at 100 V for 30 minutes and the results were shown in Figure 5-18. The 
Ag NC bands were observed under UV light because of their fluorescence properties 
and also very weak absorption making them almost invisible under normal light. The 
NC1 migrated towards the positive terminal, implying the ionized carboxylic acids 
imparted a negatively charged surface on the Ag NC-DHLA as expected for clusters 
with a negative zeta potential. Unfortunately, the very weak fluorescence of NC2 
made it difficult to see. The NC3 moved towards the negative terminal which implies 
a positive surface charge on the Ag NC. This band migration agrees with the positive 
zeta potential for NC3. The band movement NC4 was difficult to observe due to its 
weak visible luminescence. The NC5 and NC6 showed slight movement towards the 
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positive terminal suggesting the negatively charged Ag NC surface which correlate 
to the observed negative zeta potential measured for NC5 and NC6. 
 
 
For the Ag NPs, band migrations were clearly observed due to their strong 
absorption. Both NP1 and NP2 migrated towards the positive terminal while NP3 and 
NP4 did not show any observable band movement. Moreover, both NP5 and NP6 
showed a slight migration towards the positive terminal, implying a negative surface 
charge. This observation contradicted to what was expected from the positive zeta 
potentials for NP5 and NP6. The same ligands were used to prepare NP5 and NP6 
with those of NC5 and NC6 which means they should exhibit similar negative surface 
charge. The agarose gel electrophoresis provided a more convincing evidence of the 
negative surface charge for NP5 and NP6. In general, the nature of the ligand 
influences the overall surface charge of the Ag NCs and Ag NPs. The zeta potential 
measurements and agarose gel electrophoresis results suggests that DHLA and 
zwitterion stabilized Ag NC and Ag NP exhibit a net negative surface charge and 
should migrate towards the positively charged electrodes as confirmed with the 
agarose electrophoresis gels. The amine-PEG stabilized Ag NC and Ag NP exhibit a 





Figure 5-18. Agarose gels of (A) Ag NC (NC1-5) and (B) Ag NP (NP1-5).  The 
data were collected by W. Ng in Dr. Zhou’s group. Reproduced from W. Ng’s 
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charged electrode (e.g. NC3). Finally, the agarose gel experiment provided and 
evidence of a negative surface charge for OCH3-PEG stabilized Ag NCs and Ag NPs.  
 
5.4.2 Antimicrobial Tests 
Ag and Au NCs has recently been reported to exhibit potent antimicrobial properties 
and are considered as new generation of inorganic antimicrobials 308, 350. In particular, 
Xie and colleagues (2017) first reported a comparison of the antibacterial activity of 
Au NCs and Au NPs 350. The 6-mercaptophexanoic acid coated Au NCs were 
observed to possess superior growth inhibition of gram-positive S. aureus and gram 
negative E.coli as compared to  Au NPs coated with the same ligand. The authors 
reasoned that the enhanced antibacterial action of Au NCs was due to its inherently 
small size which allowed it to have better interactions with the bacteria. Intriguingly, 
the study also observed that cellular internalization of Au NCs and Au NPs have no 
significant difference. It was later shown that ~15 fold higher concentration of Au NPs 
were needed to reach the same particle number dose for Au NC 350.  
 
This study presents the antimicrobial properties of Ag NPs and Ag NCs bearing 
different terminal functional groups with two bacterial model species. The results 
gathered presents an interesting difference in the antibacterial properties between 
Ag NPs and Ag NCs. Figure 5-19 shows the experimental principle to investigate the 
antibacterial properties of Ag nanomaterials. The Ag NPs and Ag NCs were prepared 
with the same synthesis protocol and stabilized by different types of ligands. The Ag 
nanomaterials were incubated with S. aureus and E.coli. The Ag nanomaterials can 
interact with the bacteria and exert its antimicrobial effect. It is known that the 
structural differences in bacterial cell walls may result in varied interactions between the 
bacteria and Ag nanomaterials. Therefore, knowledge regarding the bacterial cell wall 
in correlating the antibacterial properties of Ag nanomaterials is imperative because 
cell walls are the first point of contact of bacteria to the “external world”.  The structure of 
bacterial cell wall can be categorized as either gram-negative or gram-positive. 351 
The gram-negative bacteria cell wall are composed of two lipid membranes with a 
thin peptidoglycan layer in between (magnified in Figure 5-19 for E.coli). 351 The outer 
membrane contains lipopolysaccharides (LPS), which have been suggested to protect 
bacteria from antibiotics 352 and surface proteins. The presence of phosphate groups as 
well as carboxylate groups present in sugar acids make the cell surface negatively 
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charged. In contrast, gram-positive bacterial cell walls feature a thick peptidoglycan 
layer (15-100 nm) 353. This layers contains polymeric teichoic acids, surface proteins, 
and a cytoplasmic membrane underneath. The cell surface is also negatively charged 
due to the polymeric chains of teichoic acid which contain anionic phosphate groups in 
the glycerolphosphate repeat units. 354 The teichoic acid chains and peptidoglycan layer 
maintain cellular integrity and have been suggested to be binding sites for divalent cations 
in solution. 351  
 
The antibacterial activities of the Ag NPs and Ag NCs against S. aureus and E.coli 
strains were evaluated based on their Minimum Inhibitory Concentration (MIC). E. 
coli, the most characterized gram negative bacterium, has been used in various 
antimicrobial testing studies whereas S. aureus, a gram positive bacteria, is 
considered to be responsible for wide range of infectious diseases ranging from 
benign skin infection to life threatening endocarditis. Moreover, S. aureus is also one 
of the major cause of nosocomial infections because of its virulence and antibiotic 
resistance 355. The MIC refers to the lowest concentration of an antimicrobial drug 
that prevents the visible growth of a microorganism after overnight of incubation with 
the media. The MIC vales reflect the potency of the antimicrobial drug, the lower the 
MIC value means the less drug is required for inhibiting of the microorganism 356.  
 
 






Figure 5-19 Schematic representation of overall experimental design. The Ag 
nanomaterial (Ag NP and Ag NC) core are denoted with a red sphere. The Ag 
nanomaterials were stabilized by (a) dihydrolipoic acid (DHLA) which is  
negatively charge, (b) DHLA-EGn-NH2 which is positively charge, (c) DHLA-
PEGn-OCH3 and (d) DHLA-Zwitterion. The Ag nanomaterials were incubated 
with E. coli and S. Aureus and their antimicrobial properties were determined 
by minimum inhibitory concentration (MIC) values.  
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The MIC values were determined for Ag NC and Ag NP are presented in Table 5-7. 
The Ag NCs revealed a different effectiveness in inhibiting the growth of the bacteria. 
The MIC values lower than 256 µgmL-1 implies that bacterial strains are sensitive to 
the antimicrobial effect of the Ag NC. The Ag NC-DHLA (NC1) and Ag NC-PEG23-
OCH3 (NC6) were able to inhibit bacterial growth for both S. aureus and E. coli . While 
NC2, NC3, and NC4 showed a MIC of >256 µgmL-1, suggesting these Ag NCs did not 
exert notable antimicrobial activity against these bacterial strains. Moreover, NC5 




The NC1 inhibited bacterial growth for both S. aureus and E.coli with a MIC of 128 
and 64 µgmL-1 respectively. Thus NC1 was more effective in inhibiting the growth of 
E.coli than S. aureus. The antibacterial property of Ag NC-DHLA (NC1) has already 
been reported by Liu and colleagues (2017) via turbidity measurements. They 
reported that Ag NC-DHLA were able to inhibit the growth of E.coli DH 5 (MIC ~ 15  
µgmL-1) and E. coli DSM 4230 (MIC ~ 10 µgmL-1) with 24 hr incubation but showed 
no inhibitory effects against S. aureus 231. The authors attributed the observed 
antibacterial action through different membrane damage mechanisms in E. coli but 
no clear explanation was made for S. aureus. The Ag NC-DHLA damage the cell 
membrane and permeate to the cell as observed for  E.coli DH 5 while Ag NC-DHLA 
Table 5-7 Minimum inhibitory concentration (MIC) of Ag NC and Ag NP 
against S. aureus and E.coli.  The data were collected by W. Ng in Dr. Zhou’s 
group. Reproduced from W. Ng’s BSc thesis (2017). 
Nanoclusters - MIC (µgmL-1) Nanoparticles - MIC (µgmL-1) 
Sample S. aureus E. coli Sample S. aureus E. coli 
NC1 128 64 NP1 64 32 
NC2 >256 >256 NP2 8 8 
NC3 >256 >256 NP3 >256 64 
NC4 >256 >256 NP4 >256 64 
NC5 > 256 128 NP5 32 32 
NC6 64 128 NP6 16 16 
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can enter into cells by diffusion as observed for E. coli DSM 4230 231. Bacterial death 
was attributed to the released Ag+ ion from Ag NC cores which generated reactive 
oxygen species and damaging the respiratory chain leading to bacterial growth 
inhibition and death 231. Interestingly, Xie and colleagues (2014) compared 
glutathione-Ag NC with the Ag core having different oxidation states. Specifically, the 
antibacterial activities of glutathione-Ag+-NC (i.e. the dominant Ag species remained 
in Ag NCs are Ag+ species) and glutathione-Ag0-NC (i.e. all Ag atoms were at zero 
valence). The results obtained from disk diffusion assay showed that glutathione–Ag 
NC with Ag+ ion rich cores exhibited better growth inhibition of gram positive bacteria 
such as S. aureus (MIC ~ 80 µM) and B. subtilis (MIC ~ 80 µM) than gram negative 
bacteria P. aeruginosa (MIC ~ 100 µM)  and E. coli  (MIC ~ 100 µM) 230. In addition, 
Xie and colleagues (2013) have also reported the antibacterial effect of glutathione-
Ag+-NCs against a multi-drug resistant bacteria P. aeruginosa (MIC ~ 11.8 µgmL-1) 
334. The comparison of antibacterial activities for Ag NC-DHLA and glutathione-Ag 
NCs is possible due to fact that both ligands contain carboxylate moieties which are 
assumed to provide negative charges and stabilize Ag NC by virtue of electrostatic 
repulsion. These two types of Ag NCs highlights the importance of the silver ions in 
achieving the desired antibacterial effect.   
 
The silver ions released from the Ag NC and Ag NP cores were determined using 
inductively coupled plasma – mass spectrometry (ICP-MS). The Ag nanomaterials 
were concentrated in a centrifugal filter (MW 5000 Da) and were washed with 1.0 mL 
of water for 5 times to remove any free silver ions and ligands. They were dried in 
vacuum and weighed. The dried Ag nanomaterials were then re-dispersed in 1.0 mL 
of ultrapure water and normalized to the same weight concentration (1 mg·mL-1). The 
Ag nanomaterials were incubated for 24 hours and the supernatants were collected 
and diluted to a final volume of 15.0 mL for ICP-MS analysis. The free Ag ion 
concentrations obtained from the supernatants were shown in Table 5-8. Notably, 
NC1 and NP1 produced rather high free Ag+ ion concentrations (273 and 248 ppb 
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Table 5-8 ICP-MS of silver ion concentration in parts per billion (ppb) from 
Ag NC and Ag NP. The ND refers to “not detected”. Each sample supernatant 
were aspirated 10 times (n=10) to the sample injection valve. The average of 
10 concertation readings  standard deviation are reported.  
Ag NC Ag+ (ppb) Ag NP Ag+ (ppb) 
NC1 273  18 
 
NP1 248  9.8 
NC2 55  1.6 NP2 5.1  2.9 
NC3 ND NP3 0.03  0.01 
NC4 ND NP4 8.17  7.1 
NC5 0.20  0.11 NP5 23.3  5.4 
 
NC6 2.24  0.30 NP6 48.4   4.8 
 
  
Recent studies have shown that materials coated with zwitterionic ligands can reduce 
bacterial attachment and biofilm formation 357-360. Zhang and colleagues (2013) 361 
demonstrated that a silver-zwitterion nanocomposite surface provided an effective, 
reliable antimicrobial and anti-adhesive platform for the prevention of microbial 
growth 361. Combining the zwitterion ligands with inorganic nanomaterials such as Ag 
NCs and Ag NPs may enhance the antibacterial activities of the Ag nanomaterials. 
Unfortunately, the Ag NC-ZW (NC2) did not inhibit the growth of both bacterial strains 
even if it released considerable amount of Ag+ ions (~55 ppb). This result is in stark 
contrast to recently reported antibacterial activity of phosphatidylcholine zwitterionic 
Ag NCs against E. coli (MIC ~100 µgmL-1)  and S. aureus (MIC ~100 µgmL-1) 229. It 
is noteworthy that the Ag NCs in this study were prepared in a similar manner to the 
ones reported. Hence, the difference in observed results might be due to the 
structural differences of the zwitterions (i.e. the orientation of charges). The NC2 in 
this study contains the sulfobetaine zwitterion moiety wherein the terminal end 
contains the negative charge (–N(CH3)2-(CH2)2-SO3) while the phosphatidylcholine 
zwitterion has the positive charge at the terminal end (-PO4-(CH2)2-N(CH3)3). These 
results imply that the structure of the capping ligand on the Ag NCs may play an 
important role in dictating their antibacterial effect. Interestingly, Rotello and 
colleagues (2016) 362 also studied the effect of particle size and charge orientation in 
zwitterionic Au nanoparticles on their antibacterial properties. Two different 
zwitterionic ligands, a sulfobetaine zwitterion (–N(CH3)2-(CH2)2-SO3) and an 
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acylsulfonamide zwitterion (-C(O)-N-SO2-(CH2)3-N(CH3)3) were used to prepare  
Au NPs of  2, 4 and 6 nm in diameter. They found that the 6 nm Au NPs stabilized by 
acylsulfonamide zwitterionic exhibited superior antibacterial activities against P. 
aeroguinosa and A. azurea as compared to the sulfobetaine zwitterionic Au NPs. The 
results may imply that positive charge terminated zwitterionic ligands have higher 
affinity to the negatively charged bacterial membranes.  Furthermore, the study also 
observed that increasing the Au NPs size from 2 nm to 6 nm increased their 
antimicrobial efficiency though bacterial membrane disruption. Surprisingly, the small 
2 nm acylsulfonamide zwitterion coated Au NPs did not induce any membrane 
damage in the bacteria tested 362. Overall, this study highlighted the importance of 
particle size and surface ligand structure (i.e. orientation of charges in the zwitterion 
ligand) in dictating the antimicrobial activity of the zwitterionic Au NPs.   
 
Several reports also showed that cationic Ag NPs 336, 363 and Au NPs364 exhibited a 
high level of effectiveness against the gram positive bacteria and gram-negative 
bacteria. These studies highlighted the importance of tuning the functional groups on 
the nanoparticle surface to achieve its desired antibacterial action. The negative 
charge in the bacterial cell wall can electrostatically attract the positive charge in NPs 
causing them to be more effective antibacterial NPs. Transmission electron 
microscopy imaging have revealed that positively charged Ag-polyethylenimine NPs 
tightly adhere to the bacterial surface and some of even fusing with cell wall. In 
contrast, no attachment was observed for the negatively charged citrate stabilized 
Ag-NPs. 365 
 
The ligands used to prepare NC3 and NC4 were designed to have a PEG moiety and 
a terminal amino group. The EG chain in NC3 has 3 ethylene glycol (EG) repeat units 
whereas NC4 has 12 EG repeat units. It was hypothesized that the protonated amino 
group will impart a positive charge on the Ag NC surface, allowing them to bind to 
the negatively charged components of the bacterial membrane such as the 
lipopolysacharride and lipoteichoic acid 366 by electrostatic interaction as shown in 
Error! Reference source not found.. Aside from imparting stability to the nanoclusters, 
the dual hydrophobic/hydrophilic character of PEG chains might allow to some extent 
enhance the permeation of the nanocluster through the cell membrane.  
 




Figure 5-20 Schematic representation of a positively charged Ag NC 
interaction with the negatively charged bacterial cell wall. The Ag NC-EGn-
NH3+ is hypothesized to permeate the bacterial cell wall. 
 
Surprisingly, the MIC results suggests that NC3 and NC4 were ineffective against S. 
aureus and E. coli. Moreover, the ICP – MS data revealed that Ag ion were too low 
to be detected in the supernatant for NC3 and NC4. In order to rationalize the MIC 
observation, a possible reason might be due to the total positive charge (i.e. charge 
density) on the surface of the Ag NCs. The total positive charge on the Ag NC surface 
might be low due to the small number of amine groups per ligand present. The effect 
of the number of cationic groups impacting their antibacterial activities was 
demonstrated by Cai and colleagues (2009) using poly(amidoamine) (PMAM) 
dendrimers 367. Unmodified PMAM and other dendrimers with hundreds of peripheral 
amino groups were active against P. aeruginosa and S. aureus due to the 
polycationic nature of the protonated amines. The PEGylation of the terminal amines 
lead to drastic decrease in the antibacterial activities, and specially against S. aureus. 
The authors attributed the reduced potency to the decrease in the protonated amine 
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groups thus, decreasing the charge density and reducing the electrostatic interaction 
of the dendrimers to the negatively charged bacterial surface 367. In a separate study, 
capping the amino groups of PMAM with acetyl groups led to a loss of ability to disrupt 
lipid bilayer membranes, an important mechanism in bacterial death 368. These 
studies highlight the importance of having a high degree of protonated amino groups 
to achieve their antimicrobial effects. In another interesting study, multi-walled carbon 
nanotubes (MWCNTs) modified by cationic amino acids arginine (Arg) and lysine 
(lys)  were also found effective against E. coli and S. typhimurium 369. Radial diffusion 
assay and MIC data showed the antibacterial activity followed the sequence of 
MWCNTs-arginine > MWCNTs-lysine > pristine MWCNTs 369. The difference in the 
activity is most likely due to the difference of  pKa of Arginine (guanidinyl group, pKa 
~ 12.5) and pKa of Lysine (primary amine group, pKa ~10.5). The higher pKa for the 
arginine simple means that guanidinyl proton are more tightly held and less easily 
are given up than in lysine. In turn, this could have provided a more positive charge 
for MWCNTs-arginine leading to a slightly higher antibacterial activities than 
MWCNTs-lysine. The current results obtained in this study implies that deprotonation 
of the amines had a detrimental effect on the antibacterial activity of NC3 and NC4. 
The deprotonated amines on the surface of Ag NC can no longer be electrostatically 
attracted to the negatively charged bacterial surface making them inactive against 
the test organisms as shown in Figure 5-21. 




In another study, Haynes and colleagues (2015) 370 shed light on the effect of different 
surface charge and charge densities Au NPs with S. oneidensis MR-1 and B. subtilis  
bacterial membranes as model organisms. The Au NPs were capped with anionic 3-
mercaptopropionic acid (MPA), cationic 3-mercaptopropylamine (MPNH2), and a cationic 
polyelectrolyte poly(allylamine hydrochloride) (PAH). The surface charge densities were 
determined using X-ray photoelectron spectroscopy (XPS) and were calculated to be 5.6, 
4.6, and 2.8 for MPA, MPNH2 and PAH modified AU NPs respectively.  The results 
showed that anionic MPA–Au NPs had minimal toxic effect while both cationic Au NPs 
impacted the growth of both bacterial species to different extents. The data further 
demonstrated that cationic polyelectrolyte-wrapped Au NPs (PAH- Au NPs) were more 
toxic to both the gram negative and gram positive bacteria. These PAH-Au NPs induced 
the greatest membrane damage and toxicity to both bacterial models. The authors 
attributed superior antibacterial activity of cationic polyelectrolyte PAH-Au NPs to large 
 
Figure 5-21 Schematic representation of Ag NC-EGn-NH2. The deprotonated 
amine are not electrostatically attracted to the negative bacterial cell wall 
leading to loss of antimicrobial activity.  
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number of protonated amines leading to high positive surface charge density. Overall, the 
observed inactivity of NC3 and NC4 highlights importance of designing the structure of the 
ligands (i.e. charge and charge density) in order to achieve antibacterial effect 370.  
 
The next design of ligand was to use longer PEG unit with a terminal methyl ether 
group to generate stable NC5 and NC6. The methyl ether group is considered neutral 
unlike the protonated amine group in NC3 and NC. Historically, it was Cox (1966)371 
who first reported the antibacterial property of polyethylene glycol solutions against  
of E. coli. S. marcesens and A. aerogenes. The data suggests that longer PEG chains 
can inhibit bacterial growth even at lower solution concentration 371. In a separate 
study, Kohn and colleagues (1983) also reported the antibacterial property of 
polyethylene glycol-400 (PEG 400) solutions372. Recent investigation also implicates 
the therapeutic PEGylated Ag nanoparticles as antibacterial agent 373. In order to re-
examine these previous observations, different PEG chain lengths (i.e. ~ 17 EG 
repeat units for NC5 and ~23 EG repeat units for NC6) were used to explore whether 
chain length has indeed a role in improving the antibacterial activity of the Ag NCs. 
The NC5 and NC6 showed different antimicrobial behaviours wherein NC5 was able 
to inhibit E. coli but ineffective against S. aureus. The generally lower efficacy against 
S. aureus over E. coli could be due to the different membrane structures. The much 
thicker peptidoglycan of gram-positive bacteria (20-80 nm, e.g. S. aureus) over that 
of gram-negative bacteria (7-8 nm, E. Coli) 374, 375 might passivate the interactions 
between the NC and bacterial membrane. This may lead to less nanocluster 
penetration and hence infectivity of NC5 as antibacterial agent towards S. aureus. 
Surprisingly, the NC6 displayed high antimicrobial potency against both strains 
despite both of them released only minimal amount of free Ag+ ions (i.e. 0.20 and 
2.24 ppb for NC5 and NC6 respectively). 
 
Considering that both NC5 and NC6 exhibited the same surface charge, the difference 
in antibacterial activity is tentatively attributed to the length of PEG chain. Comparing 
the MIC data of the PEGylated NC3 and NC4 (both ineffective) and those of NC5 and 
NC6, it appears that the PEG linker not only can provide the steric stabilization for the 
NCs but also more importantly the necessary hydrophobic/hydrophilic interactions 
with the bacterial membrane to exert its antibacterial potency. Indeed, a study 
conducted by Sogi and colleagues (2015)376 compared the antibacterial vehicles 
propylene glycol, glycerine, PEG 400, and PEG 1000 (average MW ~1000 Da) for 
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endodontic therapy. Using broth dilution method, they determined the lowest 
concentration of the vehicles that can fully inhibit bacterial growth. Propylene glycol 
was effective against three organisms namely S. mutans E. faecalis and E. coli and 
its bactericidal activity was at 50%, 25% and 50% respectively. PEG 1000 was 
effective against S. mutans and E. coli at 25% solution concentration376. Using disk 
diffusion assay, the zone of inhibition for PEG-8000 stabilized Ag NPs after 24 
incubation with Bacillus and P. Aeruginosa are 10.2 mm and 10 mm respectively, 
while for PEG-6000 stabilized Ag NPs are 7.5 mm and 9.5 mm respectively. The 
greater zone of inhibition for PEG-8000 Ag NPs implies a better antibacterial activity 
against both gram-positive and negative bacteria when compared to PEG-6000 
stabilized  Ag NPs 377. Unfortunately, these studies did not present any explanation 
on how the PEG coating have impacted the antimicrobial properties of the Ag NPs.  
Nonetheless, these studies have confirmed experimental evidence on the 
antibacterial property of PEG stabilized NPs.   
 
The antibacterial property of Ag NPs have been correlated with to the release Ag+ 
ions. It is interesting to account the possible role of the PEG coating in the 
antimicrobial property of Ag NPs and Ag NCs. When bacterial cells are exposed to a 
solution of Ag ions, the ions are distributed and surrounds the bacterial cell with no 
specific localization.  In contrast, NPs can interact with the bacterial cell wall and 
produce a localized source to continuously release ions, leading to higher toxicity to 
bacterial cells. 365  The Ag NP dissolution produces Ag ions that can be complexed 
by polyethylene glycol chains as shown in Figure 5-22 (A) 378. The complexation of 
Ag+  ions by polyethylene glycol can be analogous to the complexation of univalent 
ions (e.g. Na+ and K+) with cyclic ethers 137.  In order to achieve the desired 
antimicrobial effect, the Ag NPs should be in contact with the bacterial cell walls. The 
Ag NPs can be thought of like a “vehicle” containing large amounts  of Ag+ ions and 
delivers these Ag+ ions into the bacterial cell walls as shown in Figure 5-22 (B). The 
localized high Ag+ ion concentration of further helps to penetrate the bacterial cell 
through different membrane channels present in the bacterial cell walls. As a 
consequence, the Ag NP dissolution is localized around the bacterial membrane 
leading to bacterial toxicity as confirmed by the low MIC values for NP5 and NP6. 
 






Figure 5-22 (A) Proposed complexation of silver ions (blue spheres) by PEG 
chains. The silver ions are stabilized by electrostatic interactions. The red 
sphere is the Ag NP core and only one PEG chain is shown for clarity. (B) 
The Ag NPs acts as vehicles to transport the Ag ions to the bacterial surface. 
The Ag NPs are localized sources that continuously release Ag ions to the 
bacterial membrane which a negative surface charge. 
 
- 200 - 
 
 
The MIC data obtained for the Ag NCs showed varied antibacterial activities against 
S. aureus and E.coli.  Moreover, the ICP-MS analysis showed that the Ag+ 
concertation released from Ag NPs was higher than the Ag NCs. The clear message 
here is that the antibacterial property of Ag NC is not solely governed by its size but 
more importantly to the structure of the ligand, charge of ligand and to the amount of 
released silver ions. The inherently small size of Ag NC means that most of the Ag 
atoms are present on surfaces and are capped with stable and functional ligands to 
ensure colloidal stability. Hence, it may be more difficult for Ag NCs to release Ag+ 
ions as compared to Ag NPs. This basic structural difference might explain why the 
NPs gave better MIC values than the NCs. These results challenges the popular 
assumption that Ag NCs should possess superior antimicrobial activities over their 
larger size counterparts (i.e. NPs) solely because of their intrinsic ultra-small size350. 
It is assumed that the ultra-small NCs can easily permeate bacterial membranes, 
causing structural damage to the bacterial membrane and chemical damage by 
interacting with proteins and DNA and generating ROS inside the bacteria. If size 
were the primary factor that dictates their antimicrobial efficiency, then all Ag NCs of 
the same size, irrespective of surface charge and capping agents, would expect to 
exhibit similar levels of antimicrobial activities against S. aureus and E. coli. On the 
contrary, only a few Ag NCs inhibited bacterial growth. This study also confirms the 
antibacterial activity of Ag NC-DHLA (NC1) against both gram positive and negative 
bacteria as reported previously. To the best of our knowledge, this study represents 
the first report of the antibacterial property of Ag NC-PEG23-OCH3 (NC6) against both 
bacterial strains while Ag NC-PEG17- OCH3 (NC5) can only to inhibit E. coli bacterial 
growth. 
 
Ag NPs capped with the same ligands were synthesized in the same protocol and 
their antibacterial properties were compared to the smaller Ag NCs. Surprisingly, Ag 
NP system showed better inhibitory effect against S. aureus and E.coli with the lower 
MIC values. Interestingly, NP2 showed a drastic decrease in MIC values from >256 
(i.e. NC) to 8 gmL-1 (i.e. NP), suggesting that it was transformed from an ineffective 
to potent antibacterial agent (>~32 fold potency enhancement) by simply increasing 
the size to the nanoparticle regime. The ICP-MS data showed that the released Ag+ 
ion concentration for NC2 (i.e 55) was ~ 11 fold higher than that of NP2 (i.e 5.1 ppb). 
Interestingly, the zwitterion - stabilized NPs gave the lowest MIC among all the Ag 
NCs and NP tested despite a rather low Ag+ ion concentrations (5.09 ppb). The likely 
- 201 - 
 
 
explanation for the high antimicrobial activity of zwitterion-stabilized NP is the 
increase in monolayer organization of the ligand on the NP surface with the 
increasing particle size. For example, Murray and colleagues 379 showed that surface 
curvature decreased with the increasing NP size. The lower surface curvature for 
larger particles leads to a more densely packed ligand shell 379. Thus the small size 
NCs may feature disorganized ligand shells, whereas, larger NPs would have highly 
organized monolayer surface. The more organized ligand monolayer on the larger 
NP surface may present more of terminal charged groups towards the bacterial 
surface, causing stronger membrane damage and bacterial death as shown in Figure 
5-23. Another possible explanation is the zwitterionic capping agent might have acted 
synergistically by releasing the silver ions. Although the ICP-MS showed rather low 
released Ag+ ion concentrations, but they can still contribute for the antibacterial 
action.  
 
The NP3, NP4, NP5, and NP6 can all inhibit the growth of E. coli, but only NP5 and NP6 
can inhibit S. aureus. A probable explanation here is the aforementioned differences 
in the structural makeup of the bacterial membranes which might entail the passage 
of the Ag+ ions across the bacterial membranes. Moreover, ICP-MS data showed that 
NP6 released higher concentrations of Ag+ ions which might contribute to its better 
antibacterial efficacy than NP5. These observations clearly indicates that the overall 
antibacterial action of Ag NPs is an interplay of several parameters such as the nature 
of ligand and release of silver ions. To date, there is still no literature reported on how 
different ligands regulate the release silver ion from silver nanoclusters and how this 
affects their antibacterial activities. Thus this study provides an additional 
understanding on why there is a difference in the antimicrobial activities between Ag 
NPs and Ag NCs.  
 






Figure 5-23 Schematic illustration of interaction mechanism between 
bacterial membrane with (A) 2 nm and (B) 6 nm core sized zwitterionic 
nanoparticles. Reprinted from reference 362 
 
To investigate the optimal size for high antibacterial potency, the most potent Ag NP 
among all investigated (e.g. coated with DHLA-ZW ligands) were synthesized with 
Ag:L ratio of 1:0.1 (referred to as NP7) and 1:0.001 (referred to as NP8). It was 
assumed that the lower L:Ag ratio should provide less ligands to passivate the Ag NP 
surface, leading to bigger Ag NPs. The size of the Ag NPs were characterized by and 
transmission electron microscopy (TEM) and dynamic light scattering technique 
(DLS). The UV-Vis absorption spectra of Ag NPs were found to be dependent to the 
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particle size as shown in Figure 5-24 (A). All the DHLA-zwitterion stabilized Ag NPs 
showed a well-defined SPR band peaked 430 nm for NP6, 390 nm for NP7, and 392 
nm for NP8. 
 
(A)  































Figure 5-24. (A) UV-Visible absorption spectra of Ag NC-ZW synthesized at  
different Ag:L ratios. (B-D) TEM images and the corresponding particle 
size distribution histograms of Ag NC-ZW synthesised at an Ag:L ratio of 
(B) 1:0.1, (C) 1:0.01, and (D) 1:0.001. The data were collected by W. Ng in 
Dr. Zhou’s group. Reproduced from W. Ng’s BSc thesis (2017). 
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The Ag NPs synthesized at an Ag:L ratio of 1:0.1 appeared as non-aggregated, 
isolated small spheres as shown in Figure 5-24 (B). The Ag NP (NP7) synthesized 
at an Ag:L ratio of 1:0.01 appeared bigger than NP6 (Figure 5-24 (C)) A high degree 
of particle aggregation and large size were observed as the Ag:L ratio was further 
decreased to 1:0.001 as shown in Figure 5-24 (D). The particle size were measured 
by Image J software of the TEM images and the corresponding particle size 
distribution histograms revealed a mean size of 5.7 nm for NP6, 11.1 nm for NP7 and 
14.2 nm for NP8. These results agreed well with the expectation that reducing the 
ligand:Ag ratio led to bigger and more aggregated Ag NPs which might have a 
profound impact in their antibacterial properties. 
 
The Ag NPs were purified by centrifugal filtration to remove unreacted Ag+ ion and 
ligand as above. Their Dhs were determined and their antibacterial activities were 
evaluated against S. aureus and E. coli. Table 5-9 summarised the particle sizes 
determined using DLS and TEM, the released Ag+ ion concentration and the MIC 
data obtained from the Ag NP.  
 
 
The NP diameter measured by TEM increased with the reducing L:Ag ratio as 
expected. Surprisingly, NP7 showed a lower Dh as compared to NP6 and NP8. The 
larger particle size measured by TEM is most likely due to the particle aggregation 
that makes accurate size determination difficult. All three Ag NPs inhibited the growth 
of E.coli and S. aureus but to different extents and NP6 showed the highest potency. 
Considering that all three Ag NPs were coated with the same ligand, the most 
Table 5-9 Particle size, released Ag+ ion concentration, and MIC values for 
zwitterion stabilized Ag NP.  The data were collected by W. Ng in Dr. Zhou’s 













NP2 7.5 5.7 5.1 8 8 
NP7 5.8 11.1 2.3 64 64 
NP8 9.9 14.2 13.4 128 128 
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possible reason for their different antibacterial activity were the size and morphology 
of the nanoparticles. The size of the Ag NP has been one of the most studied 
parameters impacting their antibacterial property 380-382. A recent study on different 
size Ag NPs coated the same surface coating revealed that Ag NPs with diameters 
of < 10 nm exhibited potent antibacterial activities and those of 5 nm were optimal, 
showing the best antibacterial result and fastest bactericidal activity 332. The MIC 
results obtained in this study also agreed well with the previous literature on size–
dependent antibacterial potencies of Ag NPs towards S. aureus and E. coli. 
Furthermore, this is the first report of sulfobetaine based zwitterionic ligand capped 
Ag NPs as potent antimicrobial agents.  
 
5.5 Conclusion 
The synthesis of Ag NCs and Ag NPs bearing similar types of ligands by a common 
synthetic protocol provided a useful means of directly comparing their antibacterial 
properties. The MIC data revealed a varying degree of antibacterial effectiveness of 
the silver nanomaterials wherein only a few Ag NCs tested gave significant inhibitory 
effect against E. coli and S. aureus. On the contrary, most of the Ag NPs tend to be 
more effective antimicrobial agents. Interestingly, this study found that the ultra-small 
size does not primarily dictate the antibacterial efficiency of the nanoclusters. Instead, 
the antibacterial actions are governed by an interplay of parameters such as surface 
ligand structures and the amount of released silver ions. The Ag NP stabilized with 
zwitterionic ligands bearing the sulfobetaine group is the most potent antibacterial 
agent among all the ligands tested. Furthermore, their antibacterial potency 
decreases with the increasing particle size, with 5.7 nm giving the highest inhibition 
potency. While this study has successfully demonstrated, for the first time, that the 
antibacterial properties of silver nanomaterials differ significantly when coated with 
different ligands, more studies will be required to investigate the mechanisms of their 
anti-bacterial actions. Considering the superior antibacterial activity of the zwitterionic 
Ag NPs, these nanoparticles may be utilized effectively as coating for various surgical 
instruments and medical equipment. 
 
- 206 - 
 
 
Chapter 6  
General Conclusions and Future Work Suggestions 
 
6.1 General Conclusions 
The first part of the thesis reports the development of a magnetic nanoparticle (MNP)-
based DNA sensing technology that is suitable for rapid and sensitive detection of 
disease biomarkers such as cancer related single nucleotide polymorphisms (SNPs). 
In Chapter 2, a PEGylated amphiphilic polymer encapsulated MNP-DNA probe has 
been successfully developed for ultrasensitive DNA detection. The amphiphilic 
polymer was prepared by grafting amino-PEGn-azide and amino-PEGn-OCH3 onto 
the hydrophobic PMAO polymer. This successfully introduced not only hydrophilic 
PEG segments but also functional azide groups for further conjugation with a capture 
DNA. The polymer encapsulated MNPs were stable over a wide pH range (pH 2-12), 
temperature (25 oC-70oC), and in aqueous media containing high salt contents and 
over prolonged storage of 6 months. The capture DNA was successfully conjugated 
to the MNP by copper-free “click” reaction between the MNP surface azide moiety 
and the DBCO-group of the capture DNA. Using a DNA sandwich strategy coupled 
with a ligation step to convert each ligated target-DNA into an active HRP enzyme, 
the MNP-DNA sensor could offer a limit of detection (LOD) of ~1.0 pM for the perfect-
match target-DNA. This sensor also offered excellent SNP discrimination between 
the full-match wild type target-DNA (T1) and cancer related SPNs with a 
discrimination ratio of ~14.3 and ~16.8 for T2 (cancer SNP-1) and T3 (cancer SNP-
2), respectively before background correction. Moreover, a more powerful signal 
amplification strategy was developed by tagging a polymer nanobead (PB) with 
thousands of copies of NAV-HRP. By coupling the MNP-based DNA sandwich assay 
with the poly-enzyme PB amplification, I have demonstrated the successful 
quantification of the unlabelled target-DNA down to 10 attomolar with a large linear 
dynamic range of 5 orders of magnitude. Furthermore, the biosensor was highly 
specific and could specifically detect 1 fM full-match target-DNA (T1) even in the 
presence of 100 fold excess of SNP targets (T2 or T3).  




In Chapter 3, a new MNP-DNA-enzyme based nanoprobe was designed for detection 
of nuclease (e.g. ECOR-I) and target-DNA. Firstly, amino modified Fe3O4-SiO2 core-
shell MNPs were prepared, characterised and modified by reacting with NHS-PEG22-
Azide ligand and further blocked with  NHS-PEG17-OCH3. The introduction of the 
azide moiety provided means for DNA bioconjugation though copper free click 
chemistry approach. Two different designs of the MNP-DNA-HRP probes were 
prepared. Specifically, Design-1 probe used the non-covalent neutravidin – biotin 
interaction to link  NAV- HRP to the MNP-DNA-Biotin. Design-2 probe, the maleimide 
labelled HRP was linked to the MNP-DNA-SH through the thiol-maleimide Michael 
addition. The hybridization of the target-DNA to the MNP-DNA-HRP formed a specific 
double-stranded DNA sequence that could be recognized and cleaved specifically by 
the endo-nuclease ECOR-I. This step released the HRP label into the solution for 
target quantification via an HRP catalysed colorimetric reaction. The Incubation 
temperature and time with ECOR-I was optimized. Using Design-2, the developed 
biosensor can detect ECOR-I at 10 U·mL-1 and can detect a perfectly matched target-
DNA at ~1 nM concentration. 
 
The second part of thesis presented the preliminary findings on the antimicrobial 
properties of Ag nanoparticles (NPs) and nanoclusters (NCs). First, a series of 
thioctic acid (TA)- based ligands with different terminal hydrophilic groups were 
synthesized and characterized in Chapter 5. These ligands were used to prepare the 
Ag nanomaterials by NaBH4 reduction of AgNO3 and the particle size could be 
controlled via the Ag:Ligand (Ag:L) ratio. The low Ag:L ratios (e.g. ≤ 1) resulted in the 
formation of Ag NCs and while Ag NPs were obtained at higher Ag:L ratios (e.g. >10). 
The optical properties (i.e. absorption and fluorescence), particle size, and surface 
charge of the Ag NCs and NPs were determined by UV-Vis and fluorescence 
spectroscopy, dynamic light scattering, zeta potential and agarose gel 
electrophoresis, respectively. The antibacterial efficacy of the Ag nanomaterials was 
determined by the minimum inhibitory concertation (MIC) assay. The Ag NC surface 
ligand was found to have a profound effect on its antibacterial potency: only those 
capped DHLA and DHLA-PEG-23-OCH3 could effectively inhibit the growth of S. 
aureus and E.coli. Interestingly, the Ag NPs exhibited significantly lower MIC values 
over their Ag NC counterparts, implying that the former posed better antibacterial 
properties. Among these, Ag NP-Zwitterion displayed the lowest MIC, suggesting 
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strong antimicrobial potency against the test organisms. Moreover, different sized Ag 
NP-Zwitterions were prepared and their antibacterial properties tested, revealing that 
Ag NP-Zwitterion of ~ 6 nm exhibited the most potent antimicrobial effect. This study 
provided a detailed investigation on how surface capping ligands affect the 
antimicrobial potency of both Ag NCs and Ag NPs and provided the fundamental 
evidence of the difference in antimicrobial activities between Ag NCs and Ag NPs.  
 
6.2 Future Work Suggestions 
1. In Chapter 2, a nanoparticle-DNA sensing technology suitable for fast and 
sensitive detection of a disease biomarker such as cancer related single 
nucleotide polymorphisms (SNPs) was developed. The biosensor demonstrated 
excellent sensitivity and selectivity in detecting cancer specific SNPs (KRAS 
codon 12/13) against wild-type non-cancerous target that makes it very attractive 
and potential useful for early cancer diagnosis. However, it still remained at the 
proof-of-principle stage where all sensing experiments were carried out using 
synthetic DNA samples rather than real clinical targets. Therefore, further efforts 
should be directed on the clinical validation of the developed biosensor.  
 
 
2. In Chapter 3, two MNP-DNAss-HRP probes were designed.  Future research 
should focus on improving the biosensor performance of the MNP-DNAds-HRP 
Design-2 probe. One possible solution is to use azide modified silica coated 
magnetic microparticle (MMP) to improve the magnetic retrieval for easier sample 
retrieval (e.g. removal of any uncut MMP-HRPs). In this study, the ECOR-I can 
cut any of the double stranded DNA which may or may not be linked with HRP. 
Thus, an alternative way of covalently linking the HRP to the MNP beads can also 
be taken into consideration. The  proposed method involve the labelling of HRP 
with NHS-PEG12-Maleimide followed by incubation with the DBCO-DNA-SH. The 
HRP-DNA-DBCO conjugates can be purified by gel electrophoresis before 
conjugation to the azide modified MMPs. In this manner, all of the DNA strands 
linked to the MMP will contain an HRP moiety, ensuring that all ECOR-I cutting 
events will release an HRP to the solution for signal amplification. As a result, this 
would improve the sensitivity in both ECOR-I and DNA detection. 
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Once the DNA strands are covalently linked with HRP is ensured, work can also 
be carried out to detect  cancer related microRNAs via a similar detection strategy. 
The target miRNA hybridizes with complementary DNA to form a DNA/RNA 
hetero-duplex, which can be specifically cleaved by duplex-specific nuclease 
(DSN), leading to the release of NAV-HRP in the solution. The supernatant can 
be collected to detect the target miRNA using the same HRP catalysed Amplex 
red- H2O2 assay. 
  
3. Chapter 5 presented some preliminary results on the antimicrobial properties of 
Ag NPs and Ag NCs coated with different DHLA-based functional ligands. Despite 
some encouraging results, more repeat measurements on the release of silver 
ions from the Ag nanomaterials is needed to ensure that the measured data are accurate. Further 
work on antibacterial characterizations are necessary to fully evaluate the 
antibacterial efficiency of the Ag nanomaterials. Work should also be carried out 
in the direction of elucidating the mechanisms of bacterial death. For example, 
TEM imaging  can be employed to provide evidences about the integrity of the 
bacterial membrane after incubation with the Ag nanomaterials. Moreover, 
fluorescence microscopy could be carried out to assess Ag NC uptake in bacterial 
cells, taking the full advantage of their fluorescence properties. The information 
gathered from these experiments will deepen our understanding on the difference 
of antibacterial activities between Ag NPs and Ag NCs.  
 
Vancomycin is considered the “antibiotic of last resort”383 due to its effectiveness 
in treating severe infections caused by gram positive bacteria.  Vancomycin acts 
as inhibitor for the cell-wall biosynthesis by binding to the bacterial cell wall D-Ala-
D-Ala terminal by forming five hydrogen bonds384 as shown in Figure 6-1 (A). The 
vancomycin binding effectively prevents the incorporation of N-acetylmuramic acid 
(NAM) and N-acetylglucoasmine (NAG)-peptide subunits from binding into the 
peptidoglycan (PG) layer 385.  The peptidoglycan matrix is essential for the bacteria 
to survive because it acts as an exoskeleton that prevents the bacteria from 
rupturing due to internal pressure385.  The emergence of vancomycin-resistant 
Enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA) has 
caused a major global health issue. The ineffectiveness of vancomycin against 
VRE and MRSA is due to the D-Ala-D-Lac bacterial cell wall terminal384 as shown 
in Figure 6-1 (B). The change of the D-Alanine to D-Lactate results in a deletion 
- 210 - 
 
 
of one hydrogen bond and leads to lower binding affinity for Vancomycin by ~1000 




Figure 6-1 (A) Vancomycin complex with N-Acyl-D-Ala-D-Ala and (B) 
Vancomycin complex with N-Acyl-D-Ala-D-Lactate. The hydrogen bond 
highlighted in yellow is lost in the D-Ala-D-Lactate complex resulting in less 
than one hydrogen bond which lead to a lower binding affinity. Reprinted 
from reference384 
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Improving the antibacterial efficiency of vancomycin can further be achieved 
developing novel polyvalent multifunctional nanoparticle (PMN) strategy to exploit 
multivalency and unique properties of silver nanoparticles to overcome multi-drug 
resistance in bacteria. This can be done by modifying existing antibiotics (e.g. 
vancomycin) with a thiotic acid-PEG-linker and conjugate multiple such ligands 
onto the  Ag NP as shown in Figure 6-2. The multivalent binding could greatly 
enhance the binding affinity of the Ag NP-(Vancomycin)n to the bacterial surface, 
thus, allowing it to overcome the vancomycin resistance in microorganisms386. 
 
 
Figure 6-2. Schematic illustration of Ag NP coated with vancomycin 
ligand. The ligand contains a thioctic acid group for binding to the Ag NP 
surface, ethylene glycol (EG) spacer group, and the vancomycin molecule. 
Multi- and polyvalent ligands are expected to exhibit more effective in 
interaction bacterial cells.  
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